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Abstract 
The present study aimed at the isolation and identification of 
bacteriocin-producing lactic acid bacteria, and the characterization of 
their bacteriocins. Forty-eight bacteriocinogenic isolates, belonging to 
the genera Lactobacillus, Leuconostoc, Enterococcus, Streptococcus, 
Pediococcus, Carnobacterium and Tetragenococcus, were obtained from 
various habitats, including food, animal and human sources.  
The inhibitory activities of the partially-purified, cell-free filter-
sterilized supernatants obtained from 9 selected isolates were not 
affected by the enzyme α-amylase, but were completely arrested by 
the proteolytic enzymes proteinase-k and pepsin, indicating their 
proteinaceous nature. The bacteriocins of some isolates were 
bacteriostatic in nature while those of other isolates were bactericidal. 
The molecular weights of all 9 bacteriocins in this study ranged 
between 3.0 and 5.0 kDa. The inhibitory activities exhibited by 
bacteriocin-containing supernatants obtained from these isolates 
were best expressed at pH 5.0, with a slight reduction at pH 7.0, but 
were much reduced at the pH values of 3.0 and 9.0. The activities 
were not much reduced on heating at 40 or 60 °C for 10, 30 or 60 
minutes, but showed varying degrees of decline at 100 °C, and were 
completely abolished by autoclaving (121 °C, 15 psi). The activities 
were not affected by storage at – 80 or – 20 °C for up to 4 weeks, but 
showed differential heat stability at 4 and 35 °C. Most of the 
supernatants exhibited a fairly wide spectrum of activity, being active 
against most of the indicator bacteria, which included Staphylococcus  
aureus, Enterococcus faecalis, Bacillus subtilis, Pseudomonas aeruginosa, 
Klebsiella pneumoniae, Proteus vulgaris and Escherichia coli.  
Study of the bacteriocin production kinetics revealed that bacteriocin 
production generally followed primary metabolite kinetics, being 
correlated to growth; and that some bacteriocins were produced as 
early as 4-6 hours of incubation, while others were produced at later 
 xii 
 
stages of growth. Optimum bacteriocin production, by most of the 
studied isolates, occurred at pH 5.0-5.5, 30-37 °C and incubation for 
24-48 hours, but there was a strong interaction of these three 
variables. In some cases the pH or temperature for production of 
highest inhibitory activity did not coincide with those for maximal 
growth.  
In conclusion, the present study has revealed the widespread 
occurrence of bacteriocinogeny among the locally isolated strains of 
lactic acid bacteria. The importance and practical application of this 
trait in food preservation and health promotion was highlighted. 
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 ﻤﺴﺘﺨﻠﺹ ﺍﻟﺒﺤﺙ
ﻭﺩﺭﺍﺴﺔ  ،ﺍﻟﻤﻨﺘﺠﺔ ﻟﻠﺒﻜﺘﻴﺭﻴﻭﺴﻴﻥ ﻭﺘﺼﻨﻴﻔﻬﺎﻫﺩﻓﺕ ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ ﺇﻟﻰ ﻋﺯل ﺒﻜﺘﻴﺭﻴﺎ ﺤﻤﺽ ﺍﻟﻼﻜﺘﻴﻙ 
ﻋﺯﻟﺔ ﻤﻥ ﻫﺫﻩ ﺍﻟﺒﻜﺘﻴﺭﻴﺎ ﻤﻥ ﻤﺼﺎﺩﺭ ﻏﺫﺍﺌﻴﺔ  84ﺘﻡ ﺍﻟﺤﺼﻭل ﻋﻠﻰ . ﺨﺼﺎﺌﺹ ﺒﻜﺘﻴﺭﻴﻭﺴﻴﻨﺎﺘﻬﺎ
 ,succocoretnE ,cotsonocueL ,sullicabotcaL ﻨﺎﺱﺠﻭﺤﻴﻭﺍﻨﻴﺔ ﻭﺒﺸﺭﻴﺔ ﻭﺘﻡ ﺘﺼﻨﻴﻔﻬﺎ ﻓﻲ ﺍﻷ
  .  succoconegarteTو  muiretcabonraC      ,succocoideP ,succocotpertS
 9ﻟﻡ ﻴﺘﺄﺜﺭ ﺍﻟﻨﺸﺎﻁ ﺍﻟﺘﻀﺎﺩﻱ ﻟﻠﻁﺎﻓﻲ ﺍﻟﺨﺎﻟﻲ ﻤﻥ ﺍﻟﺨﻼﻴﺎ ﻭﺍﻟﻤﻌﻘﻡ ﺒﺎﻟﺘﺭﺸﻴﺢ ﺍﻟﻤﺘﺤﺼل ﻋﻠﻴﻪ ﻤﻥ 
 ﺃﻭ ﺇﻨﺯﻴﻡ k-esanietorp ﺒﺈﻀﺎﻓﺔ ﺇﻨﺯﻴﻡ ﺃﻤﻴﻠﻴﺯ، ﻟﻜﻨﻪ ﺘﻭﻗﻑ ﻜﻠﻴﺎﹰ  ﻋﻨﺩ ﺇﻀﺎﻓﺔ ﺇﻨﺯﻴﻡ ﺓ،ﻋﺯﻻﺕ ﻤﻨﺘﻘﺎ
ﻜﺎﻨﺕ  .ﻟﻬﺫﻩ ﺍﻟﺒﻜﺘﻴﺭﻴﻭﺴﻴﻨﺎﺕ ﺍﻟﺒﺭﻭﺘﻴﻨﻴﺔ ﺔﻁﺒﻴﻌﺍﻟﻟﺒﺭﻭﺘﻴﻥ، ﻤﻤﺎ ﻴﺩﻟل ﻋﻠﻰ ﺍﻟﺤﺎﻟﹼﻴﻥ ﺍ nispep
ﺒﻜﺘﻴﺭﻴﻭﺴﻴﻨﺎﺕ ﺒﻌﺽ ﺍﻟﻌﺯﻻﺕ ﺫﺍﺕ ﻁﺒﻴﻌﺔ ﻜﺎﺒﺤﺔ ﻟﻨﻤﻭ ﺍﻟﺒﻜﺘﻴﺭﻴﺎ، ﺒﻴﻨﻤﺎ ﻜﺎﻥ ﺍﻟﺒﻌﺽ ﺍﻵﺨﺭ ﻗﺎﺘﻼﹰ، 
ﻜﺎﻥ ﺃﻓﻀل ﺘﻌﺒﻴﺭ ﻋﻥ  .ﻜﻴﻠﻭﺩﺍﻟﺘﻭﻥ 0.5ﻭ  0.3ﻭﺘﺭﺍﻭﺡ ﺍﻟﻭﺯﻥ ﺍﻟﺠﺯﻴﺌﻲ ﻟﻠﺒﻜﺘﻴﺭﻴﻭﺴﻴﻨﺎﺕ ﺍﻟﺘﺴﻊ ﺒﻴﻥ 
 ﺍﻷﺱﻥ ﻫﺫﻩ ﺍﻟﻌﺯﻻﺕ ﻋﻨﺩ ﺍﻟﻨﺸﺎﻁ ﺍﻟﺘﻀﺎﺩﻱ ﻟﻠﻁﺎﻓﻲ ﺍﻟﺤﺎﻭﻱ ﻟﻠﺒﻜﺘﻴﺭﻴﻭﺴﻴﻥ ﺍﻟﻤﺘﺤﺼل ﻋﻠﻴﻪ ﻤ
ﺍﻟﻬﻴﺩﺭﻭﺠﻴﻨﻴﺔ  ﺍﻷﺴﺱ، ﻟﻜﻨﻪ ﺍﻨﺨﻔﺽ ﻜﺜﻴﺭﺍﹰ ﻋﻨﺩ 0.7 ﺍﻷﺱﻭﺍﻨﺨﻔﺽ ﻗﻠﻴﻼﹰ ﻋﻨﺩ  0.5ﺍﻟﻬﻴﺩﺭﻭﺠﻴﻨﻲ 
 01 ﻤﺌﻭﻴﺔ ﻟﻔﺘﺭﺓ 06ﺃﻭ  04؛ ﻭﻟﻡ ﻴﺘﺄﺜﺭ ﻫﺫﺍ ﺍﻟﻨﺸﺎﻁ ﺍﻟﺘﻀﺎﺩﻱ ﺒﺎﻟﺘﺴﺨﻴﻥ ﻟﺩﺭﺠﺔ ﺤﺭﺍﺭﺓ 0.9ﻭ  0.3
ﻤﺌﻭﻴﺔ ، ﻭﺯﺍل   001ﺩﻗﻴﻘﺔ، ﻟﻜﻨﻪ ﺍﻨﺨﻔﺽ ﺒﺩﺭﺠﺎﺕ ﻤﺘﻔﺎﻭﺘﺔ ﻋﻨﺩ ﺍﻟﺘﺴﺨﻴﻥ ﻟﺩﺭﺠﺔ  06ﺃﻭ  03 ﺃﻭ
ﻟﻡ ﻴﺘﺄﺜﺭ ﻫﺫﺍ ﺍﻟﻨﺸﺎﻁ ﺍﻟﺘﻀﺎﺩﻱ ﺒﺎﻟﺘﺨﺯﻴﻥ ﻋﻨﺩ . ﻤﺌﻭﻴﺔ  ﺒﺎﻟﺘﺴﺨﻴﻥ ﻓﻲ ﺍﻷﻭﺘﻭﻜﻼﻑ 121ﺘﻤﺎﻤﺎﹰ ﻋﻨﺩ 
 4أﺳﺎﺑﻴﻊ ﻟﻜﻨﻪ أﻇﻬﺮ ﺗﻔﺎوﺗًﺎ ﻋﻨﺪ اﻟﺘﺨﺰﻳﻦ ﻓﻲ درﺟﺎت ﺣﺮارة  4م ﻟﻔﺘﺮة  – 02أو   - 08ﺩﺭﺠﺔ ﺤﺭﺍﺭﺓ 
ﻜﺎﻥ ﺍﻟﻨﺸﺎﻁ ﺍﻟﺘﻀﺎﺩﻱ ﻟﻠﻁﺎﻓﻲ ﺍﻟﻤﺘﺤﺼل ﻋﻠﻴﻪ ﻤﻥ ﺍﻟﻌﺯﻻﺕ ﺍﻟﺘﺴﻊ ﻭﺍﺴﻊ ﺍﻟﻤﺩﻯ، ﺤﻴﺙ  .ﻤﺌﻭﻴﺔ 53أو 
ﻭ  suerua  succocolyhpatS، ﻭﺍﻟﺘﻲ ﺸﻤﻠﺕ ﺔﺍﻟﺩﺍﻟﹼﺜﺒﻁ ﻨﻤﻭ ﻤﻌﻅﻡ ﺍﻷﻨﻭﺍﻉ ﺍﻟﺒﻜﺘﻴﺭﻴﺔ 
ﻭ  asonegurea sanomoduesPﻭ  silitbus sullicaBﻭ  silaceaf succocoretnE
  . iloc aihcirehcsEﻭ  siragluv suetorPﻭ  eainomuenp alleisbelK
ﺃﻅﻬﺭﺕ ﺩﺭﺍﺴﺔ ﺤﺭﻜﻴﺔ ﺇﻨﺘﺎﺝ ﺍﻟﺒﻜﺘﻴﺭﻴﻭﺴﻴﻥ ﺃﻥ ﺇﻨﺘﺎﺠﻪ ﺍﺘﹼﺒﻊ ﺤﺭﻜﻴﺔ ﺍﻟﻨﻭﺍﺘﺞ ﺍﻷﻴﻀﻴﺔ ﺍﻷﻭﻟﻴﺔ ﺤﻴﺙ 
ﻜﺎﻥ ﻤﺭﺘﺒﻁﺎﹰ ﺒﺎﻟﻨﻤﻭ، ﻭﺃﻥ ﺇﻨﺘﺎﺝ ﺒﻌﺽ ﻫﺫﻩ ﺍﻟﺒﻜﺘﻴﺭﻴﻭﺴﻴﻨﺎﺕ ﺘﻡ ﻓﻲ ﺍﻟﺴﺎﻋﺎﺕ ﺍﻻﺭﺒﻊ ﺃﻭ ﺍﻟﺴﺕ ﺍﻷﻭﻟﻰ 
ﻨﺘﺎﺝ ﺍﺤﺩﺙ ﺃﻓﻀل  .ﻤﺘﺄﺨﺭﺓ ﻤﻥ ﺍﻟﻨﻤﻭ ﻤﻥ ﺍﻟﺘﺤﻀﻴﻥ، ﺒﻴﻨﻤﺎ ﺘﺄﺨﺭ ﺇﻨﺘﺎﺝ ﺍﻟﺒﻌﺽ ﺍﻵﺨﺭ ﺇﻟﻰ ﻤﺭﺍﺤل
  vix
 
ﻡ  73- 03ﻭﺩﺭﺠﺔ ﺤﺭﺍﺭﺓ  5.5- 0.5ﺍﻟﻬﻴﺩﺭﻭﺠﻴﻨﻲ  ﺍﻷﺱﻟﻠﺒﻜﺘﻴﺭﻴﻭﺴﻴﻥ، ﻋﻨﺩ ﻤﻌﻅﻡ ﺍﻟﻌﺯﻻﺕ، ﻋﻨﺩ 
ﻓﻲ . ﺒﻴﻥ ﻫﺫﻩ ﺍﻟﻤﺘﻐﻴﺭﺍﺕ ﺍﻟﺜﻼﺙ ﻭﺍﻀﺢ ﺴﺎﻋﺔ، ﻟﻜﻥ ﻜﺎﻥ ﻫﻨﺎﻙ ﺘﻔﺎﻋٌل 84- 42ﺓ ﻭﺍﻟﺘﺤﻀﻴﻥ ﻟﻔﺘﺭ
ﻰ ﻹﻨﺘﺎﺝ ﺍﻟﺒﻜﺘﻴﺭﻴﻭﺴﻴﻥ ﻤﻊ ﺍﻟﻬﻴﺩﺭﻭﺠﻴﻨﻲ ﺃﻭ ﺩﺭﺠﺔ ﺍﻟﺤﺭﺍﺭﺓ ﺍﻟﻤﺜﻠ ﺍﻷﺱﺒﻌﺽ ﺍﻷﺤﻴﺎﻥ ﻟﻡ ﻴﺘﻁﺎﺒﻕ 
  .ﺍﻟﻬﻴﺩﺭﻭﺠﻴﻨﻲ ﺃﻭ ﺩﺭﺠﺔ ﺍﻟﺤﺭﺍﺭﺓ ﺍﻟﻤﺜﻠﻰ ﻟﻠﻨﻤﻭ ﺍﻷﺱ
ﺨﻠﺼﺕ ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ ﺇﻟﻰ ﺃﻥ ﺨﺎﺼﻴﺔ ﺍﻨﺘﺎﺝ ﺍﺍﻟﺒﻜﺘﻴﺭﻴﻭﺴﻴﻥ ﻭﺍﺴﻌﺔ ﺍﻻﻨﺘﺸﺎﺭ ﻭﺴﻁ ﺴﻼﻻﺕ ﺒﻜﺘﻴﺭﻴﺎ 
ﺤﻤﺽ ﺍﻟﻼﻜﺘﻴﻙ ﺍﻟﺘﻲ ﺘﻡ ﻋﺯﻟﻬﺎ ﻤﺤﻠﻴﺎﹰ، ﻭﻗﺩ ﺘﻡ ﺘﺴﻠﻴﻁ ﺍﻟﻀﻭﺀ ﻋﻠﻰ ﺃﻫﻤﻴﺔ  ﻫﺫﻩ ﺍﻟﺨﺎﺼﻴﺔ ﻭﺘﻁﺒﻴﻘﺎﺘﻬﺎ 
   .ﺤﻔﻅ ﺍﻷﻁﻌﻤﺔ ﻭﻓﻲ ﺘﺤﺴﻴﻥ ﺍﻟﺼﺤﺔﺍﻟﻌﻤﻠﻴﺔ ﻓﻲ 
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CHAPTER ONE 
INTRODUCTION 
Nowadays consumers are concerned about the synthetic chemicals 
used as preservatives in food, and there is an inclination toward 
less processed foods. However, untreated foods can harbour 
dangerous pathogens.  
The production of fermented foods has been one of the oldest food 
processing techniques known to man. Since the dawn of 
civilization, methods for the fermentation of milk, meat and 
vegetables have been known (Soomoro et al., 2002). Fermentations 
resulted in the development of foods with good keeping qualities 
and organoleptically desirable characteristics. These processes 
were artisan in nature, with no appreciation of the role of 
microorganisms. 
By the middle of the 19th century, the biological bases of 
fermentation were beginning to be understood. Research on the 
role of the main groups of microorganisms responsible for the 
fermentations, such as lactic acid bacteria, has advanced to the 
point of being able to understand, control and manipulate these 
microorganisms. 
Although the original and primary purpose of food fermentation 
is to achieve a preservation effect, the development of many 
effective preservation technologies has deemed the preservative 
role of these organisms no longer the most pressing requirement. 
However, many of these foods are manufactured for their unique 
flavour, aroma and texture. Even in this situation, the conditions 
generated by the fermentation are essential in ensuring the shelf-
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life and microbiological safety of the product in a more natural 
way. 
Lactic acid bacteria have an important role in the inhibition of 
food-borne pathogenic and spoilage microorganisms such as 
Listeria monocytogenes, Clostridium spp., Staphylococcus spp., 
Enterococcus faecalis and Bacillus spp. (Galves et al., 2008). Lactic 
acid bacteria display a wide range of antimicrobial activities. 
Among these activities the production of lactic acid and acetic acid 
are the most important. However, certain strains of lactic acid 
bacteria are further known to produce bioactive molecules such as 
ethanol, formic acid, fatty acids, hydrogen peroxide, diacetyl, 
reuterin and reutericyclin. Many strains also produce bacteriocins 
and bacteriocin-like molecules that display antibacterial activity 
(de Vuyst and Vandamme, 1994). 
In the last few decades, great emphasis has been placed on the 
isolation, characterization and mode of action of bacteriocins. 
Interestingly, bacteriocin screening efforts during the last decades 
have yielded a myriad of bacteriocins with different properties, 
target species and producer organisms (Ennahar et al., 1999). This 
has prompted researchers worldwide to pursue exploration in this 
area of natural and safe antimicrobial compounds. 
The present study aimed at: 
1/ Isolation and identification of bacteriocin-producing lactic acid 
bacteria from various sources in the local environment, 
2/ Study of the spectrum, mode of action and effects of various 
factors on the inhibitory activities of the isolates, 
3/ Characterization of the factor(s) responsible for the inhibition.   
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CHAPTER TWO 
 
LITERATURE     REVIEW 
 
2.1. Food safety and food preservation 
Ever since the time of Louis Pasteur and Robert Koch there has 
been scientific recognition of an essential need to control 
detrimental organisms in our environment. The discovery of 
penicillin by Alexander Fleming in 1929 opened the door for the 
use of antibiotics in the medical and veterinary fields to combat 
disease-causing organisms. As therapeutic antibiotics are 
prohibited for use in food, the utilization of antagonistic additives 
with preservative or antimicrobial properties has since become the 
preferred approach in food safety and preservation. 
 
Food safety has become an international concern. The preservation 
and safety of food can be looked at as a continuous fight against 
microorganisms spoiling the food or making it unsafe. In the 
United States of America, Mead et al. (1999) suggested that there 
are about 76 million cases of food-borne illness which result in 
about 5000 deaths each year. The US cost of food-borne illness 
associated with Campylobacter jejuni, Clostridium perfringens, 
Escherichia coli O157:H7, Listeria monocytogenes, Salmonella, 
Staphylococcus aureus and Toxoplasma gondii was estimated by 
Buzby and Roberts (1997) to be between 6.5 and 34.9 billion 
dollars. Moreover, the consumption of more food that has been 
formulated with chemical preservatives has increased consumer 
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concern and created a demand for more "natural" and "minimally 
processed" food (Cleveland et al., 2001). 
 
 In addition to food preservation, the rising incidence of resistance 
to most traditional antibiotics has prompted the implementation of 
numerous research programs aiming to explore the potential role 
that antimicrobial compounds (particularly bacteriocins) might 
have as replacements for traditional antibiotics. Other efforts focus 
on the use of antimicrobial toxins as food preservatives (Gillor et 
al., 2004). There is also an ever-increasing interest in the use of 
bacteria as biocontrol agents for the management of fungal and 
bacterial plant pathogens and, more recently, as the active agent in 
probiotic formulations. As a result, there has been a great interest 
in naturally produced antimicrobial agents, particularly those 
from lactic acid bacteria (LAB). 
 
Within the available arsenal of preservation techniques, scientists 
and the food industry are investigating the replacement of 
traditional food preservation techniques such as intense heat, 
salting, acidification, drying and chemical preservation by new 
preservation techniques due to increased consumer demand for 
tasty, nutritious and natural food products. 
 
The most investigated new preservation technologies are non-
thermal inactivation technologies such as high hydraulic pressure 
(HHP) (Patterson, 2000; Jofré   et al., 2009) and pulsed electric fields 
(PEF) (Gongora-Nieto et al., 2002), new packaging systems such as 
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the modified atmosphere packaging (MAP) (Young et al., 1988), 
natural antimicrobial compounds such as lactoperoxidases, 
lysozyme, saponins and flavonoids (Devlieghere et al., 2004) and 
biopreservation using both bacteriocinogenic and non-
bacteriocinogenic cultures (Holzapfel et al., 1995). In spite of the 
intensive research efforts and investments, very few of these new 
preservation methods have found wide scale application. 
 
Biopreservation refers to the extension of the shelf-life and 
improvement of the safety of food using microorganisms and/or 
their metabolites. It is well known that microorganisms produce 
an extraordinary array of microbial defense systems. Their defense 
arsenal includes classical antibiotics, metabolic byproducts such as 
lactic acid, lytic agents such as lysozymes, numerous exotoxins 
and bacteriocins. This biological arsenal is striking not only in its 
diversity, but also in its natural abundance which suggests an 
important role for these antimicrobial compounds. 
 
In biopreservation, storage life is extended and the safety of food 
products is enhanced by using natural or controlled microflora, 
mainly lactic acid bacteria (LAB) and/or their antibacterial 
products such as lactic acid, bacteriocins and other products 
(Hugas, 1998). 
 
2.2. Definition of bacteriocins 
Although not exactly defined, bacteriocins differ from classical 
antibiotics. They are a heterogenous group of microbial 
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antagonists that vary considerably in molecular weight, 
biochemical properties, range of sensitive hosts and mode of 
action. Bacteriocins were originally defined by Jacob et al. (1953) as 
bactericidal proteins characterized by their lethal action, a very 
narrow range of activity and adsorption to specific cell-envelope 
receptors. Klaenhammer (1988) redefined them as "proteins or 
protein complexes with bactericidal activity directed against 
species that are usually closely related to the producer bacterium".  
 
However, in the past few years many bacteriocins (or bacteriocin-
like compounds) have been reported and characterized (Stiles and 
Hastings et al., 1991; Lewus et al., 1991; Skytta et al., 1991). Many of 
these substances do not comply with the above definitions. It is 
true that bacteriocins are generally active against closely related 
species. However, the bacteriocin nicin (from Lactococcus lactis), 
and pediocin (from Pediococcus pentosaceus) are active against a 
broader range of food-borne pathogens (Mishra and Lambert, 
1996). Moreover, it was claimed that bacteriocins from Pediococcus 
damnosus and P. pentosaceus inhibit the growth of Gram-negative 
organisms such as Yersinia enterocolitica, Pseudomonas fragi and 
Pseudomonas fluorescens (Skytta et al., 1991). Other exceptions exist 
with regard to this classical definition of bacteriocins, including 
their bactericidal mode of action, the pure protein nature and the 
narrow spectrum of activity (Upreti and Hindsdill, 1975; Sobrino et 
al., 1991). For this reason, the term "bacteriocin-like substances" has 
been suggested for those antagonistic substances that do not fit the 
traditional definition of a bacteriocin. 
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It is however critical at this stage to make a distinction between 
bacteriocins and antibiotics. The two antimicrobials differ in 
synthesis, mode of action, antimicrobial spectrum, toxicity and 
resistance mechanisms. (Cleveland et al., 2001). Bacteriocins are 
proteins that are ribosomally synthesized, while antibiotics are 
secondary metabolites; the mode of action of bacteriocins is mostly 
pore formation, and in a few cases they possibly interfere with cell 
wall formation, while antibiotics affect cell membranes or 
intracellular targets. Bacteriocins have a narrow spectrum of 
activity (usually only active against closely related bacteria) while 
antibiotics vary in spectrum from narrow to very wide action. No 
toxicity has ever been associated with the use of bacteriocins 
whereas human toxicity or side effects have frequently been 
observed with the administration of antibiotics. 
 
2.3. History of bacteriocins 
 Bacteriocins are only one category of substances produced by 
bacteria (and other microorganisms) that are inhibitory to other 
bacteria. As early as 1676, Antonie van Leeuwenhoek documented 
antibiosis in which the product from one microorganism inhibited 
growth of another (Joerger et al., 2000). In 1877, Louis Pasteur 
reported the inhibitive effect of common urine bacteria on Bacillus 
anthracis (cited by Chen and Hoover, 2003). Gratia (1925) reported 
on a substance, which he called "principe V", produced by one 
strain of E. coli that inhibited another culture of E. coli. The term 
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"colicine" was coined by Gratia and Fredericq (1946, cited by 
Chavan and Riley, 2007). Jacob et al. (1953) used the term 
"bacteriocine" as a general term for highly specific antibacterial 
proteins. This was later changed to "bacteriocin".  
 
Subsequently, a vast body of literature was generated providing 
the very first, detailed information about the diverse family of 
colicin toxins (Fredericq 1957, 1963; Reeves 1965). It is largely the 
result of this effort that the colicins became a model system for 
many subsequent studies of bacteriocin biochemistry, genetics, 
ecology and evolution (Riley and Gordon, 1992; Riley, 1993; Braun 
et al., 1994; Gordon and Riley, 1999; Smarda and Obdrzalek, 2001; 
Riley and Wertz, 2002; Kirkup and Riley, 2004). These studies have 
provided insights into the origins and function of colicins, their 
closest relatives (colicin-like bacteriocins produced by members of 
the Enterobacteriaceae), and certain types of pyocins, which are 
bacteriocins produced by Pseudomonas spp. (Parret and De Mot, 
2000; Riley et al., 2001; Michel-Briand and Baysse, 2002) Today, 
however, the term bacteriocin is used to define a much larger 
group of ribosomally synthesized antimicrobial compounds. 
 
2.4. Ecology of bacteriocins 
Production of peptide or protein antibiotics is a near-universal 
feature in all three domains of life: Eukarya (eucaryocins), Bactria 
(bacteriocins) and Archaea (archaeocins). The frequency and 
diversity of bacteriocin production varies greatly among microbial 
populations. The dynamic interactions occurring among 
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bacteriocin-producing, sensitive and resistant cells are likely 
responsible for much of this variation. However, the frequency of 
bacteriocinogeny and the diversity of bacteriocins produced are 
also determined by the habitat in which the population lives and 
by the genomic background of the producing strains. As noted by 
Riley (1998), examination of bacteriocins in natural settings, such 
as Lactobacillus plantarum in green olive fermentation, E. coli in 
guinea pig conjunctivae, and Streptococcus mutans in the human 
oral cavity, have indicated that competitive advantage is 
substantially increased for bacteriocin-producing cells against 
bacteriocin-sensitive bacteria in the same environments.  
 
Bacteriocin induction usually occurs under stressful conditions 
such as nutrient depletion or overcrowding (Riley and Gordon, 
1999). The production by a cell of two or more bacteriocins is a 
common phenomenon (Riley and Chavan, 2007). 
 
Bacteriocins are found in almost every bacterial species examined 
to date, and within a species tens or even hundreds of different 
kinds of bacteriocins are present. They have been found in all 
major lineages of Bacteria, and more recently have been described 
as universally produced by some members of the Archaea. It is 
believed that some 99% of all bacteria may elaborate at least one 
bacteriocin (Tagg, 1992; Klaenhammer, 1993). 
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2.5. Nomenclature of bacteriocins 
The nomenclature of bacteriocins is in general subjective because it 
is based on the addition of the suffix "cin" to the genus or species 
name to indicate bacteriocinogenic capability. Some bactericins 
receive their names based on the producer species. Examples are 
plantaricin (produced by Lactobacillus plantarum), sakacin 
(produced by Lb. sakei) and caseicin (produced by Lb casei.). Other 
bacteriocins receive their names from the genus; examples are 
lactococcin (produced by Lactococcus lactis subsp. cremoris), lactocin 
(produced by Lb. curvatus) and pediocin (produced by Pediococcus 
acidilactici). Other bacteriocins produced by different Lactococcus 
species are generally called lactostrepsin, nicin and diplococcin. 
 
Gram-negative bacteria produce a wide variety of bacteriocins, 
which are specifically named after the genus (e.g., klebicins of 
Klebsiella pneumoniae) or species (e.g., colicins of E. coli, marcescins 
of Serratia marcescens, alveicins of Hafnia alvei and cloacins of 
Enterobacter cloacae) of the producing bacteria. The bacteriocins 
produced by Pseudomonads are generally referred to as pyocins. 
 
The most appropriate procedure, according to Tagg et al. (1976) 
would be to call antimicrobial substances that are still not 
completely characterized "bacteriocin-like inhibitory substances" 
(BLIS), and to reserve the designation "bacteriocin" to those 
showing a protein nature and bactericidal action. 
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The nomenclature of bacteriocins is sometimes contradictory, since 
the same species might produce more than one bacteriocin, and in 
this case they can be designated by the addition of consecutive 
letters of the alphabet. However, for a more precise specification of 
a bacteriocin, the name of the producer strain should be added 
(Eckner, 1992). 
 
Another factor that makes the nomenclature of bacteriocins even 
more difficult is that there are many examples of independently 
isolated bacteriocins which received different names but were later 
shown to be the same substance based on their amino acid 
sequences (de Lima and Filho, 2005). For that reason Jack et al. 
(1995) proposed that a new name should only be assigned to a 
bacteriocin after the amino acid sequence identification proves that 
it is indeed a new bacteriocin. 
 
2.6. Extraction, purification and characterization of bacteriocins 
Bacteriocins are usually secreted in the growth medium. The 
conditions of incubation, particularly temperature, pH and time, 
strongly influence the effective yield of active bacteriocin. When 
producer cells are grown in broth culture, bacteriocins can be 
harvested in the supernatant after centrifugation of the culture. 
Subsequent precipitation with ammonium sulphate is the 
favoured method of concentration from supernatants. 
 
Solvent extraction has also been reported (Piva and Headon, 1994; 
Messi et al., 2001). Extraction with polar solvents such as hexane, 
 
 
12 
 
di-ethyl ether or petroleum ether did not result in the removal of 
the bacteriocin produced at the aqueous phase to the organic 
phase, and chloroform extraction completely destroyed the 
bacteriocin activity (Ogunbanwo et al., 2003). When different 
alcohols such as n-propanol, n-butanol and iso-amyl alcohol were 
used in the extraction procedure, bacteriocins were removed from 
the aqueous phase and recovered from the organic phase (ten 
Brink et al., 1994). However, solvent extraction with butanol, 
ethanol or chloroform/methanol (Callewaert et al., 1999) is known 
to result in reduced activity (Carolissen-Mackay et al., 1997). Bailey 
and Hurst (1971) showed that biological activity of the bacteriocin 
nicin depended on the method of extraction, which in turn 
resulted in differences in the specific activity. 
 
The characterization of bacteriocins depends on their purification. 
A wide variety of different combinations of procedures were used 
with varying success in the purification of bacteriocins. 
Ammonium sulphate precipitation is a common first step in 
bacteriocin purification; followed by sequencial steps of different 
types of chromatography that varied widely between researhers, 
and included types such as ion-exchange chromatography, 
hydrophobic interaction and reverse-phase high performance 
liquid chromatography (HPLC) which were used to purify 
curvacin A, sakacin P, lactocin S and bavaricin A (Tichaczek et al., 
1992; Mørtvedt et al., 1991; Larsen et al., 1993). In other cases, 
ammonium sulphate precepitation was followed by gel 
permeation chromatography in the purification of helveticin J and 
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lactacin F (Joerger and Klaenhammer, 1986; Muriana and 
Klaenhammer, 1991). Acidocin A was purified by ammonium 
sulphate precepitation, cation-exchange and reverse phase 
chromatography (Kanatani et al., 1995). Plantaricin C was purified 
by ammonium sulphate precepitation, hydrophobic interaction 
chromatography, and cation-exchange chromatography (Gonzalez 
et al., 1994). A few protocols use dialysis to purify bacteriocins 
(Rammelsberg et al., 1990). 
 
Certain purification protocols keep the pH of the solvents used as 
low as 2 – 3 which is claimed to improve success of purification as 
bacteriocins are most stable at low pH values (Hastings et al.,1991; 
Carolissen-Mackay et al., 1997). 
 
Purification usually results in great increase in the specific activity, 
but with only a partial recovery (≈ 10-20%) of the initial activity 
 (Kanatani et al., 1995; Carolissen-Mackay et al., 1997). For this 
reason, antagonistic assays are usually conducted using crude 
extracts from the test isolates. Moreover, researchers such as ten 
Brink et al. (1994) showed that butanol extraction yielde almost 
pure (≥ 90%) bacteriocin, and that this simple procedure could be 
adopted for partial purification of bacteriocins. 
 
The characterization of bacteriocins depends on their purification. 
Bacteriocins are usually characterized by conducting size 
determinations (by mass spectrometric analysis), identification of 
the amino acid residues (by N-terminal sequencing), molecular 
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characterization (by isolation of total DNA, PCR amplification of 
the bacteriocin structural genes and their sequencing) and by 
assaying factors such as thermal and pH stability, enzyme 
inactivation and determination of the spectrum of activity. 
 
2.7. Mode of action of bacteriocins 
The mode of action of some bacteriocins has been identified, but 
for many others only a general description of whether the effect is 
bacteriostatic (Lewus et al., 1992; Thompson et al., 1996) or 
bactericidal (van Belkum et al., 1991; Venema et al., 1993; Enan et 
al., 1996) has been reported. While bacteriocins can work via 
different mechanisms to exert an antimicrobial effect, the cell 
envelope is generally the target. The initial electrostatic attraction 
between the target cell membrane and the bacteriocin peptide is 
thought to be the driving force for subsequent events (Deegan et 
al., 2006). 
 
Riley and Gordon (1999) noted that under conditions of stress, 
such as nutrient depletion or overcrowding, a small proportion of 
colicin-producer cells in a population are induced to produce 
colicin. This induction results in the rapid release of colicin into the 
environment, generally through lysis of the producing cell. 
Colicins bind to specific cell surface receptors and are transported 
into the cell. Having gained access, they kill the cell by one of three 
primary mechanisms: forming channels in the cytoplasmic 
membrane, degrading cellular DNA or inhibiting protein 
synthesis. 
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The mechanism by which bacteriocins exert their bactericidal or 
bacteriostatic effect has been well characterized in a number of 
cases. Bacteriocin activity is directed against the cell membrane, so 
bacteriocins must penetrate the cell wall of target bacteria before 
the antagonistic effect can occur. Because of fundamental 
differences in structure between the cell walls and membranes of 
the different Gram-types of bacteria, different mechanisms are 
involved in the initial interaction. For example, production of 
small peptides (e.g. staphylococcin produced by Staphylococcus 
aureus) that can easily penetrate the thick peptidoglycan layer of 
Gram-positive cell walls and attach to the membrane (frequently 
in a nonreceptor-mediated manner). Conversely, Gram-negative 
bacteria have a thinner peptidoglycan layer in their cell walls and 
may thus be antagonized by larger proteins (usually capable of 
receptor-mediated membrane attachment), for example, colicin 
produced by Escherichia coli. Although the structures of bacteriocin 
proteins differ greatly, the mechanism by which they achieve their 
bacteriostatic or bactericidal activity is remarkably similar. 
Depletion of the transmembrane proton motive force (PMF) is a 
common mechanism in lactic acid bacteria and many other 
bacteria (Bruno and Montville, 1993). Depletion of PMF by some 
bacteriocins (Hechard and Sahl, 2002) is thought to be mediated by 
the formation of pores or ion channels in the bacterial membrane. 
These channels may result in the free efflux of ions necessary for 
energy transduction. Since the PMF is integrally linked with 
energy generation by the cell, the net result is cellular death or 
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inhibition of growth (Dykes, 1995). Driessen et al. (1995) proposed 
a model where the mode of action of nicin was determined by the 
phospholipids composition of the membrane. 
 
 While many bacteriocins have been shown to induce pore 
formation in sensitive microorganisms, the mechanism of action of 
nisin has been studied in greatest detail. Nisin forms pores that 
disrupt the proton motive force and the pH equilibrium causing 
leakage of ions and hydrolysis of ATP resulting in cell death (Benz 
et al., 1991; Sahl et al., 1987). Other lantibiotics that also form pores 
include lacticin, subtilin and epidermin (Brotz et al., 1998, Kordel et 
al., 1988). However, it is recognized that nisin also interferes with 
cell wall biosynthesis (Linnett and Strominger, 1973; Reisinger et 
al., 1980), a phenomenon mediated by the ability of nisin to bind 
lipid II (a peptidoglycan precursor), thus inhibiting cell wall 
biosynthesis. This binding also contributes to the ability of nisin to 
form pores. The possession of dual mechanisms of action renders 
nisin active at nM concentrations (Breukink et al., 1999). 
 
 Class II bacteriocins also predominantly act by forming pores, 
causing dissipation of the cell membrane, depletion of intracellular 
ATP and leakage of amino acids and ions (Deegan et al., 2006). 
However, different bacteriocins differ in the details of the 
mechanism of membrane disruption. For instance, it was shown 
that while lactococcin G does not affect the pH gradient, it leads to 
dissipation of monovalent ions (Hauge et al., 1998; Moll et al., 
1999). 
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2.8. Immunity of producer cells 
Bacteriocin producers must protect themselves from the action of 
their bacteriocins. This is accomplished by the production of 
dedicated immunity proteins. The immunity of the cell 
synthesizing the bacteriocin to its product is a phenomenon that 
distinguishes bacteriocins from antibiotics. Genes coding for 
immunity proteins are in close genetic proximity to other 
bacteriocin structural and processing genes (Seigers and Entian, 
1995). It is common for the structural bacteriocin gene and the 
immunity gene to be located on the same operon and often next to 
each other (Nes et al., 1996; Klein and Entian, 1994). Colicin-
producer cells synthesize an immunity protein that provides 
protection against their own colicin. The immunity protein is 
encoded in the same gene cluster as the colicin protein and is 
constitutively expressed. It recognizes its own colicin, generally 
binds to the carboxy-terminal end of the colicin and inhibits cell 
killing. Resistance to colicin killing can evolve through alterations 
in the cell surface receptors that colicins use to gain access to the 
cell.  
 
 The immunity of lantibiotics was initially thought to be due to an 
immunity gene, such as nisI for nisin and spaI for subtilin, which 
code for NisI and SpaI immunity proteins, respectively. It appears, 
however, that immunity to these bacteriocins is the result of the 
influence of several proteins, since the deletions of other genes 
result in altered host immunity (Klein and Entian, 1994). Two 
types of immunity have been described for lantibiotics, one relying 
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on a specific immunity protein (LanI), while the other depends on 
a separate dedicated multi-component ABC transporter (LanEFG). 
Some lantibiotic cluster of genes has only the single immunity 
protein (Reis and Sahl, 1991), whereas others possess both 
mechanisms (Kuipers et al., 1993; Seigers and Entian, 1995). It is 
thought that the LanI protein antagonizes the action of lantibiotics, 
somehow preventing the insertion of the lantibiotic in the cell 
membrane, while it has been suggested that the ABC transporter 
works by expelling the antimicrobial peptide from the cell or the 
membrane (Peschel and Gotz, 1996; Stein et al., 2005).  
 
The phenomenon of immunity is simpler in the non-lantibiotics. 
Class II bacteriocins generally have a single-cell membrane-
associated immunity protein that provides complete immunity 
(Quadri et al., 1995). It is usually a basic protein between 50 and 
150 amino acid residues long that is loosely associated with the 
membrane. The lactococcin A immunity protein (LcnI) is by far the 
most studied one, yet the basic mechanism behind the immunity is 
still not understood (Nissen-Meyer et al., 1993; Venema et al., 1994, 
1995). Based on the study of carnobacteriocin B2 (Class IIa), it 
appears that the majority of the immunity protein is located inside 
the cytoplasm and that it may interact with another protein, 
perhaps a receptor, at the cytoplasmic side of the cell membrane 
(Quadri et al., 1995; Sprules et al., 2004). Evidence for the 
production of immunity proteins, consisting of 88 to 114 amino 
acids, by producers of class IIa bacteriocins has been reported 
(Ennahar et al., 2000). In addition to providing total immunity 
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against the producer's bacteriocin, these immunity proteins appear 
to also provide ‘partial' protection against other class IIa 
bacteriocins (Eijsink et al., 1998). 
 
As of yet, there is not a clear understanding of how immunity 
proteins serve to protect the producing organism from its 
bacteriocin. In a study on the immunity of Staphylococcus simulans 
to its bacteriocin (lysostaphin) Baba and Schneewind (1996) found 
that cells of Staphylococcus simulans (producer) were much less 
susceptible than Staphylococcus aureus (target) cells to bacteriocin-
mediated killing by a factor of 105. This was explained by both the 
target cell specificity of the mature bacteriotin for Staphylococcus 
aureus and the relative immunity of S. simulans to the secreted 
bacteriocin by an unknown mechanism. Target specificity of 
lysostaphin is encoded within the 92 residues of this bacteriocin, 
which are dispensable for enzymatic activity but are an absolute 
requirement for efficient target killing in mixed populations 
 
 
2.9. Spectrum of activity 
The range of inhibitory activity exhibited by bacteriocins can be 
either narrow or wide. According to the definition of 
Klaenhammer (1988) bacteriocins are active against closely related 
bacteria. However, a few exceptions to the rule (i.e. activity against 
Gram negative bacteria by LAB bacteriocins) have been reported. 
Examples are plantaricin 35d produced by Lactobacillus plantarum 
(Messi et al., 2001), bacteriocin ST151BR produced by Lactobacillus 
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pentosus ST151BR (Todorov and Dicks, 2004), a bacteriocin 
produced by Lactobacillus paracasei subsp. paracasei (Caridi, 2002); 
thermophylin, produced by Streptococcus thermophylus (Ivanova et 
al., 1998); bacteriocin AS-48, produced by Enterococcus faecalis 
(Abrionel et al., 2001); and a bacteriocin produced by Lactococcus 
lactis KCA2386 (Ko and Ahn, 2000). 
 
 Nisin (produced by L. lactis subsp. lactis) is active against Gram-
negative bacteria, but only when used at high concentrations 
(Mattic and Hirsch, 1947; Ogden and Tubb, 1985) or when the 
target cells have been pre-treated with EDTA (Stevens et al., 1991; 
1992). Moreover, some bacteriocins appear to inhibit potential 
food-borne pathogens, including Clostridium botulinum, Bacillus 
spp., Enterococcus faecalis, Listeria monocytogenes and Staphylococcus 
aureus (Barefoot and Klaenhammer, 1983; Daba et al., 1991; Delves-
Broughton, 1990; Tichaczek et al., 1992). 
 
The largest single collection of class II bacteriocins is type IIa 
(pediocin-like bacteriocins). The bactericidal activity of class IIa 
bacteriocins seems to be targeting primarily Listeria strains since all 
these peptides show antilisterial activity, but it is also commonly 
directed against several other Gram-positive bacteria. In fact, in 
addition to all species of Listeria, species belonging to the following 
genera have been reported to be sensitive to class IIa bacteriocins: 
Lactobacillus, Leuconostoc, Pediococcus, Lactococcus, Carnobacterium, 
Enterococcus, Micrococcus, Staphylococcus, Streptococcus, Clostridium, 
Bacillus and Brochothrix (Klaenhammer, 1993; Jack et al., 1995; 
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Cintas et al., 1997; Eijsink et al., 1998; Aymerich et al., 1996; Fimland 
et al., 1996; Larsen et al., 1993). Furthermore, some class IIa 
bacteriocins have been shown to prevent the outgrowth of spores 
and vegetative cells of Clostridium spp. (Bennik et al., 1998). 
However, the extent of sensitivity to class IIa bacteriocins seems to 
vary from species to species and from strain to strain. In other 
respects, class IIa bacteriocins display overall narrow inhibitory 
spectra, as compared to bacteriocins of other groups, such as nisin. 
 
LAB bacteriocins, in general, tend to be active against a wide range 
of mostly closely related Gram-positive bacteria (Jack et al., 1995). 
Gram-negative bacteria are generally insensitive to bacteriocins 
from LAB strains because of their outer membrane providing them 
with a permeability barrier. 
 
2.10. Classification of bacteriocins 
2.10.1. Bacteriocins of Gram-negative bacteria 
Gram-negative bacteria produce a wide variety of bacteriocins. 
Gram-negative bacteriocins can be divided into three groups based 
on size:  
(1) large colicin-like (25–80 kDa) bacteriocins,  
(2) the much smaller microcins (<10 kDa) and  
(3) phage tail-like bacteriocins, which are peptide assemblies 
(Chavan and Riley, 2007). 
 
Colicins are a diverse group of inducible high molecular weight 
bacteriocins produced by Escherichia coli. Other members of the 
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Enterobacteriaceae family also exhibit a high frequency (30–50%) 
of bacteriocin production (Pugsley, 1984). Many of these 
bacteriocins are similar to colicins in structure and function, and 
share many molecular, evolutionary and ecological features as 
well. They are often referred to as colicin-like bacteriocins (CLBs). 
Colicin-like large bacteriocins are high molecular weight proteins 
(Braun et al., 1994). CLBs have narrow killing spectra which are 
generally restricted to closely related species (Riley et al., 2003). 
Thus, klebicins, alveicins and marcescins have a killing range 
generally limited to Klebsiella, Hafnia and Serratia species, 
respectively (Riley et al., 2003). Bacteriocins produced by 
Pseudomonas spp. are named pyocins. 
 
 Microcins are low molecular weight peptides similar to the 
bacteriocins of Gram-positive bacteria (Baquero et al., 1978; 
Moreno et al., 2002). Seven microcins (B17, C7, H47, J25, L, M and 
V) were detected in E. coli isolated from humans and all, but one 
(J125), were detected in the isolates from mammals (Gordon et al., 
2007). 
 
Phage tail-like bacteriocins are nuclease- and protease-resistant 
rod-like particles resembling a bacteriophage tail, which kill 
sensitive cells by depolarization of the cell membrane (Stachura et 
al., 1969; Kuroda and Kagiyama, 1983; Nakayama et al., 2000; 
Strauch et al., 2003). These are proposed to be defective phages or 
to have originated from phages which evolved to function as 
bacteriocins. For example, pyocin R2 (produced by Pseudomonas 
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spp.) appears to be a remnant of phage P2, whereas pyocin F2 is 
similar to phage lambda (Nakayama et al., 2000). 
 
 
2.10.2. Bacteriocins of Gram-positive bacteria 
Gram-positive bacteria, and especially the lactic acid bacteria 
(LAB), produce a diverse array of bacteriocins. In 1947 Mattick and 
Hirsch (1947) observed that some of the inhibitory activity of 
lactococci toward other lactic acid bacteria (LAB) was due to a 
molecule characterized as a proteinaceous antimicrobial called 
“group N inhibitory substance”, or nisin. The spectacular 
commercial success of nisin stimulated a frenzy of prospecting 
activity for comparable inhibitory agents. In 1976, the first review 
specifically of the literature on bacteriocins of Gram-positive 
bacteria noted the beginnings of this exploration for nisin-like 
molecules produced by Gram-positive bacteria, and predicted 
growing interest in their potential applications to bacterial 
interference and food preservation (Tagg et al., 1976). Two decades 
later, the scientific literature in the bacteriocin field had become 
dominated by studies of the bacteriocins of LAB. 
 
 Klaenhammer (1993) attempted to classify the bacteriocins of LAB, 
by proposing four major classes: 
 
• Class I – post-translationally modified bacteriocins, i.e., the 
lantibiotics, 
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• Class II – small (<10 kDa) heat-stable membrane-active 
bacteriocins, 
• Class III – larger (>30 kDa) heat-labile bacteriocins, and  
• Class IV – complex bacteriocins composed of essential lipid 
or carbohydrate moieties in addition to protein. 
 
This provisional scheme was adopted by most investigators in the 
field, although it was repeatedly noted that sustainable evidence 
was lacking for bacteriocins fulfilling the criteria for group IV. 
Class II was further subdivided into IIa (anti-listerial peptides 
having the amino acid motif YGNGV/L in the N-terminal part of 
the peptide), IIb (two-component peptides), and IIc (thiol-activated 
peptides requiring reduced cysteine residues for activity). The 
lantibiotics have been generally divided into linear (type A) and 
globular (type B) subtypes. Class III, the small group of large cell 
wall-active bacteriocins, has typically either been dismissed or 
largely overlooked by those focused on the membrane-active small 
peptides.  
 
An alternative system of classification, based on sulfhydryl 
groups, has been proposed by Jack et al. (1995) in which 
bacteriocins containing lanthionine rings are called lantibiotics, 
those containing disulfide bonds are designated cystibiotics, and 
those requiring sulfhydryl groups are called thiobiotics. 
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Kemperman et al. (2003) recommended recognition of new group 
(class V) comprising ribosomally synthesized, non-modified head-
to-tail ligated cyclic antibacterial peptides.  
 
Cotter et al. (2005) have proposed a more radical modification to 
the Klaenhammer classification scheme for LAB bacteriocins, in 
which there are essentially only two principal categories: 
lantibiotics (class I) and non-lanthionine-containing bacteriocins 
(class II). The former class III (large heat-labile murein hydrolases) 
is renamed bacteriolysins, and class IV (the lipid- or carbohydrate-
containing bacteriocins) is withdrawn. It was further suggested 
that the Klaenhammer class II subgroups IIa (listeria-active 
peptides) and IIb (two-peptide bacteriocins) be retained, and that 
the class V (cyclic peptides) proposed by Kemperman et al. (2003) 
be reassigned as class IIc. Class IId was proposed to be a 
repository for all of the remaining linear non-lanthionine-
containing bacteriocins. 
 
Heng et al. (2007) proposed some further modifications in which: 
Klaenhammer’s class IV (chemically complex bacteriocins) is 
eliminated, and Class IIc (thiol-activated peptides) is also 
eliminated.  In contrast to Cotter et al. (2005), Class III (large 
bacteriocins) is retained, and is subdivided into IIIa 
(bacteriolysins) and IIIb (non-lytic proteins). The cyclic 
bacteriocins (class IIc) in this proposal constitute a newly defined 
class IV, and, as a consequence of upgrading the cyclic bacteriocins 
to their own class, type IIc becomes the repository for all 
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unmodified class II inhibitors other than the listeria-active (type 
IIa) and multi-component bacteriocins (type IIb). According to this 
last modification, bacteriocin classes (and sub-classes) will look as 
follows: 
 
 
 
 
2.10.3. Bacteriocins of the Archaea 
While bacteriocins and eucaryocins have been studied for decades, 
research in the field of archaeocins (halocins and sulfolobicins) is 
just emerging. In contrast to the wealth of studies for bacteriocins 
that began in 1925 (Gratia, 1925), the characterization of peptide 
and protein antibiotics from organisms that inhabit the domain 
Archaea (“archaeocins”) is only beginning (O’Connor and Shand 
2002). The first report of an archaeocin was published in 1982 
(Rodriguez-Valera et al., 1982). The term “archaeocin” was coined 
to distinguish peptide and protein antibiotics produced by Archaea 
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from those produced by members of the domain Bacteria (Price 
and Shand, 2000).  
 
To date, archaeocins have been characterized from only two 
phylogenetic groups: euryarchaeal extreme halophiles 
(haloarchaea) that produce “halocins” (O’Connor and Shand, 
2002), and the crenarchaeal genus Sulfolobus, an aerobic 
hyperthermophile that produces a “sulfolobicin” (Prangishvili et 
al., 2000). Although “production of halocin is a practically 
universal feature of archaeal halophilic rods” (Torreblanca et al., 
1994), and based upon antagonism studies (Meseguer et al., 1986; 
Torreblanca et al., 1994), there appear to be hundreds of different 
halocins, only a handful of which have been characterized. 
 
Returning to bacteriocins, the most extensively characterized of the 
Klaenhammer (1993) class l (lantibiotics) bacteriocins is nicin 
which enjoys a "generally recognized as safe" (GRAS) status for 
use as direct human food ingredient (Federal Register, 1988). It is 
produced by strains of Lactococcus lactis subsp. lactis and has a 
broad inhibitory spectrum against Gram-positive bacteria, 
including many pathogens, and can prevent outgrowth of Bacillus 
and Clostridium spores (Daeschel, 1989). 
 
Nisin is approved for use as a component of the preservation 
procedure for processed and fresh cheese, canned foods, processed 
vegetables and baby foods, in up to 50 countries (Hurst, 1981; 
Delves-Broughton, 1990; De Vuyst and Vandamme, 1994). Nisin 
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was assessed to be safe for food use by the Joint Food and 
Agriculture Organization/World Health Organization 
(FAO/WHO) Expert Committee on Food Additives in 1969 
(WHO, 1969). The FAO/WHO Codex Committee on milk and 
milk products accepted nisin as a food additive for processed 
cheese at a concentration of 12.5-mg pure nisin per kilogram 
product. This biopreservative was also added to the European 
food additive list where it was assigned the number E234 (EEC, 
1983).Typical levels that are used in foods range between 2.5 and 
100 ppm (Caplice and Fitzgerald, 1999). Lacticin 3147, produced by 
Lactococcus spp., is another member of this group. It is effective 
against a wide spectrum of Gram-positive bacteria (Ryan et al., 
1998; McAuliffe et al., 1999). 
 
The  Klaenhammer (1993) Class ll group of bacteriocins is the 
largest, of which subgroup lla is the most common. The group is 
composed of the pediocin-like bacteriocins with anti-listerial 
activity. Pediocins are produced by Pediococcus spp. They are not 
very effective against spores but are more effective than nisin in 
some food systems such as meat. Pediocin PA/AcH (Gonzalez and 
Kunka, 1987) is the prototype bacteriocin of this class, and 
pediocin-producing cultures are readily isolated from fermented 
foods (Kimura et al., 1997). Many studies report the inhibition of 
Listeria monocytogenes by pediocins or pediocin-producing cultures 
in fermented sausages (Berry et al., 1990; Luchansky et al., 1992). 
Sakacin 674 produced by Lactobacillus sake (Holck et al., 1994) has 
been shown to delay or inhibit growth of L. monocytogenes in 
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sausages whether added in purified form or in the form of a 
bacteriocin-producing culture (Abee et al., 1995).  
 
The Klaenhammer class three bacteriocins are not as well 
characterized. They are large (> 30 kDa) heat-labile proteins that 
are of lesser interest to food scientists (Chen and Hoover, 2003). 
Examples of these are. helveticin J and lactacins A and B. 
Helveticin J is produced by Lactobacillus helveticus 481 that inhibits 
closely related species and strains (Joerger and Klaenhammer, 
1986). Although its narrow spectrum and heat-instability limit its 
use as a food preservative, this bacteriocin may contribute to the 
host's ability to compete in complex dairy ecosystems. 
 
The class lV bacteriocins are complex and require carbohydrate or 
lipid moieties for activity (Klaenhammer, 1993). Examples are 
plantaricin S, lactocin 27, and leuconocin S (Carolissen-Mackay et 
al., 1997). 
 
The state of bacteriocin classification requires constant review as 
the knowledge concerning various aspects of bacteriocin research 
rapidly accumulates and it appears that the term bacteriocin has 
been used to cover a wide range of chemically diverse substances 
which do not necessarily have much in common. It thus appears 
that more time is needed for the creation of a definitive system of 
classification for bacteriocins. 
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2.11. Lactic acid bacteria as bacteriocin producers 
Lactic acid bacteria belong to a group of Gram positive 
facultatively anaerobic bacteria that excrete lactic acid as their 
main fermentation product into the culture medium. LAB are 
among the first organisms to be used in food manufacturing. 
Today, they play crucial roles in the manufacture of fermented 
milk products, vegetables and meat, as well as in the processing of 
other products such as wines. 
 
LABs have been studied extensively, and are now among the best 
characterized microorganisms with respect to their genetics, 
physiology and applications (Konings et al., 2000). The genomes of 
several LABs were being sequenced by 2002 (Klaenhammer et al., 
2002), and the first completely sequenced genome of the LAB 
Lactococcus lactis IL1403 was presented by Bolotin et al. (1999). The 
extensive knowledge gained from LABs has opened new 
possibilities for their application. Recently progress has been made 
in the construction of LABs with desired physiological traits that 
can be applied to optimize the food manufacturing processes or to 
manipulate the organoleptic properties (i.e. the overall flavour and 
texture) of the products (Venema et al., 1999). 
 
The taxonomy of LABs has received, and is still receiving, many 
changes and alterations. The application of molecular genetic 
techniques has resulted in significant changes in their taxonomic 
classification (Stiles and Holzapfel, 1997). The LABs of importance 
in foods belong to the genera: Carnobacterium, Enterococcus, 
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Lactobacillus, Leuconostoc, Lactococcus, Oenococcus, Pediococcus, 
Streptococcus, Tetragenococcus, Vagococcus and Weissella (Vandamme 
et al., 1996). The most common members of the group which are 
exploited for food uses include lactocococci for cheese 
manufacture, Streptococcus salivarius subsp. thermophilus for cheese 
and yoghurt manufacture and various members of the Lactobacillus 
genus for a variety of dairy, meat and vegetable fermentations. 
LAB are of economic importance to the food industry. They 
predominate the natural microflora of many fermented foods 
where they have a preservative (or spoilage) role. They also play 
an important role in the digestive tracts of humans and animals, 
especially in the young. 
 
LABs produce a variety of low molecular weight compounds 
including acids, alcohols, carbon dioxide, diacetyl, hydrogen 
peroxide and other metabolites. Many of these metabolites have a 
broad spectrum of activity. LABs are capable of inhibiting various 
microorganisms in a food environment and display crucial 
antimicrobial properties with respect to food preservation and 
safety. In addition, it has been shown that some strains of LAB 
possess interesting health-promoting properties; one of the 
characteristics of these probiotics is the potential to combat 
gastrointestinal pathogenic bacteria such as Helicobacter pylori, 
Escherichia coli, and Salmonella (De Vuyst and Leroy, 2007). 
   
Bacteriocins are produced by almost all genera of LABs (Konings 
et al., 2000). Since their inhibitory activity often encompasses food 
 
 
32 
 
spoilers and foodborne pathogens, lactic acid bacteria are 
interesting additives for foods in the frame of natural food 
preservation. Alternatively, the use of bacteriocinogenic lactic acid 
bacterium strains as novel starter or co-cultures in food 
fermentation processes could contribute to the competitiveness of 
the producer strains and to the prevention of food spoilage and 
contamination (Callewaert et al., 2000; Leroy et al., 2003). 
 
Although bacteriocins may be produced by Gram-positive and 
Gram-negative bacteria, those from lactic acid bacteria (LAB) are 
of particular interest due to their potential use in the food industry 
as natural safe food preservatives (Cleveland et al., 2001; 
O’Sullivan et al.,  2002). Much of the interest in the bacteriocin-
producing LABs is driven by their perceived potential practical 
applications either to food preservation or as probiotics. 
Bacteriocins synthesized by LABs have been isolated from foods 
such as meat and dairy products, which normally contain lactic 
acid bacteria. This means that they have unknowingly been 
consumed for centuries. Bacteriocins produced by LAB are a 
heterogenous group of peptides and proteins. Most LAB 
bacteriocins are small (< 6 kDa) cationic, heat-stable, membrane-
permeabilizing peptides. 
 
Rodriguez et al. (2000) confirmed the high incidence of bacteriocin-
producing lactic acid bacteria in raw milk samples, with inhibitory 
activity against both pathogenic and spoilage microorganisms. 
Nisin-producing isolates were the most abundant, but lacticin 481-
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producing lactococci and AS-48 producing enterococci have also 
been found at high proportion. Nicin, the best known LAB 
bacteriocin, has been repeatedly shown to be safe and effective for 
use in foods for more than 30 years (Delves-Broughton, 1990; Janes 
et al., 1999). Pediocin is another well-studied bacteriocin produced 
by Pediococcus spp. (Chikindas et al., 1995). Other LAB bacteriocins 
include, for instance, acidocin (from Lb. acidophilus), 
carnobacteriocin (from Carnobacterium piscicola), enterocin (from 
Enterococcus faecium), lacticin (from Lactococcus lactis), leucocin 
(from Leuconostoc gelidum) and pediocin (from Pediococcus 
acidilactici). 
 
2.12. Kinetics of bacteriocin production 
Bacteriocin production is very sensitive to environmental 
conditions, and it is usually proportional to growth. Drosinos et al 
(2006) found that bacteriocin production by Leuconostoc 
mesenteroides displayed primary metabolite kinetics as do most 
bacteriocins produced by lactic acid bacteria. They showed that 
bacteriocin production started during the early growth phase and 
was continued until the late active growth phase or the early 
stationary phase, during which maximum bacteriocin titer was 
observed. Verellen et al. (1998) showed that the bacteriocin 
plantaricin 423 is maximally produced at the optimum growth of 
the producing strain, suggesting that primary metabolite kinetics 
is followed. However, Delgado et al. (2007) showed that 
bacteriocin production by Lactobacillus plantarum followed mixed 
metabolite kinetics. 
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2.13. Optimization of bacteriocin production 
In order to make commercial production of bacteriocin 
economically feasible, optimization of yield during growth is 
necessary. Conditions for maximal bacteriocin production should 
correspond to those conditions that allow maximal cell density of 
the producer strain. Many researchers have found that bacteriocin 
production is usually proportional to growth (Moretro et al., 2000; 
Calderon-Santoyo et al., 2001), and that it shows primary 
metabolite kinetics (de Vuyst et al., 1998; Klostermaier et al., 1999; 
Moretro et al., 2000). Nevertheless, Delgado et al. (2005) stated that 
the correlation between growth and bacteriovin production was 
often weak. Therefore, the utilization of bacteriocin production for 
food preservation requires a better understanding of the 
relationship between growth and bacteriocin production. 
 
Bacteriocin titers change with environmental conditions, 
particularly temperature, pH and phase of growth (incubation 
time) as has been noticed by Delgado et al. (2005). Many authors 
reported higher bacteriocin production at temperatures 
suboptimal for growth (Krier et al., 1998; Moretro et al., 2000; 
Calderon-Santoyo et al., 2001). As for pH, maximum bacteriocin 
production has been reported mostly in the pH range of 4.5 – 5.5 
(Krier et al., 1998; Klostermaier et al., 1999; Calderon-Santoyo et  al., 
2001). 
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Given the high number of influencing factors, the best strategy for 
optimization of bacteriocin production seems to obtain maximum 
information with a minimum number of investigations. For this 
reason, response-surface methodology and mathematical models 
are usually used as tools to analyze results and predict behaviour 
(Myers and Montgomery, 2002; Delgado et al., 2007). 
 
2.14. Bacteriocin applications   
2.14.1. Applications in food preservation 
Food processors face a major challenge in an environment in 
which consumers demand safe foods with a long shelf-life, but 
also express a preference for minimally processed products that do 
not contain chemical preservatives. Bacteriocins are an attractive 
option that could provide at least part of the solution. They are 
produced by food-grade organisms, are usually heat stable and 
they can inhibit many of the pathogenic and spoilage organisms 
that cause problems in minimally processed foodstuffs. However, 
at present, only nisin and pediocin PA1/AcH have found 
widespread use in food. The form of nisin used most widely in 
food is Nisaplin (Danisco), which is a preparation that contains 
2.5% nisin with NaCl (77.5%) and non-fat dried milk (12% protein 
and 6% carbohydrate). The use of pediocin PA1 for food 
biopreservation has also been commercially exploited in the form 
of ALTA 2431 (Quest), which is based on LAB fermentates 
generated from a pediocin PA1-producing strain of Pediococcus 
acidilactici119. Its use is covered by several US and European 
patents (Ennahar et al., 2000; Rodriguez et al., 2002). 
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 When screening for a bacteriocin for food application, there are 
several important criteria: first, the producing strain should 
preferably have ‘generally recognized as safe’ (GRAS) status; and 
second, the bacteriocin should have a broad spectrum of inhibition 
that includes pathogens, or have activity against a particular 
pathogen. Third, the bacteriocin should be heat stable; fourth, have 
no associated health risks; fifth, its inclusion in products should 
lead to beneficial effects such as improved safety, quality and 
flavour; and sixth, it should have high specific activity (Holzapfel 
et al., 1995). 
 
 Bacteriocins have been shown to have potential in the 
biopreservation of meat, dairy products, canned food, fish, 
alcoholic beverages, salads, egg products, high-moisture bakery 
products, and fermented vegetables, either alone, in combination 
with other methods of preservation, or through their incorporation 
into packaging film/food surfaces (Ryan et al., 2002; Chen and 
Hoover, 2003). Bacteriocins can be introduced into food in at least 
three different ways: in fermented food, bacteriocins can be 
produced in situ by bacterial cultures that substitute for all or part 
of the starter culture; purified or semi-purified bacteriocins (for 
example, Nisaplin) can be added directly to food; or an ingredient 
based on a fermentate of a bacteriocin-producing strain can be 
used. 
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 Although bacteriocins with a wide spectrum of activity are 
usually the most sought after, other factors including pH optima, 
solubility and stability are as important and are major 
considerations in choosing a particular inhibitor for a particular 
food or target bacterium. Furthermore, the antimicrobial spectra of 
a variety of LAB bacteriocins can be extended to encompass Gram-
negative bacteria through their use in combination with measures 
that affect the integrity of the outer membrane, such as 
temperature shock, high pressure, chelators and eukaryotic 
antimicrobial peptides. There are natural and bioengineered 
bacteriocins (Yuan et al., 2004) that possess inherent activity 
against Gram-negative microorganisms. There is also a place for 
narrow-spectrum bacteriocins. This is true of fermented foods, in 
which contamination with L. monocytogenes is a problem. 
 
 Bacteriocins can also be used to promote quality, rather than 
simply to prevent spoilage or safety problems. For example, 
bacteriocins can be used to control non-starter flora such as non-
starter lactic acid bacteria (NSLAB) in cheese and wine. The 
uncontrolled growth of NSLAB can cause major economic losses 
owing to calcium lactate formation (Thomas and Crow, 1983), slit 
defects in cheeses, and the production of detrimental compounds 
in wine. Bacteriocin-producing starters have been found to 
significantly reduce these problems (Ryan et al., 1996; Daeschel et 
al., 1991). Bacteriocins can also be applied in other ways to enhance 
food fermentation. This has been shown during cheese 
manufacture in which bacteriocin production brings about the 
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controlled lysis of starter LAB, which results in the release of 
intracellular enzymes and ultimately accelerated ripening and 
even improved flavour (Oumer et al., 2001). 
 
 Although traditionally, the use of bacteriocins is associated with 
the preservation of food, in the near future food might merely act 
as a vehicle for the delivery of bacteriocin-producing probiotic 
bacteria. The production of antimicrobials by a probiotic culture is 
a desirable trait as they are thought to contribute to the inhibition 
of pathogenic bacteria in the gut (Dunne et al., 1999). Whereas 
bacteriocins in food are degraded by the proteolytic enzymes of 
the stomach, probiotic bacteria might be ingested in a form that 
facilitates gastric transit, allowing the in vivo production of the 
bacteriocin in the small or large intestine. It has also been 
speculated that recombinant probiotic strains that can be induced 
to produce bacteriolysin could be developed to facilitate the in vivo 
delivery of bioactive compounds that are produced intracellularly 
(Hickey et al. 2004). Unlike most other preservation methods such 
as heat or low pH, which are essentially indiscriminate in their 
antimicrobial effect, it is this ability to precisely influence the 
developing flora in an otherwise perishable food that leads 
scientists to describe the use of bacteriocins as a form of ‘innate 
immunity’ for food. It is unlikely that the use of bacteriocins in 
food will negatively impact the natural flora of either the human 
(or animal) host, or the environment. The low level of bacteriocins 
required to eliminate or reduce small numbers of pathogenic or 
spoilage organisms in food are unlikely to have an impact on more 
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microorganism-rich environments. In any event, bacteriocins are 
unlikely to survive gastric transit, as they are sensitive to 
proteolytic degradation. 
2.14.1.1. Application in the preservation of dairy products 
A problem often encountered in cheese production is the 
outgrowth of butyric acid bacteria such as Clostridium 
tyrobutyricum (Hurst,  1981). In dairy practice, nitrate is commonly 
added to cheesemilk to prevent outgrowth of Clostridium spores. 
Nitrate can be very efficiently replaced by nisin A. Outgrowth of 
C. tyrobutyricum spores in nitrate-free Gouda cheese was 
completely prevented when a nisin A producing strain was added 
to the starter culture (10% nisin A producers) (Hugenholtz and de 
Veer, 1991). Nisin A is also an effective inhibitor of Listeria 
monocytogenes, and growth of this pathogen was effectively 
inhibited by Nisin A in camembert cheese (Maisnier-Patin et al., 
1992) and in cottage cheese at 4°C as well as at 37°C (Benkerroum 
and Sandine, 1988). These results strongly suggest a potentially 
wider role for nisin A in the future preservation of a variety of 
dairy products. However, de Vos et al. (1993) suggested that nisin 
Z has better diffusion properties than nisin A in agar. Whether 
nisin Z will perform better as a biopreservative in certain foods 
than nisin A remains to be investigated. Nonetheless, the 
application of nisin in dairy foods which require lactic acid starter 
bacteria presents a problem because the wide spectrum of 
inhibition associated with nisin includes LAB themselves. 
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 An alternative approach which could be used to control specific 
pathogens or spoilage organisms in dairy foods is to employ 
bacteriocins with a highly specific activity range. The pediocin-
like, heat-stable bacteriocin enterocin 1146, which is produced by 
Enterococcus faecium DPC1146, is extremely active against L. 
monocytogenes at levels which have no effect on lactococcal starters 
(Parente and Hill, 1992a, b). E. faecium DPC1146 was used to 
ferment milk, which was subsequently pasteurized. The 
bacteriocin is produced in milk and is unaffected by the heat 
treatment. This milk was mixed with fresh milk and used for 
cheese making. The lactococcal starters were shown to grow and 
produce acid normally in this mix, whereas L. monocytogenes 
introduced in at the same time was rapidly killed. This inhibitory 
effect was not observed when a variant of DPC1146 was used 
which no longer produced the bacteriocin. 
 
2.14.1.2. Biopreservation of meat products 
Over the past three decades there has been an increasing research 
interest in the development of nitrite-free meat curing systems. 
The principle concern with the use of nitrite for curing of meat is 
the eventual formation of carcinogenic N-nitrosamines. Recently, 
attempts have been made to use nisin A as an alternative to nitrite. 
While the use of this bacteriocin alone was not successful, 
promising results were obtained when it was combined with 
reduced levels of nitrite: l00-250 ppm nisin A combined with 120 
ppm nitrite was more effective than the conventional 156 ppm 
nitrite (Shahidi, 1991). Nisin A is apparently not the bacteriocin of 
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choice for meat preservation in contrast to its effectiveness in dairy 
products. Bacteriocins produced by LAB associated with meat and 
meat fermentations such as Pediococcus, Leuconostoc, Carnobacterium 
and Lactobacillus spp. are likely to have much greater potential as 
meat preservatives (Stiles and Hastings, 1991; Shahidi, 1991; 
Yousef et al., 1991). 
 
 L. monocytogenes is a food-borne pathogen which is ubiquitous in 
the environment and can be isolated from foods of different origin, 
including meats and meat products. In meat processing plants it 
may be present in slicing rooms and eventually contaminate 
pasteurized products during slicing and packaging. Recently, 
some biopreservation techniques have been applied to meat 
products and these involved the introduction of a competitive 
microflora of LAB as protective cultures for chill-stored ready-to-
eat meat products, including bacteriocin producing LAB; and the 
use of purified anti-listerial bacteriocins added directly as natural 
food additives. 
 
 Lactobacillus sake Lb674, a mildly acidifying lactic acid bacterium 
originally isolated from meat, produces the bacteriocin sakacin 
674, which is identical to sakacin P and very similar to pediocin 
PA-1 (Krockel, 1992; Tichaczek et al., 1994; Holck et al., 1994). On 
vacuum-packed sliced Bologna-type sausage stored at + 7°C L. sake 
Lb674 produces detectable amounts of bacteriocin and delays or 
completely inhibits the growth of Listeria monocytogenes when 
inoculated at levels of at least l05-l06LAB/g, while bacteriocin 
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negative LAB had no inhibitory effect on growth of this organism. 
As a purified additive, sakacin 674 exhibits a marked initial effect 
against L. monocytogenes and reduces listerial growth during 
storage of this fermented meat product (Abee et al., 1995). Yousef 
et al. (1991) investigated the growth of L. monocytogenes in packed 
wiener sausage, a fully-cooked, cured meat product which is 
susceptible to contamination by L. monocytogenes before packaging. 
These researchers provided evidence that Pediococcus inoculants or 
purified pediocin can function as biopreservatives to eliminate 
Gram-positive pathogenic bacteria in cooked meats during 
extended refrigerated storage.  
 
2.14.1.3. Biopreservation of fish 
The application of nisin A in the preservation of fish products has 
been studied by Taylor et al. (1990) who showed that nisin 
treatment of cod, herring, and smoked mackerel fillets inoculated 
with Clostridium botulinum spores brought about a delay in toxin 
production of 5 days at 10°C but only by half a day at 26°C. Nisin 
treatment did not interfere with growth of non-pathogenic bacteria 
and in all samples botulinum toxin was formed before spoilage 
was evident. 
 
 The effects of nisin Z, carnocin U149 and bavaricin A on bacterial 
growth and shelf life of brined shrimp was evaluated and 
compared with those of a benzoate-sorbate solution and a control 
with no added preservatives (Einarsson and Lauzon, 1995). 
Typically this product contains 3 to 6% NaCl and sorbic and 
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benzoic acids in concentrations from 0.05 to l.0%, with pH ranging 
from 5 to 6, and is stored at temperatures from 0 to 6°C. The 
benzoate-sorbate solution preserves the brined shrimp for the 
whole storage period (59 days). The shelf life of the shrimp in the 
absence of preservatives was found to be 10 days. Carnocin U149 
had no influence on shelf life, while crude bavaricin A (a cell-free 
supernatant of Lactobacilh bauaricus MI 401) extended the shelf life 
to 16 days. Significantly, when crude or purified nisin Z was 
applied to the same material the shelf life was extended to 31 days. 
Such results offer clear perspectives for the biopreservation of 
certain fish products with nisin Z. 
 
 
2.14.2. Applications in Livestock  
Antibiotics have been used as therapeutic and prophylactic 
treatments to control a variety of bacterial infections in livestock 
for more than 50 years. Different types of antibiotics have also 
been fed at sub-therapeutic levels to cattle, poultry and swine to 
increase productivity and feed efficiency (McDermott et al., 2002). 
The emergence of antibiotic-resistance in many bacteria relevant 
for animal and public health stresses the importance of decreasing 
the use of antibiotics in animal production. The reduction of 
antibiotic application in livestock can only be achieved if 
alternative antimicrobial strategies are available. Among those 
interventions that have been investigated and applied are: 
immunization, diet modification, sanitation, feed additives, and 
probiotic bacteria (Callaway et al., 2004; Gillor et al., 2004). 
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One of the potential benefits of using bacteriocin-producing 
bacteria in livestock is the stimulation of animal productivity. 
However, due to the specificity of bacteriocins it is very unlikely 
that their growth enhancement would be similar to the effect of 
antibiotics. Several reports have indicated that ruminal 
microorganisms are capable of producing a variety of bacteriocins 
and some of these organisms have been isolated for an eventual 
application to manipulate the rumen environment (Russell and 
Mantovani, 2002). The application of bacteriocin-producing 
bacteria for improvements in productivity has not been limited to 
cattle, as several researchers have explored the use of probiotic 
strains capable of producing bacteriocins to increase the growth 
rate of swine (Rodriguez et al., 2003). In poultry, the use of 
bacteriocin-producing bacteria has been mainly targeted for the 
control Salmonella. 
 
The utilization of bacteriocin-producing bacteria as a pre-harvest 
food safety strategy is considered as one of the most viable 
interventions for reducing the gastrointestinal colonization of 
livestock by foodborne pathogens (Callaway et al., 2004; Gillor et 
al., 2004; Renter and Sargeant, 2002; Timmerman et al., 2004). 
 
The second major area of opportunity for bacteriocin application 
into animal production is the pre-harvest control of foodborne 
pathogens. The two bacteria of interest that will likely continue to 
be the main focus of future work will be Salmonella in different 
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animals and enterohemorrhagic E. coli (EHEC) in cattle. It was 
shown that the use of a single type of colicinogenic E. coli could 
reduce the fecal shedding of EHEC (Schamberger et al., 2004), but a 
mixture of strains capable of producing different colicins would 
likely accomplish a greater reduction (Schamberger and Diez-
Gonzalez, 2004). For Salmonella control it is likely that a similar 
strategy will be used. 
 
Moreover, the use of bacteriocins as growth promoters remains 
also a largely unexplored field with very interesting possibilities. 
Several researchers have explored the use of probiotic strains 
capable of producing bacteriocins to increase the growth rate of 
swine (Rodriguez et al., 2003). 
 
2.14.3. Clinical applications  
Although the role of LAB bacteriocins in food has been 
emphasized, the non-toxicity of lantibiotics and their activity 
against Gram-positive human and animal pathogens has led to 
research investigating their potential clinical application. In 
particular, the elucidation of the precise mechanism of action of 
some lantibiotics and their activity against multi-drug-resistant 
pathogens by a novel mechanism makes them an attractive option 
as possible therapeutic agents. The broad-spectrum lantibiotics 
could theoretically be of use against any clinical Gram-positive 
human or animal pathogen. For example, the two-peptide 
lantibiotic lacticin 3147 has in vitro activity against Staphylococcus 
aureus (including methicillin-resistant S. aureus (MRSA)), 
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enterococci, streptococci (Streptococcus pneumoniae, S. pyogenes, S. 
agalactiae, S. dysgalactiae, S. uberis, S. mutans), Clostridium botulinum, 
and Propionibacterium acnes 151. Initial in vivo trials with animal 
models have demonstrated the success of lantibiotics in treating 
infections caused by S. pneumoniae 152, and in preventing tooth 
decay and gingivitis (Blackburn and Goldstein, 1995). The use of 
nisin for human clinical applications has been licensed to 
Biosynexus Incorporated, and the use of an anti-mastitic nisin-
containing product has been licensed to Pfizer Animal Health 
(Cotter et al., 2005). Nisin is also used as an active agent in Wipe- 
Out (a teat wipe), and lacticin-3147-containing Teat Seals have 
been shown to prevent deliberate infection by mastitis-causing 
staphylococci and streptococci in animal challenge trials (Ryan et 
al., 1999). A strain that produces the lantibiotic mutacin 1140 is 
entering Phase I clinical trials in the US with a view to replacement 
therapy, and the dietary supplement BLIS K12 throat guard, which 
contains a Streptococcus salivarius that produces two lantibiotics 
salivaricin A2 and B, is sold in New Zealand as an inhibitor of the 
bacteria responsible for bad breath (Valdes-Stauber and Scherer, 
1994).  
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CHAPTER THREE 
MATERIALS AND METHODS 
 
 
3.1. Screening for bacteriocin-producing bacteria 
3.1.1. Sample collection and isolation of bacteria 
In the search for likely sources of bacteriocin-producing lactic acid 
bacteria, the following sources were tapped for isolation of these 
bacteria: fresh cow milk, human and camel milk, soured cow milk 
(rob), fermented beef (sharmout), fermented sorghum flour (ajeen), 
fermented fish (faseekh), human mouth wash, infant faeces and 
chicken faeces. Samples were aseptically taken from their sources, 
collected in sterile McCartney bottles, using sterile spatulae, and 
were immediately transferred to a refrigerator (≈ 4 ºC) till used for 
isolation of bacteria.  
 
For isolation of bacteria, 10g (or 10-ml, where appropriate) were 
aseptically taken from each sample, added to 90 ml of sterile 
peptone water (10 g peptone/liter distilled H2O), carefully shaken 
and were left to homogenize for I hour. Serial decimal dilutions 
(up to 10-3) were prepared from each sample homogenate, and 
were streaked onto duplicate plates of de Man, Rogosa, Sharpe 
(MRS) medium (de Man et al., 1960). Composition of the medium 
per liter: glucose 20g, beef extract 10.0 g; peptone 10.0 g; sodium 
acetate 5.0 g; yeast extract 5.0 g; ammonium citrate 2.0 g;  Na2HPO4 
2.0 g; tween-80 1.0 g; MgSO4.7H2O 0.1 g; MnSO4.5H2O 0.05 g; pH 
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6.5.  The medium was prepared by adding the  components to 
distilled water and the volume was brought to 1.0 liter, mixed 
thoroughly and gently heated to boiling, distributed into tubes and 
then autoclaved for 15 minutes at 15 psi pressure, 121°C.To this 
medium, 0.1% (w/v) nystatin had been added to inhibit fungal 
growth (Bowman, 2004). The streaked plates were incubated 
anaerobically at 30 ºC for 2-3 days using an anaerobic jar system 
(GasPak; BBL) with a gas-generating kit (Oxoid BR0038B ).  
 
After appearance of visible growth in the plates, well-isolated 
colonies with distinct cultural differences, such as differences in 
shape, colour or size, were carefully picked from each plate and 
were subsequently purified through repeated rounds of streaking 
on fresh MRS agar plates till pure colonies were obtained. These 
were maintained on MRS agar slopes in a refrigerator. The pure 
colonies obtained through this procedure were examined for their 
Gram reaction, catalase activity, and spore formation. Only those 
isolates conforming to the notable characteristics of lactic acid 
bacteria (viz. Gram-positive, catalase-negative, non-spore-forming 
rods or cocci) were selected to be tested for antagonistic activity 
against certain chosen indicator bacteria. Isolates showing 
inhibitory activity against selected indicator strains by the spot-on-
lawn method were selected for study. 
 
3.1.2. Gram staining procedure 
The procedure followed for Gram staining of the isolates was that 
described by Chaskes (2009). In this procedure, a heat-fixed smear 
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of the isolate was air-dried and treated with crystal violet solution 
(2 g crystal violet, 20 ml 95% ethyl alcohol, 0.8 g ammonium 
oxalate, and 100 ml distilled water) as a primary stain for one 
minute, and washed with tap water. The smear was then treated 
with Gram's iodine (2 g potassium iodide, 1 g iodine crystals, and 
100 ml distilled water) as a mordant for one minute and washed. 
The smear was then decolorized with a 1:1 mixture of acetone and 
ethanol for 10 seconds and washed with tap water. Finally, the 
preparation was counterstained with safranin (4.0 g safranin, 200 
mL 95% ethanol, and 800 mL distilled water.) for one minute and 
washed with tap water. 
 
3.1.3. Catalase test 
Catalase activity was tested by the method of Collee et al. (1992) in 
which a few drops of 3% hydrogen peroxide were added to a test 
tube of MRS agar containing a 24-hour old culture of each isolate. 
The release of gas bubbles (O2) indicated presence of a catalase 
enzyme. 
 
3.1.4. Endospore staining 
The procedure followed for endospore staining was that of 
Schaeffer and Fulton as described by Harley-Prescott (2002). 
Bacterial smears were air-dried and heat-fixed. The slides were 
placed on a rack over boiling water in a water bath. The slides 
were covered with a solution of malachite green stain and the stain 
was allowed to boil for 5-6 minutes, replacing the stain as it 
evaporates so that the slide remains saturated during heating. The 
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slides were cooled, rinsed with water for 30 seconds, 
counterstained with safranin for 60 to 90 seconds and rinsed again 
with water for 30 seconds. Slides were then blotted dry and 
examined under oil immersion. The endospores stain green; 
vegetative cells stain red. 
 
3.2. The target organisms (indicator bacteria) 
Four bacterial species were used as target organisms against which 
the antagonistic activities of the isolated test strains were assayed. 
The target organisms were kindly donated by the Central Public 
Health Laboratory, Khartoum State. The target organisms used 
were: 
       1/  Staphylococcus aureus ATCC43306 
       2/ Bacillus subtilis NCTC8236 
       3/ Enterococcus faecalis ATCC10541 
       4/ Escherichia coli ATCC25922 
 
3.3. Susceptibility testing 
The antagonistic activities of the isolates were initially screened by 
the direct spot-on-lawn method ((Lewus and Montville, 1991) 
which was afterwards confirmed by the well diffusion method 
(Barefoot and Klaenhammer, 1983). 
 
3.3.1. Screening by the spot-on-lawn method 
In this method, aliquots of about 20 µl of 48-hours old MRS broth 
cultures of each isolate were spotted on the surface of MRS agar 
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plates (1.5% agar) and were aerobically incubated at 35 ºC for 24 
hours. 
 
Twenty-four-hour old washed cells of indicator bacteria to be 
tested for sensitivity (previously grown in Nutrient Broth) were 
inoculated (0.2 mL of a 105 CFU/ml bacterial suspension) into 7.0 
ml of soft Nutrient Agar medium (0.8 % agar). The seeded soft 
agar was poured as an overlay onto the MRS plates on which the 
test bacteria had grown for 24 hours (deferred antagonism). The 
antagonism was detected by the formation of a growth inhibition 
halo of the indicator microorganism around bacteriocinogenic test 
isolates. Isolates producing clear inhibition zones were selected 
and used for further testing by the agar well-diffusion method. 
 
3.3.2. Testing by the well-diffusion method 
Strains showing promise of antagonistic activity against the 
indicator bacteria were further used for confirmation of their 
activity by the well-diffusion method. In this method cell-free 
supernatants of the test isolates were used to inhibit growth of the 
indicator bacteria. 
 
3.3.2.1. Preparation of the cell-free supernatants 
For the detection of antibacterial activity of each isolate, the 
method of Çadirci and Çitak (2005) was followed, in which a 24-
hour old culture of the isolate was used to inoculate MRS broth 
(2%) in test tubes. The inoculated tubes were incubated at 30 ºC for 
24, 48 and 72 hours without shaking. At the end of the incubation 
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period the broth culture was centrifuged at 6000 g for 15 minutes 
in a centrifuge (EBA20, Zentrifugen, Tuttlingen, Germany). The 
cell-free supernatants were carefully decanted, filter-sterilized 
(pore size 0.22 µm, Millipore Corporation) and were kept at 4 ºC 
for use in the determination of their antagonistic activities against 
the four indicator bacteria, and for their characterization. 
 
3.3.2.2. Conducting the well-diffusion test 
 Molten Nutrient Agar (N.A.) medium (45-48 ºC) was first seeded 
with washed cells of the indicator bacteria, and the inoculated 
medium was immediately poured into sterile Petri dishes. After 
solidification, the medium was allowed to dry for at least 30 
minutes at room temperature. Four wells of uniform diameter 
(about 5 mm) were aseptically bored in the agar using a sterile 
Pasteur pipette. Fifty µl of each of the three cell-free supernatants 
of each test isolate (24, 48 and 72 hours) were dispensed into three 
wells, while sterile MRS  agar medium was poured into the fourth 
well to serve as a control treatment. Plates were left to stand for at 
least five hours at room temperature to allow diffusion of the cell-
free extracts. The plates were then incubated inverted at 30 ºC for 
24 hours. At the end of the incubation period, diameters of the 
resulting inhibition zones, if any, were measured and the results 
recorded in mm. 
 
3.4. Identification of the isolated producer strains  
All isolates were identified to the generic level based on their 
physiological and biochemical characteristics making use of the 
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schemes provided by Schillinger and Lücke (1987), Wood and 
Holzapfel (1995), Stiles and Holzapfel (1997) and Axelsson (2004). 
The isolates were initially examined for Gram reaction, catalase 
reaction, cell morphology using phase contrast microscopy, gas 
production from glucose, hydrolysis of arginine, growth at pH 4.4 
and 9.6, salt tolerance and growth at 10 ºC and 45 ºC. 
 
Gas production from glucose was determined in modified MRS 
broth containing inverted Durham tubes with diammonium citrate 
replaced by ammonium sulphate (Samelis et al. 1994). Glucose was 
sterilized separately (115 ºC for 10 minutes) and was aseptically 
added to the medium. 
  
Hydrolysis of arginine was tested in MRS broth without glucose or 
meat extract but containing 0.3% arginine and 0.2% sodium citrate 
instead of ammonium citrate. Ammonia was detected using 
Nessler’s reagent (Schillinger and Lücke, 1989). 
 
Growth at pH 4.4 and 9.6 was tested in MRS broth adjusted to 
these pH values using 1N HCl. Salt tolerance was tested in MRS 
broth supplemented with 6.5% NaCl. Growth at different 
temperatures was observed in MRS broth after incubation for 3 
days at 15 ºC and 45 ºC. 
 
Identification of the selected 9 isolates to the species level was 
achieved by studying their biochemical profiles using the KB009 
HiCarbohydrate identification kit (HiMedia Laboratories, 
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Mumbai, India), which makes use of the patterns of utilization of 
35 sugars. 
 
 3.5. Characterization of the cell-free supernatants 
3.5.1. Partial purification of the supernatants 
For partial purification of the cell-free supernatants, a modification 
of the method of ten Brink et al. (1994) was adopted. In this method 
50 ml of n-butanol and 5 g NaCl were added to 50 ml of cell-free 
supernatant, mixed well and the mixture was centrifuged (6000 g) 
for 10 minutes. The n-butanol was then evaporated at 45 ºC and 
the residue was resuspended in 50 ml saline (9 g NaCl/liter). The 
partially purified supernatants were used for determination of 
their characteristics and their antagonistic activities against 
Staphylococcus aureus ATCC43306  
 
3.5.2. Sensitivity of the cell-free supernatants to enzymes 
Sensitivity of the cell-free supernatants to the effects of various 
enzymes, including proteolytic ones, was conducted as suggested 
by Barefoot and Klaenhammer (1983). 
 
3.5.2.1. Sensitivity to proteases 
Each of the 9 isolates was grown for 24 hours in MRS broth at 30 
ºC, the cells were harvested by centrifugation (6000 g for 15 
minutes), and the cell-free supernatant was adjusted to pH 6.0 
with 1N NaOH. One ml of the supernatant was incubated at 37 ºC 
for 1 hour in the presence of the proteolytic enzymes Proteinase K 
(Vivantis Technologies Sdn Bhd, Revongen Corporation Center, 
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Subang Taya, Selangor DE, Malaysia), and  Pepsin (Sigma). Both 
enzymes were added to a final concentration of 2.0 mg/ml. 
Enzyme-free, as well as cell-free, supernatants were used as 
controls. Residual antimicrobial activity was assayed by the agar 
well-diffusion method using Staphylococcus aureus ATCC 43306 as 
the indicator organism. 
 
3.5.2.2. Sensitivity to α-amylase 
As for the proteolytic enzymes, the effect of the enzyme α-amylase 
(Mühlenchemie GmbH, Ahrensburg, Germany) was assayed in I.0 
ml aliquots of the cell-free supernatants of the 9 test isolates, and 
the enzyme was added to a final concentration of 2.0 mg/ml. 
Residual activity was also assayed by the agar well-diffusion 
method using Staphylococcus aureus ATCC 43306 as the indicator 
organism. 
 
3.5.3. Production of the inhibitory factor during anaerobic 
growth 
The principal aim behind this investigation was the exclusion of 
any possible inhibition due to production of hydrogen peroxide 
(H2O2) by the test isolates using the technique of Lewus et al. 
(1991). In this investigation, each of the 9 test isolates was grown 
under anaerobic conditions for 24 hours at 35 ºC in an anaerobic 
jar system (GasPak; BBL). At the end of the incubation period, cell-
free supernatants were prepared as described in section 3.3.2.1 
above. Antagonistic activities of these supernatants against the 
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indicator bacterium Staphylococcus aureus ATCC43306 were 
assayed by the agar well-diffusion method. 
 
3.5.4. Heat stability 
The effect of heat on the supernatants was tested, as described by 
Ivanova et al. (1998), by heating cell-free supernatants to 40, 60 and 
100 ºC for 10, 30 and 60 minutes at each temperature in a water 
bath (No. Y22, Grant Instruments, Cambridge, UK). Moreover, an 
additional treatment of autoclaving the supernatant at 121 ºC for 
15 minutes was included. Cell-free supernatants were prepared as 
in section 3.3.2.1 above. The residual antagonistic activity was also 
assayed by the agar well-diffusion method using Staphylococcus 
aureus ATCC43306 as the indicator organism. 
 
3.5.5. Effect of different pH values 
Following the method of Ivanova et al. (1998), cell-free 
supernatants were adjusted to pH 3.0, 5.0, 7.0 and 9.0 with 1M HCl 
or 1M NaOH. The supernatants were then incubated at 37 ºC for 4 
hours after which the pH values were re-adjusted to 6.0 for all 
treatments. Inclusion of the pH values of 7.0 and 9.0 also served 
for exclusion of the effect of any acids that might be produced by 
the test isolates. Residual antimicrobial activity was determined by 
the agar well-diffusion method using Staphylococcus aureus 
ATCC43306 as the indicator organism. 
 
3.5.6. Effect of storage temperature 
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To test stability of the antagonistic activity of the cell-free extracts 
during storage, samples from the extracts prepared as described 
above were stored at -80, -20, 4 and 35 ºC for 4 weeks. The retained 
activity in all tests was determined using the agar well diffusion 
test utilizing Staphylococcus aureus ATCC43306 as the indicator 
organism. 
 
3.5.7. Molecular weight determination 
The active peptides in the cell-free filter-sterilized supernatants of 
seven of the bacterial isolates (K8, K11, N2, N3, M2, M3 and R1) 
were first precipitated by addition of 40% (w/v) ammonium 
sulfate, centrifuged (6000 rpm for 15 minutes), and their pellets 
and pellicles were concentrated and were used for protein 
separation by Tricine- sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (Tricine-SDS-PAGE) using 15% acrylamide. The 
gel electrode assembly was placed in a Mini PROTEAN II 
electrophoresis chamber (BIORAD), and the proteins were 
electrphoresed at 100 volts for about 2 hours. A protein molecular 
weight marker (MoBiTec GmbH) with a molecular weight range of 
14.0 to 116.0 KDa was included. 
 
Staining of the gels was done by covering with Coomassie blue 
stain overnight. The Coomassie blue stain was composed of 5.75 
ml glacial acetic acid, 0.157 g Coomassie blue dye, 28.5 ml 
methanol and 62.5 ml deionized water. 
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The preparations were destained with a buffer composed of 10.0 
ml glacial acetic acid, 50.0 ml methanol and 100 ml deionized 
water. 
 
 
3.6. Spectrum of activity of the cell-free supernatants 
The inhibitory activities of the cell-free supernatants of the nine 
chosen test isolates were tested against ten indicator bacteria, 
namely: Staphylococcus aureus ATCC43306, S. aureus ATCC25923, 
Bacillus subtilis NCTC8236, Enterococcus faecalis ATCC10541, 
Escherichia coli ATCC25922, E. coli (local isolate), Pseudomonas 
aeruginosa ATCC27853, Klebsiella pneumoniae ATCC10031, Proteus 
vulgaris ATCC6380 and Salmonella typhi ATCC1319106. Cell-free 
supernatants were prepared from the test strains as described 
above, and the antagonistic activities were determined by the well 
diffusion method in Nutrient Agar plates. Diameters of the 
inhibition zones were measured after 24 hours of incubation at 35 
ºC. 
 
3.7. Mode of action of the cell-free supernatants  
This investigation was carried out to find out whether the 
antagonistic effects of the cell-free supernatants were bactericidal 
or bacteriostatic in nature. The procedure followed was similar to 
that described by Faye et al. (2000) and Nilsen et al. (2003) in  which 
4-ml aliquots of the supernatant were added to 20 ml of a 
suspension of washed 24-hour old Staphylococcus aureus 
ATCC43306 cells (ca. 106 CFU/mL) in Nutrient Broth in a 
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McCartney bottle. S. aureus cells were first allowed to grow for 
four hours before addition of the supernatant and their optical 
densities (OD at 540 nm) were recorded at hourly intervals. 
Thenceforth, optical densities were measured at hourly intervals 
for five more hours. The investigation was terminated by plating 
aliquots on Nutrient Agar plates and incubating at 35 ºC for 24 
hours to determine presence or absence of growth.  
 
3.8. Kinetics of growth and bacteriocin production 
The kinetics of growth and production of the antagonistic activity 
was investigated in each of the 9 isolates that were used in the 
present study. The procedure followed was similar to that 
described by Ghrairi et al. (2008). MRS broth (250 ml) was 
inoculated with 1% of an overnight culture of each strain and 
incubated at 30 ºC without agitation under uncontrolled pH 
conditions. Samples were removed at hourly intervals up to 13 
hours, and then at 24, 25 and 26 hours from start of the 
investigation. Measurement of biomass by absorbance at 600 nm, 
pH measurement and determination of the antibacterial activity 
were carried out by assaying the effect of serial two-fold dilutions 
of cell-free culture supernatants on Staphylococcus aureus ATCC 
43306 by the well-diffusion method. The antimicrobial titer was 
expressed in arbitrary units (AU/ml). One arbitrary unit was 
defined as the reciprocal of the highest dilution showing a clear 
inhibition zone around the well (van Reenen et al., 1998). 
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3.9. Optimization of growth and bacteriocin production 
For determination of the effects of incubation temperature, pH of 
the growth medium and incubation period on the growth and 
bacteriocin production, three levels of each of these three factors 
were chosen and tested in a 3X3X3 factorial combination. The 
temperature levels were 25, 30 and 37 ºC, the pH values were 5.0, 
5.5 and 6.0 while the incubation times were 24, 48 and 72 hours. 
The test isolates were grown in MRS broth. Growth was measured 
as optical densities (O.D.) at the wavelength of 600 nm, and 
inhibitory activity was measured in arbitrary units (AU) as has 
been reported in section 3.8 above. The results were statistically 
analyzed using the SAS (1989) package to determine main and 
interaction effects due to the three variables. Separation of means 
was achieved by the Duncan Multiple Range test (Gomez and 
Gomez, 1984). 
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CHAPTER FOUR 
RESULTS 
 
4.1. Isolation of bacteriocinogenic bacteria  
This study was started by the isolation of a large number of promising 
bacteriocin-producing bacteria from a wide variety of samples, 48 of 
which produced promising inhibition zones against indicator bacteria. 
Table 1 lists these isolates, the sources wherefrom they were obtained, 
as well as their cell shape, Gram reaction, catalase activity, spore 
formation and capability of growth under anaerobic conditions. The 
sources of isolates included camel milk (8 isolates), fermented fish (4 
isolates), human breast milk (6 isolates), chicken faeces (11 isolates), 
fermented meat (4 isolates), infant faeces (6 isolates), fermented cow 
milk (one isolate), fermented sorghum flour (one isolate), human mouth 
flora (2 isolates) and fresh cow milk (5 isolates). 
Cell shapes included rods, cocci and tetrad-forming cocci. All isolates 
were Gram-positive, catalase–negative, non-spore formers capable of 
growth under anaerobic conditions. These are characteristics of lactic 
acid bacteria (Axelsson, 2004). 
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Table 1. Sources of isolates of lactic acid bacteria and some of their 
characteristics  
Serial Isolate 
code 
Source Cell shape Gram 
reaction 
Catalase 
activity 
Spore 
formation 
anaerobic 
growth 
1 C1 Camel milk C + - - + 
2 C2 '' R + - - + 
3 C3 '' R + - - + 
4 C4 '' C + - - + 
5 C5 '' R + - - + 
6 C6 '' R + - - + 
7 C7 '' R + - - + 
8 C8 '' R + - - + 
9 F1                        
Fermented 
fish 
C + - - + 
10 F2 '' T + - - + 
11 F3 '' T + - - + 
12 F4 '' T + - - + 
13 H1 Human milk C + - - + 
14 H2 '' C + - - + 
15 H3 '' R + - - + 
16 H4 '' R + - - + 
17 H5 '' C + - - + 
18 H6 '' C + - - + 
19 K1 Chicken 
faeces 
C + - - + 
20 K2 '' C + - - + 
21 K3 '' T + - - + 
22 K4 '' C  + - - + 
23 K5 '' T + - - + 
24 K6 '' R + - - + 
25 K7 '' R + - - + 
26 K8 '' R + - - + 
27 K9 '' R + - - + 
28 K10 '' C + - - + 
29 K11 '' R + - - + 
30 M1 Fermented 
meat 
T + - - + 
31 M2 '' T + - - + 
32 M3 '' R + - - + 
33 M4 '' R + - - + 
34 N1 Infant faeces C + - - + 
35 N2 '' T + - - + 
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R = rod shaped, C = cocci, T = Tetrad-forming cocci. 
 
 
 
 
 
 
 
 
Table 1 (cont.) 
 
Serial Isolate 
code 
Source Cell shape Gram 
reaction 
Catalase 
activity 
Spore 
formation 
anaerobic 
growth 
36 N3 Infant faeces C + - - + 
37 N4 '' R + - - + 
38 N5 '' C + - - + 
39 N6 '' C + - - + 
40 R1 Fermented 
cow milk 
R + - - + 
41 S1 Fermented 
sorghum 
flour 
T + - - + 
42 U1 Mouth flora C + - - + 
43 U2 ''         " R + - - + 
44 W1 Fresh cow 
milk 
R + - - + 
45 W3 ''         '' R + - - + 
46 W4 ''         '' C + - - + 
47 W5 ''          '' R + - - + 
48 W6 ''           '' C + - - + 
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4.2. Screening for antagonistic activity 
A preliminary screening of the possible antagonistic activity of the 
isolates against four indicator bacteria (Staphylococcus aureus ATCC 
43306, Bacillus subtilis NCTC 8236, Enterococcus faecalis ATCC 10541, and 
E. coli ATCC 25922) was carried out using crude cultures of the purified 
isolates. The screening was conducted by the spot-on-lawn method 
(Lewus et al. 1991). Table 2 shows that 48 of the isolates produced 
inhibition zones against all or some of the indicator strains, 23 of which 
showed antagonistic activity against all four indicator bacteria. Seven of 
these were obtained from camel milk, six from chicken faeces , four 
from fermented meat, two from fresh cow milk and one each from 
infant faeces, fermented cow milk and human breast milk. 
Most of the remaining isolates exhibited inhibitory activity against two 
or three of the indicator bacteria. However, isolate U1 was active only 
against Enterococcus faecalis and isolate H6 only against E. coli but its 
activity against Enterococcus faecalis was not determined. Plate 1 shows 
the inhibition zones produced by the isolates N2, M2 and R1 against the 
indicator bacterium Staphylococcus aureus ATCC 43306 by the spot-on-
lawn method. 
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Table 2. Screening for growth inhibition of four target organisms by the 
spot-on-lawn method. 
Serial Isolate 
code 
Inhibition zone against 
  Staph. 
aureus 
Bacillus 
subtilis 
Entero. 
faecalis 
E. coli 
1 C1 + + + + 
2 C2 + + + + 
3 C3 + + + + 
4 C4 + + + + 
5 C5 - + + + 
6 C6 + + + + 
7 C7 + + + + 
8 C8 + + + + 
9 F1 - + - + 
10 F2 - + + - 
11 F3 + + - - 
12 F4 - + + + 
13 H1 + + - + 
14 H2 + - + + 
15 H3 + + + + 
16 H4 - + + + 
17 H5 - - + + 
18 H6 - - ND + 
19 K1 + + + - 
20 K2 + + + - 
21 K3 + + - - 
22 K4 + + - + 
23 K5 + + + + 
24 K6 + + + + 
25 K7 + + + + 
26 K8 + + + + 
27 K9 + + + + 
28 K10 - + + + 
29 K11 + + + + 
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Table 2 (cont.) 
Serial Isolate 
code 
Inhibition zone against 
 
  Staph. 
aureus 
Bacillus 
subtilis 
Entero. 
faecalis 
E. coli 
30 M1 + + + + 
31 M2 + + + + 
32 M3 + + + + 
33 M4 + + + + 
34 N1 + + + - 
35 N2 + + + + 
36 N3 + + - + 
37 N4 + - + + 
38 N5 + - + + 
39 N6 + - + + 
40 R1 + + + + 
41 S1 + + + + 
42 U1 - - + - 
43 U2 - - + + 
44 W1 + + + + 
45 W3 - + - + 
46 W4 + + + + 
47 W5 + + + - 
48 W6 + + + - 
 
+ = positive inhibition, = Negative (no inhibition), ND = Not determined 
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Plate 1. Inhibition zones produced by isolates N2, M2 and R1 against 
Staph. aureus ATCC 43306 by the spot-on-lawn method. 
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4.2.1. Screening by the well-diffusion method   
More stringent screening of the 48 isolates was carried out by the well-
diffusion method (Barefoot and Klaenhammer 1983) using cell–free 
supernatants prepared from the test isolates. Supernatants were 
prepared from each strain after incubation for 24, 48 and 72 hours in 
MRS broth at 30 °C. 
Table 3 shows diameters of inhibition zones produced by the test 
isolates against the indicator bacterium Staphylococcus aureus 
ATCC43306. Forty-one isolates produced inhibition zones against 
Staphylococcus aureus. Most of these started producing inhibition zones 
as early as 24 hours of growth, but some of them (isolates C4, C5, F1, F2, 
and W3) required 48 hours of growth to exhibit inhibition activity. 
Production of the inhibitory activity, when determined, persisted to the 
end of the assay period (72 hours) except for isolate C5 which showed 
inhibitory activity only after 48 hours of growth but not after 24 or 72 
hours. 
 It is noteworthy that isolates N1 and N2, which were obtained from 
infant faeces, produced comparatively wide inhibition zones (more 
than 20 mm in diameter) against Staphylococcus aureus. Plate 2 shows 
inhibition of Staphylococcus aureus ATCC 43306 by isolate N1 using the 
well-diffusion method in MRS agar. 
As for the inhibition zones produced against the indicator bacterium   
Bacillus subtilis NCTC 8236, it can be seen that (Table 4) forty of the 48 
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Table 3. Inhibition zone diameters (mm) produced against Staphylococcus 
aureus ATCC 43306, by the agar well-diffusion method using 
supernatants obtained after 24, 48 or 72 hours of growth. 
Isolate code  24h 48 h 72 h 
C1 + ++ + 
C2 + + + 
C3 + + ++ 
C4 - + + 
C5 - + - 
C6 + ++ + 
C7 + + + 
C8 + + ++ 
F1 - ++ ND 
F2 - ++ ND 
F3 ++ - ND 
F4 - - - 
H1 ++ + + 
H2 + + + 
H3 + ++ ++ 
H4 - - - 
H5 - - - 
H6 - - - 
K1 + + + 
K2 ++ ++ ++ 
K3 + + + 
K4 ++ ++ ++ 
K5 ++ ++ ++ 
K6 + + + 
K7 + ++ ++ 
K8 ++ ++ ++ 
K9 + ++ ++ 
K10 - - - 
K11 ++ ++ ++ 
M1 ++ ++ ND 
M2 ++ ++ ND 
M3 ++ ++ ND 
M4 ++ ++ ND 
N1 +++ +++ +++ 
N2 +++ +++ +++ 
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Table 3 (cont.) 
Isolate code After 24h After 48h After 72h 
N3 ++ ++ ++ 
N4 + + + 
N5 + + + 
N6 + + + 
R1 ++ ++ ++ 
S1 ++ ++ ++ 
U1 - - - 
U2 - - - 
W1 + ++ ND 
W3 - + + 
W4 + + + 
W5 + + + 
W6 + ++ ++ 
       — = No inhibition, + = 6-12 mm, ++ = 13-19 mm, +++ = >20 mm,  
      ND = Not determined. 
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Plate 2. Inhibition of Staph. aureus ATCC 43306 by supernatants 
obtained from isolate N1 after 24, 48 and 72 hours of growth, using 
the agar well-diffusion method. 
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Table 4. Inhibition zone diameters (mm) produced against Bacillus 
subtilis NCTC 8236, by the agar well-diffusion method using 
supernatants obtained after 24, 48 or 72 hours of growth.  
Isolate code 24h 48h 72h 
C1 - + + 
C2 + + + 
C3 + + + 
C4 + + + 
C5 + ++ + 
C6 - + + 
C7 + + + 
C8 - + + 
F1 - + + 
F2 + ++ ++ 
F3 - + + 
F4 - + + 
H1 + + + 
H2 - - - 
H3 + ++ ++ 
H4 + + + 
H5 - - - 
H6 - - - 
K1 - + + 
K2 ++ + + 
K3 + ++ + 
K4 + + ++ 
K5 ++ ++ ++ 
K6 ++ ++ ++ 
K7 + + + 
K8 ++ ++ + 
K9 + ++ ++ 
K10 - + ++ 
K11 + ++ ++ 
M1 + ++ ND 
M2 ++ ++ ND 
M3 ++ ++ ND 
M4 + + ND 
N1 ++ ++ + 
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Table 4 (cont.) 
Isolate code 24h 48h 72h 
N2 ++ ++ ++ 
N3 ++ ND ++ 
N4 - - - 
N5 - - - 
N6 - - - 
R1 ++ ++ ++ 
S1 ++ ++ ND 
U1 - - - 
U2 - - - 
W1 + ++ ++ 
W3 - + + 
W4 + + + 
W5 + + + 
W6 + ++ ++ 
 
       - = No inhibition, + = 6-12 mm, ++ = 13-19 mm, +++ = >20 mm 
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isolates succeeded in inhibiting the growth of this indicator bacterium. 
The 8 isolates that failed to produce inhibition zones were obtained 
from human breast milk, infant faeces and human mouth flora. 
Most of the inhibitory isolates produced persistent inhibition whether 
grown for 24, 48 or 72 hours, and only a few of them (e.g. isolates C6, 
C8, F1, F3 and F4) exhibited inhibition after 48 and 72 hours but not 
after 24 hours of growth. It should also be noted that isolates N1, N2, 
N3 (from infant faeces), R1 (from fermented milk) and S1 (from 
fermented sorghum flour) produced comparatively wide inhibition 
zones (13-19 mm diameters) all through the assay period. Plate 3 shows 
inhibition of Bacillus subtilis NCTC 8236 by the cell-free supernatant 
obtained from isolate N3 in MRS agar.  
Table 5 shows that 40 isolates produced inhibition zones against 
Enterococccus faecalis ATCC 1054.  Six of the remaining 8 isolates failed 
to inhibit growth of this test bacterium while the inhibitory action of the 
remaining two isolates (W5 and W6) was not determined.   
The inhibitory activity of 4 of the 40 active isolates (C1, C3, C6 and C7), 
all of which were obtained from camel milk, was evident after 48 and 72 
hours but not after 24 hours, while that of the remaining 36 isolates was 
persistent all through  the assay period  (24, 48 and 72 hours). The most 
prominent inhibitory activity was produced by the isolates K8, M2, R1 
and S1 which produced inhibition zones between 13 and 19 mm in 
diameters. Plate 4 shows inhibition of (a) Bacillus subtilis, (b) Staph.  
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Table 5. Inhibition zone diameters (mm) produced against Enterococcus 
faecalis ATCC 1054, by the agar well-diffusion method using 
supernatants obtained after 24, 48 or 72 hours of growth. 
Isolate code  24h  48h  72h 
C1 - + + 
C2 + + + 
C3 - + - 
C4 + + + 
C5 + + + 
C6 - + + 
C7 - + + 
C8 + + + 
F1 - - - 
F2 + + + 
F3 - - - 
F4 + + + 
H1 - - - 
H2 + + + 
H3 + + + 
H4 + + + 
H5 + + + 
H6 ND ND ND 
K1 + + + 
K2 + + + 
K3 - - - 
K4 - - - 
K5 + + + 
K6 + + + 
K7 + + + 
K8 ++ ++ ++ 
K9 + + + 
K10 + + + 
K11 + + + 
M1 ++ ++ ++ 
M2 + + + 
M3 + ++ ND 
M4 + + + 
N1 + + + 
N2 + + + 
 
 
 
 77 
 
Table 5 (cont.) 
Isolate code  24h  48h  72h 
N3 - - - 
N4 + + + 
N5 + + + 
N6 + + + 
R1 ++ ++ . ++ 
S1 + ++ ++ 
U1 + + + 
U2 + + + 
W1 + + + 
W3 + + + 
W4 + + + 
W5 ND ND ND 
W6 ND ND ND 
 
— = No inhibition, + = 6-12 mm, ++ = 13-19 mm, +++ = >20 mm, 
ND = Not determined. 
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aureus and (c) Enterococccus faecalis by supernatants obtained from 
isolate N2 after 24, 48 and 72 hours of growth in MRS agar . 
With regard to the inhibition zones produced by the test isolates against 
E. coli ATCC 25922, it can be depicted that 39 of the isolates could 
inhibit growth of E. coli, while 8 strains could not produce any 
inhibition zones, and the inhibition by isolate K2 was not determined 
against this indicator bacterium (Table 6). 
It is noteworthy that all the inhibitory isolates produced persistent 
inhibition throughout the test period (24-72 hours) except isolate N4 
which produced inhibition zones after 48 and 72 hours but not after 24 
hours of growth, and isolate W1 which exhibited inhibition against E. 
coli after 24 and 48 hours of growth but not after 72 hours. Plate 5 shows 
inhibition of E. coli ATCC 25922 by cell-free supernatant obtained from 
isolate W1. 
The most prominent inhibition zones were produced by the isolates M2, 
M3, R1 and S1. It is also to be noted that isolate N1, which produced 
prominent inhibition against Staphylococcus aureus and Bacillus subtilis 
and moderate inhibition against Enterococccus faecalis, failed to show 
any inhibition against E. coli. 
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                          a                                          b                                          c 
Plate 4.  Inhibition  of  (a)  Bacillus  subtilis,  (b)  Staph.  aureus  and  (c) 
Enterococcus faecalis by supernatants obtained from isolate N2 after 24, 48 
and 72 hours of growth. 
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Table 6. Inhibition zone diameters (mm) produced against E. coli 
ATCC 25922, by the agar well-diffusion method using supernatants 
obtained after 24, 48 or 72 hours of growth.    
Isolate code After 24h After 48h After 72h 
C1 + + + 
C2 + + + 
C3 + ++ + 
C4 + + + 
C5 + ++ + 
C6 + + + 
C7 + + + 
C8 + + + 
F1 + + + 
F2 - - - 
F3 - - - 
F4 + + + 
H1 + ++ + 
H2 + + + 
H3 + + + 
H4 + + + 
H5 + + + 
H6 + + + 
K1 - - - 
K2 ND ND ND 
K3 - - - 
K4 + + + 
K5 + + + 
K6 + + + 
K7 + + + 
K8 + + + 
K9 + + + 
K10 + + + 
K11 + + + 
M1 + ++ ++ 
M2 ++ ++ ++ 
M3 ++ ++ ++ 
M4 + + + 
N1 - - - 
N2 + + + 
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Table 6 (cont.) 
Isolate code  24h  48h  72h 
N3 + + + 
N4 - + + 
N5 + + + 
N6 + + + 
R1 ++ ++ ++ 
S1 + ++ ++ 
U1 - - - 
U2 + + + 
W1 + + - 
W3 - - - 
W4 + + + 
W5 + + + 
W6 + + + 
 
— = No inhibition, + = 6-12 mm, ++ = 13-19 mm, +++ = >20 mm, 
ND = Not determined. 
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4.3. Generic identification of the 48 isolates 
The 48 bacterial isolates that exhibited positive inhibitory activity 
against the four indicator bacteria were identified to the generic level 
following the scheme of Schillinger and Lüke (1987). The isolates were 
first divided into two groups based on the production of gas from the 
fermentation of glucose: 22 of the isolates were heterofermentative 
(producing gas from glucose), while the remaining 26 isolates were 
homofermentative (not producing gas from glucose, presumably 
producing acid only) as is shown in Table 7. Further characterization of 
the isolates was carried out making use of cell shape, growth at 10 °C 
and 45 °C, growth at the pH values of 4.4 and 9.6 and growth in the 
presence of 6.5% NaCl. 
It can be seen from Table 7 that 13 of the 22 heterofermentative isolates 
(isolates C3, C5, C6, C7, C8, H3, H4, K6, K7, K8, K9, U2 and W5) could 
be assigned to the genus Lactobacillus and nine (C4, H2, H5, H7, K10, 
N1, U1, W4 and W6) to the genus Leuconostoc. Seven of the eight rod-
shaped homofermentative isolates (K11, M3, M4, N4, R1, W1 and W3) 
belonged to the genus Lactobacillus (homofermentative lactobacilli), and 
one (C2) to the genus Carnobacterium. Eight of the nine 
homofermentative non-tetrad-forming cocci (C1, F1, H1, K1, K2, K4, 
N3, and N6) were assigned to the genus Enterococcus, and one (N5) to 
the genus Streptococcus. Of the nine tetrad-forming cocci, seven (F2, K3, 
K5, M1, M2, N2 and S1) were assigned to the genus Pediococcus and two 
(F3 and F4) to the genus Tetragenococcus. 
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Table 7. Growth (Optical densities) at 10 ºC and 45 ºC; at pH 4.4 and 
9.6; in 6.5% NaCl; CO2 production, and presumptive genera of the test 
isolates 
serial 
 
 
Isolate 
code 
Gas  
from 
glucose 
Cell 
shape 
Growth at 
 
10ºC   
45ºC 
 
 
Growth at 
pH 
4.4         9.6  
Growth 
in 6.5% 
NaCl 
NH3 
from 
Arginine 
Presumptive 
genus 
1 C3 + R + + + - + + Lactobacillus 
2 C5 + R + + - - ± + Lactobacillus 
3 C6 + R - + + - + + Lactobacillus 
4 C7 + R - + + - + + Lactobacillus 
5 C8 + R + + + - - + Lactobacillus 
6 H3 + R - + + - + + Lactobacillus 
7 H4 + R + + + - + + Lactobacillus 
8 K6 + R + + + - + + Lactobacillus 
9 K7 + R - + + - + + Lactobacillus 
10 K8 + R - + + - + + Lactobacillus 
11 K9 + R - + + - + + Lactobacillus 
12 U2 + R + + + - + + Lactobacillus 
13 W5 + R + + + - ± + Lactobacillus 
14 C4 + C + - + - - - Leuconostoc 
15 H2 + C + - + - - - Leuconostoc 
16 H5 + C + - + - + - Leuconostoc 
17 H7 + C + - + - + - Leuconostoc 
18 K10 + C + - + - ± - Leuconostoc 
19 N1 + C + - + - + - Leuconostoc 
20 U1 + C + - + - + - Leuconostoc 
21 W4 + C + - - - + - Leuconostoc 
22 W6 + C + - + - - - Leuconostoc 
23 K11 - R - + + - + - Lactobacillus 
24 M3 - R - + + - ± - Lactobacillus 
25 M4 - R - + + - - - Lactobacillus 
26 N4 - R + + - - - - Lactobacillus 
27 R1 - R + + + - + - Lactobacillus 
28 W1 - R - + ± - - - Lactobacillus 
29 W3 - R + + - - + - Lactobacillus 
30 C2 - R + + - + ±  Carnobacterium 
31 C1 - C - + + + ± + Enterococcus 
32 F1 - C + + - + + + Enterococcus 
33 H1 - C + + + + + + Enterococcus 
34 K1 - C - + + + + + Enterococcus 
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Table 7 (cont.) 
Serial 
 
 
Isolate 
code 
Gas  
from 
glucose 
Cell 
shape 
Growth 
at 
 
10ºC 
45ºC 
 
 
Growth 
at pH 
4.4       9.6   
Growth 
in 6.5% 
NaCl 
NH3 
from 
Arginine 
Presumptive 
genus 
35 K2 - C - + ND + + + Enterococcus 
36 K4 - C - + + + + + Enterococcus 
37 N3 - C + + + + - + Enterococcus 
38 N6 - C + + + + - + Enterococcus 
39 N5 - C + + + - + + Streptococcus 
40 F2 - T + + + - ± + Pediococcus 
41 K3 - T - + - - + + Pediococcus 
42 K5 - T - + + - + + Pediococcus 
43 M1 - T ND + - - - + Pediococcus 
44 M2 - T + + + - ± + Pediococcus 
45 N2 - T + + + - ND + Pediococcus 
46 S1 - T - + + - + + Pediococcus 
47 F3 - T + + - + + + Tetragenococcus 
48 F4 - T + + - + + + Tetragenococcus 
 
R = rod-shaped, C = coccus, T = Tetrad-formin cocci, + = Good growth,  
-  = No growth, ±  = Weak growth, ND = Not determined. 
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Table 8. Carbohydrate utilization patterns of nine isolates and their 
identification to the species level. 
 
Carbohydrates Isolates 
 N2 N3 K5 K8 K11 M2 M3 M4 R1 
Lactose + + + + + + + + + 
Xylose + - + + - + - - + 
Maltose + + + + - + - + + 
Fructose + + + + + + + + + 
Dextrose + + + + + + + + + 
Galactose + + + + + + + + + 
Raffinose + + + + + - - + + 
Trehalose + - + + + + + + + 
Melibiose + - + + + - - + + 
Sucrose - + - + + + - + + 
L-Arabinose + - + + + + - + + 
Mannose + + + + + + + + + 
Inulin + + + + + - - + + 
Sodium Gluconate + + + + + - - + + 
Glycerol + + + + + + - + + 
Salicin + + + + + + - + + 
Glucosamine - + + + - + + + + 
Dulcitol + + + + - - - + + 
Inositol + + + + + - - + + 
Sorbitol - + - + - - - + + 
Mannitol - + - + - - - + + 
Adonitol + + + + - - - - + 
α- Methyl-D-glucoside + + + + - - - + + 
Ribose + - + + + + + + + 
Rhamnose - + - + - - - + + 
Cellobiose + + + + - + - + + 
Melezitose - + - + + - - + + 
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Table 8 (cont.) 
Carbohydrates Isolates 
α- Methyl-D-
mannoside 
+ + + + + - - + + 
Xylitol + + + + + - - + + 
ONPG - - - - - - - - - 
Esculin hydrolysis + - + - + + + - + 
D-Arabinose + - - + + - - + + 
Citrate utilization + + + + + + - + + 
Malonate utilization + + + + + - - + + 
Sorbose + + + + - - - + + 
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 N.B.: Uninoculated media showed no reactions. += Positive reaction, - = 
Negative 
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4.4. Identification of nine isolates to the species level 
Nine of the most promising isolates were chosen for further 
characterization and study. These were the isolates N2, N3, K5, K8, K11, 
M2, M3, M4 and R1. These isolates were identified to the species level 
through studying their biochemical profiles using the KB009 
HiCrbohydrate identification kit (HiMedia Laboratories, Mumbai, 
India). Table 8 shows the patterns of utilization of 35 sugars by the nine 
isolates. Two of the isolates (N2 and K5) were identified as Pediococcus 
pentosaceus, two (M4 and R1) as Lactobacillus plantarum, one (N3) as 
Enterococcus faecalis, one (K8) as Lactobacillus fermentum, one (K11) as 
Lactobacillus sake, one (M2) as Pediococcus acidilactici and one (M3) as 
Lactobacillus curvatus. 
 
4.5. Characterization of the partially-purified supernatants 
To determine the nature and characteristics of the partially purified 
supernatants obtained from the nine chosen isolates, the supernatants 
were subjected to various treatments which included the action of 
protein and carbohydrate-degrading enzymes, effect of different pH 
adjustments on supernatant activity (to eliminate effects due to lactic 
acid production), study of the heat stability, effect of storage, and 
elimination of the possible effects due to H2O2 production by the test 
isolates. 
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4.5.1. Effect of enzymes 
Table 9 shows the effects of subjecting the supernatants obtained from 
each of the isolates to the enzymes proteinase-k, pepsin and α-amylase, 
and then using them to inhibit growth of the indicator bacterium 
Staphylococcus aureus ATCC 43306. It can be seen that no inhibition was 
produced by any of the cell-free supernatants in presence of the 
protein-digesting enzymes (proteinase-k and pepsin) indicating 
complete digestion of the inhibitory substance in the supernatants, and 
asserting its proteinaceus nature; while no reduction in the inhibitory 
activity was observed in the presence of the carbohydrate-degrading α-
amylase. No inhibitory activity was shown in the uninoculated medium 
containing no enzyme (negative control). 
 
4.5.2. Effect of pH on the inhibitory activity 
Figures 1 through 9 show the effects of adjusting the pH of the 
supernatants to various values on the inhibitory activity of these 
supernatants on the indicator bacterium. As can be seen in Fig. 1, the 
highest inhibitory activity (inhibition zone diameter) due to the 
supernatant obtained from isolate N2 (Pediococcus pentosaceus) was 
recorded at pH 5.0 (17 mm in diameter), decreasing slightly at pH 7.0 
(16 mm) and pH 3.0 (15 mm), but dropping to 10 mm at pH 9.0 (a 
decrease of 41% from that at pH 5.0). 
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 Table 9. Effect of enzymes on activity of cell-free supernatants obtained 
from nine chosen producer isolates against Staph. aureus ATCC 43306 
(Inhibition zone diameters in mm) 
Isolate 
code 
Proteinase-
K 
Pepsin α -
amylase 
uninoculated 
medium 
with no 
enzyme 
Enzyme-free 
cell 
supernatants 
N2 0.0 0.0 13 0.0 14  
N3 0.0 0.0 13 0.0 13 
K5 0.0 0.0 8.0 0.0 9.0 
K8 0.0 0.0 13 0.0 14 
K11 0.0 0.0 14 0.0 15 
M2 0.0 0.0 10 0.0 11 
M3 0.0 0.0 13 0.0 14 
M4 0.0 0.0 14 0.0 14 
R1 0.0 0.0 13 0.0 14 
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The supernatant obtained from isolate N3 (Enterococcus faecalis) also 
showed highest inhibitory activity at pH 5.0 (15 mm inhibition zone 
diameter), followed by activity at pH 7.0, and then at the pH values of 
3.0 and 9.0, both of which showed inhibition zones of 13 mm diameter 
(Fig. 2). 
The supernatant from isolate K5 (another Pediococcus pentosaceus) 
behaved similar to those from isolates N2 and N3 by showing highest 
inhibitory activity at pH 5.0, followed by activity at pH 7.0, and then at 
the pH values of 3.0 and 9.0 (Fig. 3). However, the decrease in activity 
at pH 3.0 and 9.0 was less pronounced (23.5 %). 
Figure 4 shows the effects of pH on activity of the supernatant from 
isolate K8 (Lactobacillus fermentum). Similar to the afore-mentioned 
isolates, the highest inhibitory activity was recorded at pH 5.0, followed 
by pH 7.0, then pH 3.0 and 9.0. As in the supernatant from isolate K5, 
the decrease in inhibitory activity at pH 3.0 and 9.0 was not very great. 
This typical pattern of the effect of pH on the inhibitory activity of 
supernatants can also be seen in the supernatant obtained from isolate 
K11 (Lactobacillus sake) as is shown in Fig. 5, with highest activity at pH 
5.0, followed by the pH values of 7.0, 3.0 and 9.0. 
Figure 6 shows the effects of pH on activity of the supernatant obtained 
from isolate M2 (Pediococcus acidilactici). Here again the highest activity 
was recorded at 5.0 followed by the pH values of 7.0, 3.0 and then 9.0, 
but the degree of reduction in the activity was more pronounced, being 
40% at pH 7.0, 46.7 % at pH 3.0 and 53.3% at pH 9.0. 
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The supernatant from isolate M3 (Lactobacillus curvatus) showed the 
same general mode of behaviour at the tested pH values, with peak 
value at pH 5.0 and a decline at the other pH values. However, the 
reduction in inhibitory activity at the other pH values was not great, 
amounting only to 16.7% at pH 9.0 as is shown in Fig. 7. 
The pattern of pH effect on the supernatant from isolate M4 
(Lactobacillus plantarum) did not deviate from the general pattern 
obtained with supernatants from the other isolates (Fig. 8), showing 
widest inhibition zone diameter at pH 5.0 (20 mm), followed by pH 7.0, 
then pH 9.0 and 3.0 (14 mm). 
Figure 9 shows that the effect of pH on activity of the supernatant from 
isolate R1 (another Lactobacillus plantarum) also followed the general 
pattern of exhibiting highest inhibitory activity at pH 5.0, followed by 
pH 7.0, then pH 3.0 and 9.0. The decrease in activity was more 
noticeable between pH 5.0 (20 mm zone diameter) and pH 7.0 (15 mm), 
but there was no great difference between this last value and those 
obtained at pH 3.0 (14 mm) and pH 9.0 (13 mm). 
 
4.5.3. Heat stability of the supernatants 
The heat stability of the 9 supernatants was studied by heating each 
supernatant to 40, 60, 100 and 121 ºC for 10, 30 and 60 minutes, after 
which time their inhibitory activities on the indicator bacterium 
Staphylococcus aureus ATCC were assayed as diameters of inhibition 
zones. 
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Figure 10 shows the effect of heating the supernatant obtained from 
isolate N2 (Pediococcus pentosaceus) to 40, 60, 100 and 121 ºC for 10, 30 
and 60 minutes. No reduction in activity was observed on heating the 
supernatant to 40, 60 or 100 ºC for 10 or 30 minutes, but on heating at 
these temperatures to 60 minutes, a reduction of 54% was recorded. On 
the other hand, no activity was detected in autoclaved supernatant even 
after 10 minutes only. 
On heating the supernatant obtained from isolate N3 (Enterococcus 
faecalis) to 40 ºC for 10 or 30 minutes no reduction in activity was 
recorded, but on heating for 60 minutes a reduction of 54.5% was 
observed. When the supernatant was heated to 60 or 100 ºC for up to 30 
minutes, a slight reduction in activity (9.1%) was observed, but by 60 
minutes the reduction amounted to 54.5% as in the heating at 40 ºC for 
this same period of time. No activity was detected in the autoclaved 
supernatant even on heating for only 10 minutes (Fig. 11). 
As shown in Fig. 12, the activity of the supernatant obtained from 
isolate K5 (Pediococcus pentosaceus) was not reduced on heating to 40 ºC 
for 10 or 30 minutes, but a reduction of 45.5% was observed when the 
heating was extended to 60 minutes. When the supernatant was heated 
to 60 ºC, no reduction in inhibitory activity was observed after 10 
minutes, and only a slight reduction was recorded when the heating 
was extended to 30 minutes. However, no activity was observed on 
heating to 60 ºC for 60 minutes. On the other hand, a slight reduction 
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was observed on heating to 100 ºC for 10 minutes, but only 55% of the 
activity was retained after 30 minutes, and was completely lost after 60 
minutes. Autoclaving resulted in complete loss of the activity. 
The inhibitory activity of the supernatant obtained from isolate K8 
(Lactobacillus fermentum) was not affected by heating at 40 or 60 ºC for 
up to 60 minutes (Fig. 13). No reduction in activity was recorded for up 
to 30 minutes on heating at 100 ºC, but activity was completely lost by 
60 minutes. As with the previously tested supernatants, no inhibitory 
activity was observed on heating to 121 ºC for any length of time. 
Figure 14 shows the effects of heating on the supernatant obtained from 
isolate K11 (Lactobacillus sake). When the supernatant was heated at 40 
ºC no reduction in activity was observed for up to 30 minutes, but only 
63.6% of the activity was retained after 60 minutes. A slight reduction in 
activity (9%) was observed on heating at 60 or 100 ºC for 10 or 30 
minutes, but again only 63.6% of the activity was retained after 60 
minutes. No activity was shown by the autoclaved supernatant. 
The effect of heating the supernatant obtained from isolate M2 
(Pediococcus acidilactici) is shown in Fig. 15. It can be seen that no 
reduction in activity was recorded on heating the supernatant to 40 ºC 
up to 30 minutes, but by 60 minutes only 54.5% of the activity was 
retained. At 60 ºC, no reduction was observed after 10 minutes, but a 
reduction of 18% took place after 30 minutes, and activity was 
completely lost after 60 minutes.  When it was heated at 100 or 121 ºC, 
no activity was observed even after heating for only 10 minutes. 
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No reduction was observed in the activity of the supernatant of isolate 
M3 (Lactobacillus curates) on heating to 40 ºC for 10 minutes (Fig. 16), but 
a reduction of 17.6% was observed on heating for 30  or 60 minutes. 
When the supernatant was heated at 60 ºC, a reduction of 35.3% was 
observed whether heated for 10, 30 or 60 minutes. On heating to 100 ºC, 
a reduction of 17.6% was observed after 10 minutes, with further 
reduction on extending the heating to 30 or 60 minutes.  
Figure 17 shows the effect of heating the supernatant from isolate M4 
(Lactobacillus plantarum). When the supernatant was heated to 40 ºC, no 
reduction was observed in the inhibitory activity when the heating was 
continued for 10 or 30 minutes, but a slight reduction was observed 
when the heating was for 60 minutes. On heating at 60 ºC, a 7.7% 
reduction in activity was observed whether heated for 10, 30 or 60 
minutes. Heating to 100 or 121 ºC resulted in complete loss of the 
activity regardless of the length of the heating period. 
No loss of activity was observed when the supernatant from isolate R1 
(another Lactobacillus plantarum) was heated to 40 ºC even for 60 
minutes. However, a reduction in activity of 31% was observed when it 
was heated at 60 ºC whether for 10, 30 or 60 minutes. No activity was 
recorded on heating the supernatant to 100 or 121 ºC (Fig. 18). 
 
4.5.4. Effect of storage temperature on the supernatants 
The effects of storage on the stability of the inhibitory activities of the  
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partially purified supernatants obtained from the 9 selected isolates 
against the indicator bacterium Staphylococcus aureus ATCC are shown 
in Figs. 19 to 27. 
No decrease in the activity of the supernatant obtained from isolate N2 
was observed when it was stored for one week at any of the storage 
temperatures tested (-80, -20, 4 and 35 ºC). However, by the second 
week a slight drop in activity (6.7%) took place when the supernatant 
was stored at -80 or -20 ºC. A similar decrease was recorded by the third 
week at both -80 and -20 storage temperatures (lines coinciding). No 
further drop was observed by the fourth week at these two storage 
temperatures. However, at 4 and 35 ºC a gradual decrease in activity 
was observed by the second, third and fourth weeks of storage, 
reaching 26.7% and 46.7% by the fourth week at 4 and 35 ºC, 
respectively (Fig. 19). 
The supernatant obtained from isolate N3 exhibited a  trend more or 
less similar to that seen in the supernatant obtained from isolate N2 
(Fig. 20). No drop in activity was recorded after storage for one week at 
-80 or -20 ºC, and only a slight drop (7%) occurred by the second week. 
No further drop was observed by the third or fourth weeks. Similarly, 
no drop in activity was noticed by the first week when this supernatant 
was stored at 4 or 35 ºC. However, a drop of 7% was recorded by the 
second week at both temperatures. This drop in activity continued up  
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to the fourth week, reaching 28.6% and 38.5% at 4 and 35 ºC, 
respectively. 
Figure 21 shows the effects of storage temperatures on the inhibitory 
activity of the supernatant obtained from isolate K5 on the indicator 
bacterium Staphylococcus aureus ATCC. It can be seen that no drop in 
activity was observed at -80 or -20 ºC up to four weeks of storage. 
Likewise, no drop in activity occurred during the first week of storage 
at either 4 or 35 ºC. However, a gradual decrease started to appear by 
the second week, reaching 18% at 4 ºC and 20% at 35 ºC by the fourth 
week. 
The supernatant obtained from isolate K8 (Fig. 22) showed differential 
stability when stored at any of the four storage temperatures. No drop 
in the inhibitory activity was observed at -80 ºC up to the fourth week. 
At -20 ºC a drop of 7% was recorded by the end of the first week, which 
persisted unchanged up to the fourth week. When stored at 4 ºC, no 
drop in activity was observed up to the third week, but a drop of 23% 
was recorded by the end of the fourth week. Although no drop in 
activity occurred at 35 ºC by the first week, a decrease of 41.3% was 
recorded by the second week, and a sharp drop occurred by the fourth 
week leaving only 57% of the original inhibitory activity at this storage 
temperature. 
When the partially purified supernatant obtained from isolate K11 was 
stored at -80 ºC, no drop in activity took place by the first week. A slight 
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Fig. 21: Effect of storage at -80, -20, 4 and 35 ºC for   
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drop (6%) occurred by the second week with no further decline up to 
the fourth week (Fig. 23). However, no drop in the inhibitory activity of 
this supernatant was observed when stored at -20 ºC up to the fourth 
week. On storage at 4 or 35 ºC, no decline in activity was observed by 
the first week. However, by the second week, activity at 4 ºC showed a 
drop of 19% as compared to a drop of 7% at 35 ºC. Nonetheless, by the 
end of the fourth week, the final activities were 75% and 71.4% of the 
original activities at 4 and 35 ºC, respectively. 
Figure 24 shows the effect of storage temperatures on the inhibitory 
activity of the partially purified supernatant obtained from isolate M2 
on the indicator bacterium Staphylococcus aureus ATCC. As can be seen, 
no drop in the inhibitory activity of this supernatant was observed at   
  80 or   20 ºC up to four weeks of storage. On storage at 4 or 35 ºC, 
no drop in activity occurred by the first week. However, a gradual 
decrease in activity was recorded starting from the second week. By the 
fourth week, 84.6% and 66.7% of the original inhibitory activity was 
retained at 4 and 35 ºC, respectively. 
 As in the supernatant of isolate M2, that obtained from isolate M3 
showed no drop in activity at -80 or -20 ºC up to four weeks of storage 
(Fig. 25). At 4 and 35 ºC, a gradual decline in activity was noticed 
starting from the second week. By the fourth week, 71.4% and 76.9% of 
the original activity was retained at 4 and 35 ºC, respectively. 
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Fig. 23. Effect of storage at -80, -20, 4 and 35 ºC for   
four weeks on activity of isolate K11 supernatant. 
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Fig.  24: Effect of storage at -80, -20, 4 and 35 ºC for   
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Fig. 25. Effect of storage at -80, -20, 4 and 35 ºC for   
four weeks on activity of isolate M3 supernatant. 
80ºC
20ºC
4ºC
35ºC
 124 
 
 
 
 
 
 
 
 
0
2
4
6
8
10
12
14
16
0 1 2 3 4
In
hi
bi
tio
n 
zo
ne
 d
ia
m
et
er
s 
(m
m
)
Time (weeks)
Fig. 26. Effect of storage at -80, -20, 4 and 35 ºC for   
four weeks on activity of isolate M4 supernatant. 
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Figure 26 shows that the effects of storage temperatures on the 
supernatant of isolate M4 were similar to their effects on the 
supernatant from isolate M3, with no drop in activity at -80 or -20 ºC up 
to four weeks of storage. However, a gradual decline in activity was 
observed starting from the second week. By the fourth week, the 
retained activities were 78.6% and 77% of the starting activities at 4 and 
35 ºC, respectively. 
As in the supernatants obtained from isolates M2 and M3, no drop in 
activity of the supernatant obtained from isolate R1 was observed when 
stored at -80 or -20 ºC up to four weeks of storage (Fig. 27). At 4 and 35 
ºC, a gradual decrease in activity was observed starting from the second 
week. By the fourth week, 77% and 66.7% of the original activity was 
retained at 4 ºC and 35 ºC, respectively. 
 
4.5.5. Molecular weight determination 
Fig. 28 shows the bands produced by the electrophoretic separation of 
the proteins in the cell-free filter-sterilized supernatants obtained from 
seven of the bacterial isolates in comparison to a marker of standard 
protein molecular weights. It can be visualized that the molecular 
weights of six of the seven proteins were in the approximate range of 3 - 
4 KDa, with isolate R1 showing a slightly higher (~ 5.0 KDa) molecular 
weight. 
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Fig. 27. Effect of storage at -80, -20, 4 and 35 ºC for   
four weeks on activity of isolate R1 supernatant. 
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4.6. Elimination of the effects due to H2O2 production 
As one of the potent defense weapons in the arsenal of lactic acid 
bacteria is the production of hydrogen peroxide under aerobic 
conditions, elimination of this possible effect was achieved through 
growing the nine test isolates under anaerobic conditions and 
evaluating the inhibitory activities produced under anaerobiosis. Table 
10 shows the activities of supernatants obtained from the nine isolates 
grown under anaerobic conditions against Staphylococcus aureus ATCC. 
It can be seen that the inhibitory activities that were obtained were 
comparable to those observed using supernatants obtained from 
aerobically grown cultures. 
 
4.7. Spectrum of the inhibitory activity 
Table 11 depicts the spectrum of activity of the nine partially purified 
supernatants against 10 bacterial strains, viz. Enterococcus faecalis ATCC 
10541, Bacillus subtilis NCTC 8230, Staphylococcus aureus ATCC 43306, 
Staphylococcus aureus ATCC 25923, Pseudomonas aeruginosa ATCC 27853, 
Klebsiella pneumoniae ATCC 10031, Proteus vulgaris ATCC 6380, 
Salmonella typhi ATCC 1319106, E. coli ATCC 25922 and a local  E. coli 
isolate. As can be seen in the table, the supernatants exhibited variation 
in the width of their inhibition spectrum, whereby that of isolate K8 
inhibited 9 of the 10 target strains, those of isolates N2, M3, M4 and R1 
inhibited 7 each, those from N3, K11 and M2 inhibited 6 each, while the 
supernatant of isolate K5 inhibited only five of the 10 target strains. It is 
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Table 10. Inhibition zone diameters (mm) produced against 
Staphylococcus aureus ATCC 43306 by supernatants produced during 
aerobic and anaerobic growth of the test isolates. 
 
 Inhibition zone diameter (mm) 
Isolates code aerobic anaerobic 
N2 15 13 
N3 14 14 
K5 13 10 
K8 13 11 
K11 10 10 
M2 15 15 
M3 15 15 
M4 14 13 
R1 14 12 
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Table 11. Spectrum of inhibitory activity against ten target organisms (zone diameters, mm). 
 
Isolate 
code 
Enterococcus 
faecalis 
ATCC 10541 
Bacillus 
subtilis 
NCTC 
8230 
Staph. 
aureus 
ATCC 
25923 
Staph. 
aureus 
ATCC 
43306 
Pseudomonas 
aeruginosa 
ATCC 27853 
Klebsiella 
pneumoniae 
ATCC 
10031 
Proteus 
vulgaris 
ATCC 
6380 
Salmonella 
typhi 
ATCC 
1319106 
E. coli 
ATCC 
25922 
E. coli 
(local 
isolate
) 
N2 12 14 15 18 0.0 6 11 0.0 10 0.0 
N3 0.0 15 13 17 0.0 9 0.0 6 7 0.0 
K5 8 15 15 13 0.0 0.0 0.0 0.0 9 0.0 
K8 13 17 15 10 12 12 11 9 12 0.0 
K11 11 17 14 10 0.0 8 0.0 0.0 11 0.0 
M2 12 15 15 10 0.0 0.0 7 0.0 10 0.0 
M3 13 16 10 15 0.0 9 10 0.0 6 0.0 
M4 12 12 12 10 0.0 9 11 0.0 10 0.0 
R1 14 15 13 14 0.0 7 10 0.0 9 0.0 
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noteworthy that the two Staph. aureus strains (ATCC 25923 and ATCC 
43306) and E. coli ATCC 25922 were inhibited by all 9 supernatants, 
while the local E. coli isolate was resistant to all of them.   
 
4.8. Mode of action of the inhibitory substance 
In the investigations exploring the mode of action of the inhibitory 
substance in the nine partially purified cell-free extracts (Figs. 29 -37), it 
can be seen that on addition of the supernatant obtained from isolate N2 
(Pediococcus pentosaceus) to Staphylococcus aureus ATCC 43306 already 
growing for four hours, growth of this bacterium was greatly retarded. 
In the following five hours of incubation, an increase of only 45.6% in the 
optical density of the broth treated with the supernatant was recorded, 
as compared to an increase of 255.5% in the untreated broth (Fig. 29). On 
streaking aliquots from the treated broth culture on fresh Nutrient Agar 
plates, growth was resumed on the plates after 24 hours of incubation at 
30 ºC. 
The effect of the supernatant from isolate N3 (Enterococcus faecalis) on 
growth of the indicator bacterium is shown in Fig. 30. A retardation of 
growth similar to that obtained with the supernatant from isolate N2 
was obtained. A 60% increase in the optical density of the treated broth 
was obtained 5 hours after the addition of the supernatant, as compared 
to an increase of 290% in the untreated control broth. Similar to the 
results obtained with the supernatant obtained from isolate N2, growth 
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of the target bacterium was resumed after streaking aliquots from the 
treated broth culture on Nutrient Agar plates. 
The same trend of growth retardation was obtained with the 
supernatant obtained from isolate K5 where an increase of 36.3% in 
optical density was recorded 5 hours after addition of the supernatant 
as compared to an increase of 254.5% in the broth receiving no 
supernatant (Fig. 31). As with the supernatants from isolates N2 and 
N3, streaking of aliquots from the broth culture treated with this 
supernatant on fresh Nutrient Agar plates resulted in re-growth of the 
indicator bacterium after 24 hours of incubation at 30 ºC. 
A comparatively stronger inhibition of the growth of Staphylococcus 
aureus ATCC 43306 was obtained with addition of the supernatant 
obtained from isolate K8 (Lactobacillus fermentum) as shown in Fig. 32. 
The increase in optical density during the five hours that followed 
amounted to only 9.1% in the treated broth as compared to an increase 
of 254.5% in the untreated control broth. However, in contrast to results 
obtained using supernatants from isolates N2, N3 and K5, no growth 
could be obtained on streaking aliquots from the broth culture treated 
with K8 supernatant. 
Figure 33 shows the effect of adding the supernatant of isolate K11 
(Lactobacillus sake) to the growth of the indicator bacterium. After 5 
hours from addition of the supernatant, the optical density of the 
treated broth increased from 0.1 to 0.16 while in the untreated control 
 
 133 
 
 
 
 
 
 
 
 
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
0.45
0 1 2 3 4 5 6 7 8 9
O
.D
.
Time (h)
Fig. 29. Mode of action of isolate N2 supernatant. 
Arrow indicates time of addition of supernatant.
supernatant
control
↓
 134 
 
 
 
 
 
 
 
 
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
0.45
0 1 2 3 4 5 6 7 8 9
O
.D
.
Time (h)
Fig. 30. Mode of action of isolate N3 supernatant. 
Arrow indicates time of addition of supernatant.   
supernatant
control
↓
 135 
 
 
 
 
 
 
 
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
0.45
0 1 2 3 4 5 6 7 8 9
O
.D
Time (h)
Fig. 31. Mode of action of isolate K5 supernatant. 
Arrow indicates time of addition of supernatant.
supernatant
control
↓
 136 
 
the optical density rose to 0.39 (48 times as much). Nevertheless, growth 
of the indicator bacterium was resumed on streaking the treated broth 
culture on fresh Nutrient Agar plates. 
As is shown in Figure 34, growth of the indicator bacterium was 
strongly inhibited by addition of the supernatant obtained from isolate 
M2 (Pediococcus acidilactici), showing an increase in optical density from 
0.11 to 0.13 after 5 hours from addition of the supernatant, while the 
optical density of the untreated control increased from 0.11 to 0.39. As 
with the supernatants obtained from isolates N2, N3 and K11, growth 
of the indicator bacterium was resumed on streaking aliquots from the 
treated broth culture on fresh medium and incubating for 24 hours at 30 
ºC. 
A strong inhibition of the growth of the indicator bacterium was 
obtained due to addition of the supernatant obtained from isolate M3 
(Lactobacillus curvatus), where an increase of only 10% in optical density 
was obtained 5 hours after addition of the supernatant, as compared to 
an increase of 290% in the untreated control broth (Fig. 35). On re-
culturing of the treated broth culture on fresh medium, no growth was 
obtained. 
On addition of the supernatant from isolate M4 (Lactobacillus plantarum) 
to Staphylococcus aureus ATCC 43306 growth was completely arrested, 
with no increase in the optical density of the treated broth culture up to 
five hours from the time of addition, while the optical density of the 
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untreated broth culture rose from 0.1 to 0.39 during those five hours 
(Fig. 36). No growth was obtained on re-culturing the treated broth 
culture on fresh Nutrient Agar medium. 
A trend similar to that shown in Fig. 36 was obtained on addition of the 
supernatant obtained from isolate R1 (another Lactobacillus plantarum) to 
the indicator bacterium, where growth was completely arrested after 
addition of the supernatant, while an increase of 254.5% was obtained 
in the optical density of the untreated control broth culture (Fig. 37). As 
with the M3, M4 and K8 supernatants, no growth could be obtained on 
streaking the treated broth culture on fresh medium.  
 
4.9. Kinetics of growth and bacteriocin production 
The results obtained from investigations on the kinetics of bacteriocin 
production in relation to growth at uncontrolled pH conditions at 30 ºC 
are shown in Figs 38 to 46. 
As shown in Fig. 38, using isolate N2 (Pediococcus pentosaceus), increase 
in growth (O.D.) was detectable since the start of the investigation, but 
the active growth phase seemed to start after 8 hours from inoculation 
and continued up to  the 25th hour after which it started to decline. On 
the other hand, no antagonistic activity could be detected against Staph. 
aureus up to eight hours of growth. Thenceforth, antagonistic activity 
began to be detected, and showed a steady increase up to 26 hours of 
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growth when the investigation was terminated. Maximal activity 
appeared to coincide with optimal growth, but also coincided with the 
drop in pH to the range of 4.5 to 4.2. 
Figure 39 shows the kinetics of growth and bacteriocin production of 
isolate N3 (Enterococcus faecalis). Very little growth was obtained in the 
first six hours from inoculation, but a gradual increase was started and 
continued up to 25 hours, after which it started to decline. No inhibitory 
activity was shown in the first six hours of growth, but from the 6th 
hour onwards a gradual increase was obtained in the inhibitory activity 
which coincided with the phase of optimal growth up to 25 hours from 
inoculation. Maximum inhibitory activity was obtained at the pH value 
of 4.1. 
Weak growth (increase in optical density) was shown by isolate K5 
(Pediococcus pentosaceus) in the first eight hours from inoculation, but 
then it took off and showed appreciable increase up to 25 hours from 
inoculation, after which no increase was obtained. On the other hand, 
no inhibitory activity was detected during the first 7 hours of growth, 
but a gradual increase in inhibitory activity was evident, and continued 
up to 10 hours from inoculation after which no increase was obtained. 
Maximum activity was obtained at the pH range of 5.2 – 4.5 (Fig. 40). 
Unlike isolates N2 and N3, the time of maximal production of the 
inhibitory activity by isolate K5 did not coincide with the time of 
maximum growth (25-26 hours from inoculation). 
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Growth of isolate K8 (Lactobacillus fermentum) was slow in the first 8 
hours, but showed a gradual increase up to 25 hours from inoculation 
and declined by the 26th hour. No inhibitory activity was detected up to 
10 hours, but then a gradual increase in activity was obtained and 
continued up to the 24th hour, with no further increase. Maximal 
inhibitory activity accompanied the maximal growth phase which 
occurred at the pH value of 4.3 (Fig. 41). 
Isolate K11 (Lactobacillus sake) showed slow growth in the first 3 hours, 
but growth gradually increased up to the end of the investigation (26 
hours). However, no inhibitory activity was detected in the first 7 
hours, after which a gradual increase in activity was obtained, and 
continued up to the 13th hour, after which no increase was detected. 
Best growth and highest inhibitory activity were recorded at the pH 
range of 4.6 – 4.2 (Fig 42). 
Isolate M2 (Pediococcus acidilactici) showed a steady increase in growth, 
which continued up to 13 hours from inoculation, after which a gradual 
decline could be seen. However, no inhibitory activity was detected up 
to five hours from inoculation, but a steady increase was obtained 
thenceforth, which continued up to 12 hours after which a steady level 
was obtained. Maximum growth and inhibitory activity were obtained 
at the pH value of 4.3 (Fig. 43). 
  
 
 148 
 
         
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
0
20
40
60
80
100
120
1 2 3 4 5 6 7 8 9 10 11 12 13 24 25 26
Ba
ct
er
ia
l g
ro
w
th
 (O
.D
.)
Ba
ct
er
io
ci
n 
ac
tiv
ity
 (A
U
)
Time (hours)
Fig. 40. Kinetics of growth and bacteriocin production 
by isolate K5.
AU
pH
OD
 149 
 
 
          
 
0
0.5
1
1.5
2
2.5
3
0
20
40
60
80
100
120
1 2 3 4 5 6 7 8 9 10 11 12 13 24 25 26
Ba
ct
er
ia
l g
ro
w
th
 (O
.D
.)
Ba
ct
er
io
ci
n 
ac
tiv
ity
 (A
U
)
Time (hours)
Fig. 41. Growth and bacteriocin production by 
isolate K8.
AU
pH
OD
 150 
 
 
         
 
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
0
10
20
30
40
50
60
1 2 3 4 5 6 7 8 9 10 11 12 13 24 25 26
Ba
ct
er
ia
l g
ro
w
th
 (O
.D
.)
Ba
ct
er
io
ci
n 
ac
tiv
ity
 (A
U
)
Time  (hours)
Fig. 42. Kinetics of growth and bacteriocin production by 
isolate K11.
AU
pH
OD
 151 
 
Figure 44 depicts the growth and bacteriocin production of isolate M3 
(Lactobacillus curvatus). As can be seen, the isolate showed an early 
increase in growth, which continued up to 24 hours from inoculation, 
after which a gradual decline could be seen. The inhibitory activity 
could be detected as early as five hours from inoculation, with a 
gradual increase up to 12 hours, after which a steady state in activity 
was obtained. Maximum growth and activity were obtained at the pH 
value of 4.2. 
Figure 45 shows that bacteriocin production (measured as inhibitory 
activity) by isolate M4 (Lactobacillus plantarum) generally coincided with 
the phase of maximum growth where maximum activity was obtained 
between 10 and 26 hours and maximal growth occurred at the 25th hour 
from inoculation, after which it started to decline. The pH range at 
which both maximum growth and inhibitory activity were obtained 
was 4.4 – 4.2. 
With isolate R1 (Lactobacillus plantarum) inhibitory activity was detected 
as early as 4 hours from inoculation and increased up to the 11th hour, 
after which a steady rate was maintained up to the end of the 
investigation (26 hours). A gradual increase in optical density was 
recorded up to 13 hours from inoculation, after which a gradual decline 
in growth was obtained. However, the kinetics of production of the 
inhibitory activity were similar to those of growth, and maximum 
inhibitory activity was obtained during the phase of optimal growth, 
which occurred at the pH range of 4.3 -4.2 (Fig. 46). 
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4.10. Optimization of growth and bacteriocin production 
Optimization of growth and bacteriocin production for the 9 selected 
isolates was studied in MRS broth using temperature, pH and length of 
incubation period (time) as variables. Tables 12 – 29 display the results 
that were obtained. 
Table 12 shows that growth (optical density) of isolate N2 was 
significantly affected by the interactions of temperature, pH and time. 
The main effects of these three factors show that 37 ºC, pH 5.0 and 
incubation for 48 hours were generally the best settings for optimal 
growth. However, due to interaction of these factors, the highest optical 
density was obtained with the combination of 37 ºC, pH 5.0 and 
incubation for 24 hours. As for bacteriocin production (expressed as 
inhibitory activity), the highest activity was obtained with the 
combinations of 30 ºC, pH 5.0 and 48 hours, or 30 ºC, pH 5.5 and 72 
hours , and 30 ºC , pH 5.0 and 24 hours (Table 13). 
Table 14 depicts the interaction of temperature, pH and incubation 
period on the growth of isolate N3. Although differences in the main 
effects of all three variables did not attain statistical significance, there 
were significant interactions between them, with 37 ºC X pH 5.5 for 24, 
48 or 72 hours being the best combinations for growth. On the other 
hand, although pH 5.5 was generally the most suitable for bacteriocin 
production, the combination of 30 ºC and pH 5.0 for 48 hours yielded 
the highest inhibitory activity (Table 15). 
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Table 12. Growth (O.D.) of isolate N2 as affected by temperature, pH 
and time. 
 
(a) Temperature X time X pH interaction 
Temp. 
(T ) 
°C 
pH Mean 
(T) 5.0 5.5 6.0 
24h 48h 72h Mean 
(TxpH) 
24h 48h 72h Mean 
(TxpH) 
24h 48h 72h Mean 
(TxpH) 
25 1.1 1.8 1.8 1.6 1.2 2.1 2.1 1.8 1.5 1.8 2.1 1.8 1.7 c 
30 2.1 2.5 2.5 2.3 2.1 2.1 1.8 2.0 2.4 1.8 1.8 2.0 2.1 b 
37 2.9 2.4 2.3 2.5 2.6 2.1 2.1 2.3 2.1 1.9 1.9 2.5 2.2 a 
Mean 
(pHxt) 
2.0 2.2 2.2  2.0 2.1 2.0  2.0 1.8 1.9  
Mean 
(pH) 
2.1 a 2.0 b 1.9 c 
 
 
 
 
 
         (b) Temperature X Time interaction 
Temp.  (T ) °C Time Mean (T) 
24h 48h 72h 
25 1.3 1.9 2.0 1.7 c 
30 2.2 2.1 2.0 2.1 b 
37 2.5 2.1 2.1 2.2 a 
Mean (t) 1.99 c 2.05 a 2.03 b  
 
Values in the same column (row) followed by the same letter are not 
significantly different by the Duncan Multiple Range test. 
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Table  13. Inhibitory activity (AU) of isolate N2 as affected by 
temperature, pH and time. 
(a) Temperature X pH X Time interaction 
Temp 
(T)  
°C 
pH Mean 
(T) 5.0 5.5 6.0 
24h 48h 72h Mean 
(TXpH) 
24h 48h 72h Mean 
(TXpH) 
24h 48h 72h Mean 
(TXpH) 
25 100 100 100 100 99.7 100 100 99.9 50.7 50 49.7 50.1 83.3 
b 
30 200 199 199.7 199.6 199.7 200 200 199.9 100 100 100 100 166.5 
a 
37 99.7 99.7 99.7 99.7 100 100 99.7 100 50 50 50 50.1 83.3 
b 
Mean 
(pHxt) 
133.2 132.9 133.1  133.1 133.4 133.2  66.9 66.7 66.7  
Mean 
(pH) 
133.1 a 133.3 a 66.7 b 
 
 
 
 
(b) Temperature X Time interaction 
Temp.  (T  °C) time Mean (T) 
25 24h 48h 72h 83.3 b 
30 83.4 83.3 83.2 166.5 a 
37 166.6 166.3 166.6 83.3 b 
Mean (time) 111.1 a 111.0 a 111.0 a  
 
Values in the same column (row) followed by the same letter are not 
significantly different by the Duncan Multiple Range test. 
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Table 14. Growth (O.D.) of isolate N3 as affected by temperature, pH 
and time 
 
(a) Temperature X pH X Time interaction 
Temp. 
(T ) 
°C 
pH Mean 
(T) 5.0 5.5 6.0 
24h 48h 72h Mean 
(TXpH) 
24h 48h 72h Mean 
(TXpH) 
24h 48h 72h Mean 
(TXpH) 
25 0.7 1.4 2.1 1.4 1.0 1.8 2.4 1.7 1.9 2.0 2.1 2.0 1.7 a 
30 1.8 2.1 2.4 2.1 1.8 1.9 1.8 1.8 1.9 1.9 1.9 1.9 1.9 a 
37 2.3 2.2 2.1 2.2 2.6 2.6 2.6 2.6 2.4 2.4 2.4 2.4 2.4 a 
Mean 
(pHxt) 
1.6 1.9 2.2  1.8 2.1 2.3  2.1 2.1 2.1  
Mean 
(pH) 
1.9 a 2.0 a 2.1 a 
 
 
 
 
(b) Temperature X Time interaction 
Temp.  (T)  °C Time Mean (T) 
24h 48h 72h 
25 1.2 1.7 2.2 1.7 a 
30 1.8 2.0 2.0 1.9 a 
37 2.4 2.4 2.4 2.4 a 
Mean (time) 1.8 a 2.0 a 2.2 a  
 
Values in the same column (row) followed by the same letter are not 
significantly different by the Duncan Multiple Range test. 
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Table15. Inhibitory activity (AU) of isolate N3 as affected by 
temperature, pH and time. 
 
(a) Temperature X pH X Time interaction 
Temp. 
(T ) 
°C 
pH Mean 
(T) 5.0 5.5 6.0 
24h 48h 72h Mean 
(TXpH) 
24h 48h 72h Mean 
(TXpH) 
24h 48h 72h Mean 
(TXpH) 
25 100 99.7 100 99.9 100 99.7 100 99.9 50 50 50 50 83.3 b 
30 166.3 200.3 199.7 188.8 200 199.7 199.7 199.8 99.7 99.7 100 99.9 162.8 
a 
37 100.3 100 99.7 100 100 100 99.7 99.9 50 50 50 50 83.3 b 
Mean 
(pHxt) 
122.2 133.4 133.1  133.3 133.1 133.1  66.6 66.6 66.7  
Mean 
(pH) 
129.6 a 133.2 a 66.6 b 
 
 
 
 
(b) Temperature X Time interaction  
Temp.  (T)  °C time Mean (T) 
24h 48h 72h 
25 83.3 83.1 83.3 83.3 b 
30 155.3 166.6 166.4 162.8 a 
37 83.4 83.3 83.1 83.3 b 
Mean (time) 107.4 a 111 a 111 a  
 
Values in the same column (row) followed by the same letter are not 
significantly different by the Duncan Multiple Range test. 
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Table 16 shows that several combinations of temperature, pH and 
incubation period could be used to attain optimal growth of isolate K5, 
yet 30 ºC and pH 5.5 for 72 hours was the best combination for 
maximum production of inhibitory activity (Table 17). 
The combination of 30 ºC, pH 5.0 and incubation for 24 hours recorded 
maximal growth of isolate K8 (Table 18). However, maximum 
inhibitory activity was obtained with the combination of 30 ºC and pH 
5.0 for 48 or 72 hours (Table 19). 
Similar to isolate K8, the best combination for growth of isolate K11 was 
30 ºC and pH 5.0 for 24 hours (Table 20), but maximal inhibitory 
activity was obtained with the combination of 30 ºC and pH 5.5 for 24 
or 72 hours (Table 21). 
Isolate M2 showed highest optical density when adjusted to pH 5.0 and 
incubated at 37 ºC for 48 hours (Table 22), but highest inhibitory activity 
was obtained at pH 5.5 and 25, 30 or 37 ºC for 24, 48 or 72 hours  (Table 
23). 
Isolate M3 seemed to require a higher temperature for growth, as the 
highest optical density was recorded with the combination of 37 ºC 
with either pH 5.0 for 48 or 72 hours, or pH 5.5 for 48 or 72 hours (Table 
24). On the other hand, four combinations of temperature, pH and 
incubation period (30 ºC X pH 5.0 for 24 or 72 hours, 30 ºC X pH 5.5 for 
24, 48 or 72 hours and 37 ºC X pH 5.5 for 24 or 48 hours) yielded 
maximum inhibitory activity (Table 25). 
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Table 16. Growth (O.D.) of isolate K5 as affected by temperature, pH 
and time. 
 
(a) Temperature X pH X Time interaction 
Temp. 
(T ) 
°C 
pH Mean 
(T) 5.0 5.5 6.0 
24h 48h 72h Mean 
(TXpH) 
24h 48h 72h Mean 
(TXpH) 
24h 48h 72h Mean 
(TXpH) 
25 0.4 0.8 0.8 0.6 1.1 1.7 1.8 1.5 0.8 1.8 1.8 1.5 1.2 b 
30 1.7 1.7 1.8 1.7 1.7 1.8 1.5 1.7 1.5 1.6 1.2 1.4 1.6 a 
37 1.8 1.8 1.8 1.8 1.5 1.7 1.8 1.7 1.4 1.4 1.6 1.5 1.6 a 
Mean 
(pHxt) 
1.3 1.4 1.5  1.4 1.8 1.7  1.2 1.6 1.5  
Mean 
(pH) 
1.4 c 1.6 a 1.5 b 
 
 
 
 
(b) Temperature X Time interaction 
Temp.  (T)  °C time Mean (T) 
24h 48h 72h 
25 0.8 1.4 1.5 1.2 b 
30 1.6 1.7 1.5 1.6 a 
37 1.6 1.7 1.7 1.6 a 
Mean (time) 1.32 c 1.60 a 1.56 b  
 
Values in the same column (row) followed by the same letter are not 
significantly different by the Duncan Multiple Range test. 
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Table  17. Inhibitory activity (AU) of isolate K5 as affected by 
temperature, pH and time. 
 
(a) Temperature X pH X Time interaction 
Temp. 
(T ) °C 
pH  Mean 
(T) 5.0  5.5  6.0 
24h  48h  72h  Mean 
(TXpH) 
24h  48h  72h  Mean
(TXpH) 
24h  48h  72h  Mean
(TXpH) 
25  50  50  50 50  100.3 99.7 100 100 50 50  50  50  66.7 c
30  100  99.7  100  99.9  199  200  201  200  99.7 99.7  50  83.1  127.7 
a 
37  100  99.7  100  99.9  199 99.7 100 132.9 99.7 50  50  66.6  99.8 b
Mean 
(pHxt) 
83.3  83.1  83.3    166.1 133.1 133.7   83.1 66.6  50   
Mean 
(pH) 
83.3 b  144.3 a  66.6 c 
 
 
 
 
  (b) Temperature X Time interaction 
Temp.  (T)  °C  time Mean (T) 
24h  48h  72h 
25  66.8  66.6  66.7  66.7 c 
30  132.9  133.1  117  127.7 a 
37  132.9  83.1  83.3  99.8 c 
Mean (time)  110.9 a  94.3 b  89 c   
 
Values in the same column (row) followed by the same letter are not 
significantly different by the Duncan Multiple Range test. 
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Table 18. Growth (O.D.) of isolate K8 as affected by temperature, pH 
and time. 
 
(a) Temperature X pH X Time interaction 
Temp. 
(T ) °C 
pH  Mean 
(T) 5.0  5.5  6.0 
24h  48h  72h  Mean 
(TXpH) 
24h  48h  72h  Mean
(TXpH) 
24h  48h  72h  Mean 
(TXpH) 
25  1.2  2.2  2.6  2.0  1.5  1.8  2.1  1.8  1.9  1.7  1.7  1.8  1.8 b 
30  2.7  2.3  2.3  2.4  2.5  2.0  2.0  2.1  2.1  1.5  1.5  1.7  2.1 a 
37  2.5  2.3  2.3  2.3  2.3  2.0  2.0  2.1  2.1  1.6  1.5  1.7  2.0 a 
Mean 
(pHxt) 
2.1  2.2  2.4    2.1  2.0  2.0    2.0  1.6  1.6   
Mean 
(pH) 
2.2 a  2.0 b 1.7 c
 
 
 
 
(b) Temperature x Time interaction 
Temp.  (T)  °C  time  Mean (T) 
24h  48h  72h 
25  1.5  1.9 2.1 1.8 b 
30  2.4  1.9  1.9  2.1 a 
37  2.3  1.9  1.9  2.0 a 
Mean (time)  2.08 a  1.90 c  1.96 b   
 
Values in the same column (row) followed by the same letter are not 
significantly different by the Duncan Multiple Range test. 
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Table 19. Inhibitory activity (AU) of isolate K8 as affected by 
temperature, pH and time. 
 
(a) Temperature X pH X Time interaction 
Temp. 
(T ) °C 
pH  Mean
(T) 5.0  5.5  6.0 
24h  48h  72h  Mean 
(TXpH)
24h  48h  72h  Mean 
(TXpH)
24h  48h  72h  Mean 
(TXpH)
25  99.7  100  100.3  100  100  99.7  99.7  99.8  99.7  99.7  50  83.1  94.3 
b 
30  200  200.3  200.3  200.2  200  199.7 199.7 199.8  100  50  50  66.7  155.6 
a 
37  100  48.3  50  66.1  100  100.3 100  100.1  50  50  50  50  72.07 
c 
Mean 
(pHxt) 
133.2  116.2  116.9    133.3 133.2 133.1   83.2  66.6  50   
Mean 
(pH) 
122.1 b  133.2 a  66.6 c 
 
 
 
 
(b) Temperature X Time interaction 
Temp.  (T)  °C  time  Mean (T) 
24h  48h  72h 
25  99.8  99.8  88.3  94.3 b 
30  166.7  150.0  150.0  155.6 a 
37  83.3  66.2  66.7  72.07 c 
Mean (time)  116.6 a  105.3 b 100 c  
 
Values in the same column (row) followed by the same letter are not 
significantly different by the Duncan Multiple Range test. 
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Table 20. Growth (O.D.) of isolate K11 as affected by temperature, pH 
and time. 
 
(a) Temperature X pH X Time interaction 
Temp. 
(T ) °C 
pH  Mean 
(T) 5.0  5.5  6.0 
24h  48h  72h  Mean 
(TXpH) 
24h  48h  72h  Mean
(TXpH) 
24h  48h  72h  Mean 
(TXpH) 
25  0.7  1.5  1.9  1.3  1.3  1.4  1.7  1.5  1.3  1.3  1.0  1.2  1.3 b 
30  2.2  1.8  1.6  1.8  2.0  1.4  1.3  1.6  1.8  1.8  1.3  1.7  1.7 a 
37  1.9  1.8  1.7  1.8  1.7  1.5  1.5  1.6  1.7  1.4  1.4  1.5  1.6 a 
Mean 
(pHxt) 
1.6  1.7  1.7    1.7  1.4  1.5    1.6  1.5  1.2   
Mean 
(pH) 
1.7 a  1.5 b 1.5 c
 
 
 
 
(b) Temperature x Time interaction 
Temp.  (T)  °C  time  Mean (T) 
24h  48h  72h 
25  1.1  1.4  1.5  1.3 b 
30  2.0  1.7  1.4  1.7 a 
37  1.8  1.6  1.5  1.6 a 
Mean (time)  1.62 a  1.55 b  1.50 c   
 
Values in the same column (row) followed by the same letter are not 
significantly different by the Duncan Multiple Range test. 
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Table 21. Inhibitory activity (AU) of isolate K11 as affected by 
temperature, pH and time. 
 
(a) Temperature X pH X Time interaction 
Temp. 
(T ) °C 
pH  Mean 
(T) 5.0  5.5  6.0 
24h  48h  72h  Mean 
(TXpH) 
24h  48h  72h  Mean
(TXpH) 
24h 48h  72h  Mean
(TXpH) 
25  100  100  99.7  99.9  200  100  100  133.3  50  50  50  50  94.4 
b 
30  100  99.7  100  99.9  200.3 200  200.3 200.2  50  50  50  50  116.7 
a 
37  100  99.7  100  99.9  99.7  99.7  50  83.1  50  50  50  50  77.7 
c 
Mean 
(pHxt) 
100  99.8  99.9    166.7 133.2 116.8   50  50  50   
Mean 
(pH) 
99.9 b  138.9 a  50 c 
 
 
 
 
(b) Temperature X Time interaction 
Temp.  (T)  °C  time  Mean (T) 
24h  48h  72h 
25  116.7  83.3  83.2  94.4 b 
30  116.8  116.6  116.8  116.7 a 
37  83.2  83.1  66.7  77.7 c 
Mean (time)  105.6 a  94.3 b  88.9 c   
 
Values in the same column (row) followed by the same letter are not 
significantly different by the Duncan Multiple Range test. 
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Table 22. Growth (O.D.) of isolate M2 as affected by temperature, pH 
and time. 
 
(a) Temperature X pH X Time interaction 
Temp. 
(T ) °C 
pH  Mean 
(T) 5.0  5.5  6.0 
24h  48h  72h  Mean 
(TXpH) 
24h  48h  72h  Mean
(TXpH) 
24h  48h  72h  Mean 
(TXpH) 
25  1.3  1.6  1.7  1.5  1.4  1.5  1.5  1.5  1.7  1.7  1.7  1.7  1.57 c 
30  1.9  1.9  1.5  1.8  1.7  1.8  1.6  1.7  1.6  1.6  1.6  1.6  1.67 b 
37  1.5  2.1  1.8  1.8  1.7  1.8  1.8  1.8  1.6  1.8  1.6  1.65  1.73 a 
Mean 
(pHxt) 
1.5  1.8  1.7    1.6  1.7  1.6    1.6  1.7  1.7   
Mean 
(pH) 
1.7 a  1.6 a 1.7 a
 
 
 
 
(b) Temperature X Time interaction 
Temp.  (T)  °C  time  Mean (T) 
24h  48h  72h 
25  1.5  1.6  1.6  1.57 c 
30  1.7  1.7  1.6  1.67 b 
37  1.6  1.9  1.7  1.73 a 
Mean (time)  1.59 c  1.73 a  1.64 b   
 
Values in the same column (row) followed by the same letter are not 
significantly different by the Duncan Multiple Range test. 
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Table 23. Inhibitory activity (AU) of isolate M2 as affected by 
temperature, pH and time. 
 
(a) Temperature X pH X Time interaction 
Temp. 
(T ) °C 
pH  Mean 
(T) 5.0  5.5  6.0 
24h  48h  72h  Mean 
(TXpH) 
24h  48h  72h  Mean
(TXpH) 
24h  48h  72h  Mean
(TXpH) 
25  50  50  50  50  199.7 200 200 199.9  50  50  50  50  100 b 
30  100  50  50  66.67  200  200 200 200  100  100  50  83.3  116.7 
a 
37  50  50  50  50  200  200 200 200  50  50  50  50  100 b 
Mean 
(pHxt) 
66.67  50  50    199.9 200 200   66.7 66.7  50   
Mean 
(pH) 
55.6 c  200 a  61.1 b 
 
 
 
 
(b) Temperature X Time interaction 
Temp.  (T)  °C  time  Mean (T) 
24h  48h  72h 
25  99.89  100  100  100 b 
30  133.3  116.7  100  116.7 a 
37  100  100  100  100 b 
Mean (time)  111.1 a  105.6 b  100 c   
 
Values in the same column (row) followed by the same letter are not 
significantly different by the Duncan Multiple Range test. 
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Table 24. Growth (O.D.) of isolate M3 as affected by temperature, pH 
and time. 
 
(a) Temperature X pH X Time interaction 
Temp. 
(T ) °C 
pH  Mean 
(T) 5.0  5.5  6.0 
24h  48h  72h  Mean 
(TXpH) 
24h  48h  72h  Mean
(TXpH) 
24h  48h  72h  Mean 
(TXpH) 
25  1.3  1.3  1.7  1.4  1.6  1.7  1.8  1.7  1.5  1.6  1.5  1.5  1.6 b 
30  1.5  1.6  1.6  1.6  1.5  1.7  1.5  1.6  1.6  1.6  1.5  1.6  1.6 b 
37  1.7  1.9  1.9  1.8  1.5  1.9  1.9  1.7  1.6  1.8  1.8  1.7  1.8 a 
Mean 
(pHxt) 
1.5  1.6  1.7    1.6  1.7  1.7    1.5  1.7  1.6   
Mean 
(pH) 
1.6 a  1.7 a 1.6 a
 
 
 
 
(b) Temperature X Time interaction 
Temp.  (T)  °C  time  Mean (T) 
24h  48h  72h 
25  1.5  1.5  1.7  1.6 b 
30  1.5  1.6  1.6  1.6 b 
37  1.6  1.8  1.8  1.8 a 
Mean (time)  1.53 c  1.67 b  1.68 a   
 
Values in the same column (row) followed by the same letter are not 
significantly different by the Duncan Multiple Range test. 
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Optimal growth of isolate M4 was recorded at 30 ºC and pH 5.5 for 48 
or 72 hours, or 30 ºC and pH 6.0 for 48 or 72 hours (Table 26). 
Nevertheless, the best combination for maximum production of 
inhibitory activity was 30 ºC and pH 5.5 whether incubated for 24, 48 or 
72 hours (Table 27). 
The interaction of temperature, pH and incubation period showed that 
best growth of isolate R1 was obtained with the combinations of 30 ºC 
and pH 5.5 for 48 hours, or 37 ºC and pH 5.5 for 24 or 48 hours (Table 
28). However, maximum inhibitory activity was obtained with the 
combinations of 30 ºC and pH 5.5 for 24, 48 or 72 hours, or 30 ºC and pH 
6.0 for 24 hours (Table 29). 
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Table 25.  Inhibitory activity (AU) of isolate M3 as affected by 
temperature, pH and time. 
 
(a) Temperature X pH X Time interaction 
Temp. 
(T ) °C 
pH  Mean
(T) 5.0  5.5  6.0 
24h  48h  72h  Mean 
(TXpH)
24h  48h  72h  Mean 
(TXpH)
24h  48h  72h  Mean 
(TXpH)
25  99.7  100  100  99.9  99.7  100  99.7  99.8  99.7  50  50  66.6  88.7 
c 
30  200  199.7 200  199.9  200  200  200  200  100  50  50  66.7  155.5 
a 
37  99.7  100  50  83.2  200  200  99.7  166.6  50  50  50  50  99.9 
b 
Mean 
(pHxt) 
133.1  133.2 116.7    166.6 166.7 133.1   83.2  50  50   
Mean 
(pH) 
127.7 b  155.4 a  61.1 c 
 
 
 
 
(b) Temperature X Time interaction 
Temp.  (T)  °C  time Mean (T) 
24h  48h  72h 
25  99.7  83.3  83.2  88.7 c 
30  166.7  149.9  150.0  155.5 a 
37  116.6  116.7  66.6  99.9 b 
Mean (time)  127.6 a  116.6 b  99.9 c   
 
Values in the same column (row) followed by the same letter are not 
significantly different by the Duncan Multiple Range test. 
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Table 26. Growth (O.D.) of isolate M4 as affected by temperature, pH 
and time. 
 
(a) Temperature X pH X Time interaction 
Temp. 
(T ) °C 
pH  Mean 
(T) 5.0  5.5  6.0 
24h  48h  72h  Mean 
(TXpH) 
24h  48h  72h  Mean
(TXpH) 
24h  48h  72h  Mean 
(TXpH) 
25  1.0  1.2  1.5  1.4  1.0  1.6  2.1  1.7  0.8  1.5  2.1  1.5  1.4 b 
30  1.2  1.8  1.8  1.6  1.5  2.1  2.1  1.6  1.4  2.1  2.1  1.6  1.8 a 
37  1.5  1.8  1.8  1.8  1.9  1.9  1.8  1.7  1.6  1.8  1.8  1.7  1.8 a 
Mean 
(pHxt) 
1.2  1.6  1.7    1.5  1.9  2.0    1.3  1.8  2.0   
Mean 
(pH) 
1.5 c  1.8 a 1.7 b
 
 
 
 
(b) Temperature X Time interaction 
Temp.  (T)  °C  time  Mean (T) 
24h  48h  72h 
25  0.9  1.4  1.9  1.4 b 
30  1.4  2.0  2.0  1.8 a 
37  1.7  1.9  1.8  1.8 a 
Mean (time)  1.3 c  1.8 b  1.9 a   
 
Values in the same column (row) followed by the same letter are not 
significantly different by the Duncan Multiple Range test. 
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Table 27. Inhibitory activity (AU) of isolate M4 as affected by 
temperature, pH and time. 
 
(a) Temperature X pH X Time interaction 
Temp. 
(T ) °C 
pH  Mean 
(T) 5.0  5.5  6.0 
24h  48h  72h  Mean 
(TXpH) 
24h  48h  72h  Mean
(TXpH) 
24h  48h  72h  Mean
(TXpH) 
25  50  50  50  50  100 100 100 100 50 50  50  50  66.7 
c 
30  50  50  50  50  200  200  200  200  100  50  50  66.7  105.6 
a 
37  100  50  50  66.7  100  100  100  100  50  50  50  50  72.2 
b 
Mean 
(pHxt) 
66.7  50  50    133.3 133.3 133.3   66.7 50  50   
Mean 
(pH) 
55.6 b  133.3 a  55.6 b 
 
 
 
 
(b) Temperature X Time interaction 
Temp.  (T)  °C  time  Mean (T) 
24h  48h 72h
25  66.7  66.7  66.7  66.7 c 
30  116.7  100  100  105.6 a 
37  83.3  66.7  66.7  72.2 b 
Mean (time)  88.9 a   77.8 b  77.8 b   
 
Values in the same column (row) followed by the same letter are not 
significantly different by the Duncan Multiple Range test. 
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Table 28. Growth (O.D.) of isolate R1 as affected by temperature, pH and 
time. 
 
(a) Temperature X pH X Time interaction 
Temp. 
(T ) °C 
pH  Mean 
(T) 5.0  5.5  6.0 
24h  48h  72h  Mean 
(TXpH) 
24h  48h  72h  Mean
(TXpH) 
24h  48h  72h  Mean 
(TXpH) 
25  0.6  0.9  1.5  1.0  0.7  1.4  1.7  1.3  0.5  1.2  1.6  1.1  1.1 b 
30  1.1  1.8  1.5  1.5  1.6  2.1  2.0  1.9  1.1  1.7  1.7  1.5  1.6 a 
37  1.5  1.7  1.5  1.6  2.1  2.1  1.8  2.0  1.5  1.7  1.5  1.6  1.7 a 
Mean 
(pHxt) 
1.1  1.5  1.5    1.4  1.8  1.8    1.0  1.5  1.6   
Mean 
(pH) 
1.3 b  1.7 a 1.4 b
 
 
 
 
(b) Temperature X Time interaction 
Temp.  (T)  °C  time  Mean (T) 
24h  48h  72h 
25  0.6  1.2  1.6  1.1 b 
30  1.3  1.8  1.7  1.6 a 
37  1.7  1.8  1.6  1.7 a 
Mean (time)  1.2 b  1.6 a  1.6 a   
 
Values in the same column (row) followed by the same letter are not 
significantly different by the Duncan Multiple Range test. 
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Table 29. Inhibitory activity (AU) of isolate R1 as affected by temperature, 
pH and time. 
 
(a) Temperature X pH X Time interaction 
Temp. 
(T ) °C 
pH  Mean 
(T) 5.0  5.5  6.0 
24h  48h  72h  Mean 
(TXpH) 
24h  48h  72h  Mean
(TXpH) 
24h  48h  72h  Mean
(TXpH) 
25  99.7  50  50 66.6  100 100 100 100 50 50  50  50 72.2 
c 
30  100  100  100  100  200  200  200  200  200  100  99.7  133.2  144.4 
a 
37  100  99.7  50  83.2  100  100  100  100  100  100  100  100  94.4 
b 
Mean 
(pHxt) 
99.9  83.2  66.7    133.3 133.3 133.3   116.7 83.3  83.2   
Mean 
(pH) 
83.3 c  133.3 a  94.4 b 
 
 
 
 
(b) Temperature X Time interaction 
Temp.  (T)  °C  time  Mean (T) 
24h  48h  72h 
25  83.2  66.7  66.7  72.2 c 
30  166.7  133.3  133.2  144.4 a 
37  100  99.9  83.3  94.4 b 
Mean (time)  116.6 a  100 b  94.4 c   
 
Values in the same column (row) followed by the same letter are not 
significantly different by the Duncan Multiple Range test. 
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CHAPTER  FIVE 
DISCUSSION 
The present study was carried out with the objective of isolating 
lactic acid bacteria (LAB) from various sources, hoping to 
demonstrate the ability of some of them to produce bacteriocins 
which would be of potential use as safe and natural antimicrobials for 
combating pathogenic and food spoilage organisms. Moreover, 
identification of the producer strains and characterization of the 
inhibitory substances they produce were also undertaken. 
 
Forty-eight isolates of lactic acid bacteria were obtained from various 
sources which included fresh cow, camel and human milk, fermented 
meat, fermented fish, chicken faeces, newborn infant faeces, human 
mouth flora and fermented sorghum flour. Screening of these isolates 
for inhibition of the growth of four indicator bacteria (Staphylococcus 
aureus ATCC43306, Bacillus subtilis NCTC8236, Enterococcus faecalis 
ATCC10541 and Escherichia coli ATCC25922) resulted in inhibition of 
the growth of these strains. Lactic acid bacteria are known to produce 
several low molecular weight antimicrobial substances which can 
inhibit the growth of other bacteria. Their antimicrobial activity could 
be due to the production of organic acids (in particular, lactic acid 
and acetic acids), carbon dioxide, ethanol, hydrogen peroxide, 
bacteriocins and diacetyl (Daeschel, 1989; De Vuyst and Vandamme, 
1994). With such a wide range of possible inhibitory products, it is 
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possible that some bacteriocin-like activities may not be caused by 
bacteriocins at all. It cannot therefore be ascertained at this stage 
whether the inhibition observed here was due to bacteriocins or to 
any of those substances. This has to await characterization of the 
inhibitory substances and exclusion of the other possible causative 
agents. 
 
 Lactic acid bacteria capable of inhibiting the growth of other bacteria 
are commonly obtained from sources similar to the ones tapped in 
the present study. For instance, Arici et al. (2004) isolated 21 
lactobacilli from newborn infant faeces all of which produced 
bacteriocins or bacteriocin-like substances that inhibited the growth 
of various indicator bacteria, including Staph. aureus and E. coli. Other 
research workers isolated bacteriocinogenic LAB strains from sources 
such as fresh and processed meat (Lewus et al., 1991; Kröckel, 1992; 
Tichaczek et al., 1994; De Martinis and Freitas, 2003; Verluyten et al., 
2004), milk (Héchard et al., 1990; Casla et al., 1996; Rodriguez et al., 
1998), dairy products (Gonzalez et al., 1994; Samelis et al., 1994; Rekhif 
et al., 1995), cereal beverages (Todorov and Dicks, 2005a; 2007), 
various fermented foods (Olukoya et al., 1994; Ogunshe et al.,2007), 
vegetables (Harris et al., 1992; Breidt et al., 1993; Choi et al., 1999), fish 
(Stoffels et al., 1992; Fricourt et al., 1994; Duffes et al., 2000) and 
poultry (De Martinis and Freitas, 2003; Strompfova and Laukova, 
2007). 
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The strains isolated in the present project belonged to the LAB genera 
Lactobacillus, Leuconostoc, Carnobacterium, Enterococcus, Pediococcus and 
Tetragenococcus all of which, except Tetragenococcus, are documented 
to encompass bacteriocinogenic spp. (Daeschel, 1989; Carolissen-
Mackay et al., 1997). Accordingly, nine selected isolates, viz., N2, N3, 
K5, K8, K11, M2, M3, M4 and R1, were further investigated for their 
inhibitory capacities, their specific affiliations and for characterization 
of the substances responsible for the observed inhibition. These 
isolates were identified as Pediococcus pentosaceus (isolate N2), 
Enterococcus faecalis (N3), Pediococcus pentosaceus (K5), Lactobacillus 
fermentum (K8), Lactobacillus sake (K11), Pediococcus acidilactici (M2), 
Lactobacillus curvatus (M3), Lactobacillus plantarum (M4) and 
Lactobacillus plantarum (R1). 
When cell-free filter-sterilized extracts from each of the nine selected 
isolates were tested for inhibition of ten target bacterial strains by the 
agar well-diffusion assay (Barefoot and Klaenhammer, 1983) clear 
inhibition zones were produced by each of them against most of the 
target strains. To exclude the possible action of hydrogen peroxide 
(H2O2), the isolates were grown under anaerobic conditions and their 
extracts were tested. They produced inhibition zones comparable to 
those obtained using extracts produced under aerobic conditions. 
Exclusion of the effect due to H2O2 is ideally achieved by inclusion of 
the enzymes catalase or peroxidase which destroy H2O2. However, 
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H2O2 is only produced under aerobic conditions (Ouwehand and 
Vesterlund, 2004). Moreover, some workers (e.g. Fontaine et al., 1996) 
question whether in vivo H2O2 production has any significant 
bactericidal effect. 
When investigating bacteriocins produced by LAB strains, one must 
always be aware of the possible presence of relatively high amounts 
of organic acids and take appropriate steps to determine or eliminate 
their effects. In the present work the effect due to organic acids was 
excluded by testing inhibition by the extracts after adjusting them to 
different pH values. It was shown that (Figs. 1-9) maximum 
inhibition by all nine extracts was produced at the pH value of 5.0, 
and was slightly reduced at pH 7.0. Moreover, the activity was 
greatly reduced at the pH values of 3.0 and 9.0.The great reduction in 
inhibitory activity at pH 3.0 excludes any major effect due to the 
production of organic acids by the test isolates. Correction of the cell-
free supernatants to pH 6.0 is usually used by research workers to 
exclude the inhibitory effect due to lactic acid (Todorov and Dicks, 
2007). 
Reuterin is a non-proteinaceous metabolite of glycerol that is 
produced by Lactobacillus reuteri. It has a broad spectrum of 
antimicrobial activity against Gram-positive and Gram-negative 
bacteria, yeasts and filamentous fungi (Nout and Rombouts, 1992). 
As it is a specific property of Lactobacillus reuteri (Talarico et al., 1990), 
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no interference by this compound was envisaged in the present 
investigations. 
On the other hand, citrate metabolism by Lactobacillus lactis subsp. 
lactis (biovar diacetylactis) and Leuconostoc mesentroides subsp. cremoris 
strains may result in excess pyruvate in the cell. The pyruvate may be 
converted to diacetyl, an important flavour and aroma component of 
butter and some other milk products (Cogan and Hill, 1993). 
However, diacetyl is rarely present in food fermentations at sufficient 
levels to make a major contribution to antibacterial activity (Caplice 
and Fitzgerald, 1999). Diacetyl has a broad spectrum of antimicrobial 
activity at concentrations of 300-1000 ppm. The levels of diacetyl that 
are found naturally in LAB-fermented foods (0.2-1.5 ppm) are too low 
to be effective (Helander et al., 1997). 
Further investigation on the nature of the inhibitory substance of the 
cell-free supernatants confirmed their proteinaceous nature as the 
active inhibitory moiety was destroyed by proteases. Moreover, all 
nine supernatants exhibited good heat stability (Figs. 10-18), and 
were of low molecular weights (3-5 KDa) as shown by Tricine-SDS-
PAGE electrophoreisis. Therefore, taking into account their 
bactericidal (or bacteriostatic) nature (Figs. 29-37), their heat stability 
(Figs. 10-18) and their low molecular weights (Fig. 28), the active 
substances in the present extracts can be classified as bacteriocins 
according to the definition given by Klaenhammer (1993) and other 
workers. 
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Bacteriocins are small peptides with antimicrobial properties against 
bacteria of closely related species (narrow spectrum of action). 
However, most of the present isolates exhibited a broad spectrum of 
activity, including unrelated bacterial species. This finding of a broad 
spectrum of inhibitory activity is in line with the findings of many 
research workers (Rantsiou et al. 2006; Galvez et al. 2008; Settanni and 
Corsetti 2008) who reported broad spectra encompassing distantly 
related genera and species. Pediocin PA-1 has been shown by 
Rodriguez et al. (2002) to have a wide spectrum of action. Lactacin 
3147 was effective against a wide spectrum of Gram-positive bacteria 
(McAuliffe et al. 1998; Ryan et al. 1998). Lactocin S, secreted by 
Lactobacillus sake, was found by Aymerich et al. (1998) to have a 
spectrum of inhibitory activity that comprised several LAB strains as 
well as Clostridium. Plantaricin 35d, produced by Lactobacillus 
plantarum, showed a wide range of inhibitory spectrum affecting 
different non-taxonomically related genera, including food-borne 
pathogens such as Staphylococcus aureus and Listeria monocytogenes 
(Messi et al. 2001). Todorov and Dicks (2005,b) stated that the 
bacteriocins ST28MS and ST26MS (from Lactobacillus plantarum) 
exhibited antibacterial activities against genera such as Pseudomonas, 
Staphylococcus, Klebsiella, Escherichia and Acinetobacter. In the present 
study, the local E. coli strain (obtained from the Central Public Health 
Laboratory, Khartoum State) was found to resist inhibition by any of 
the supernatants obtained from the 9 isolates. No possible 
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explanation can be thought of, and resistance by this isolate deserves 
further detailed investigation. 
The mode of action of some of the present bacteriocins (those 
produced by the isolates N2, N3, K5, K11 and M2) appeared to be 
bacteriostatic in nature as growth of the inhibited bacterial isolates 
was resumed 24 hours after re-streaking on fresh Nutrient Agar. On 
the other hand, bacteriocins produced by the other four isolates (K8, 
M3, M4 and R1) appeared to be bactericidal in nature as no growth of 
the inhibited target strain could be obtained on re-streaking on fresh 
media. Bacteriocins have been described as a heterogenous group of 
antibacterial compounds varying in their mode of action, activity 
spectrum, molecular weight, biochemical properties and genetic 
origin (Klaenhammer 1988; 1993). Thus, while the mode of action of 
bacteriocins such as lactacin 3147, produced by Lactobacillus lactis 
subsp. lactis (Ryan et al. 1996), pediocin SA-1, produced by Pediococcus 
acidilactici (Anastasiadou et al. 2008), plantaricin 35d (Messi et al. 2001) 
and plantaricin 423 (Verellen et al. 1998) was strongly bactericidal, 
other bacteriocins were found to be of a bacteriostatic nature. 
Examples of the latter group include sakacin K, produced by 
Lactobacillus sake (Hugas et al. 1998), lactocin 27, produced by 
Lactococcus helveticus (Upreti and Hindstill 1975) and bacteriocins 
ST28MS and ST26MS, (Todorov and Dicks 2005,b).  
The present nine investigated isolates belonged to the genera 
Pediococcus (N2 and K5), Enterococcus (N3), Lactobacillus (K8, K11, M3, 
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M4 and R1) and Pediococcus (M2). Their bacteriocin molecular 
weights were in the range 3-5 KDa. This indicates that they belong to 
the Klaenhammer (1993) class II non-lanthionine containing, heat-
stable, membrane-active bacteriocins. 
 Isolate N2 (Pediococcus pentosaceus) produced a bacteriocin of 
molecular weight of about 3.0 KDa. Pinto et al. (2007) found that 
Pediococcus pentosaceus produced a bacteriocin of molecular weight of 
2.5 KDa, and Venema et al. (1997) reported a molecular weight of 3.4 
KDa for pediocin PA-1 produced by this same species.  
Isolate N3 (Enterococcus faecalis) produced a bacteriocin of molecular 
weight in the same range (about 3.0 KDa).This is not far from the 
range reported for enterocins 1071A and 1071B (produced by an 
Enterococcus faecalis isolated from pigs) which had molecular weights 
of 4.285 and 3.899 KDa, respectively (Balla et al. 2000). Losteinkit et al. 
(2001) reported a molecular weight of 3-5 KDa for an Enterococcus 
faecalis bacteriocin, while Wachsman et al. (2003) reported a molecular 
weight of 3.5 for enterocins of Enterococcus faecalis and Enterococcus 
faecium.  
Lactobacillus fermentum (isolate K8), Lb. sake (K11), Lb. curvatus (M3) 
and Lb. plantarum (R1), produced bacteriocins of molecular weights in 
the range of 3-5 KDa. Similar molecular weights have been reported 
for bacteriocins produced by Lactobacillus species (Messi et al. 2001; 
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Gonzalez et al. 1994; Garver and Muriana 1994) which is supported 
by the present findings. 
Similarly, the molecular weight reported here for Pediococcus 
acidilactici (3.0 KDa) falls in the range of molecular weights usually 
reported for bacteriocins produced by this species. For instance, 
Motlagh et al. (1992) reported a molecular weight of 2.7 KDa for the 
bacteriocin pediocin AcH produced by P. acidilactici, while 
Anastasiadou et al. (2008) reported a molecular weight of 3.66 for 
pediocin SA-1 produced by Pediococcus acidilactici NRRL B5627. 
 
The kinetics of bacteriocin production by lactic acid bacteria in 
relation to environmental factors has been studied in detail through 
mathematical modeling and predictive microbiology. In general, the 
cultivation conditions (such as temperature, pH and nutrient 
availability) directly affect bacteriocin production as such, and 
indirectly through biomass production. This has been explained by 
the fact that bacteriocin production is a growth-dependent 
physiological trait, and hence follows primary metabolite kinetics (De 
Vuyst et al. 1996; Leroy and De Vuyst, 1999), and bacteriocin titers 
have been shown to change with environmental conditions (Leal-
Sanchez et al. 2002, Matargas et al. 2004). Nevertheless, the correlation 
between growth and bacteriocin production has often been observed 
to be weak (Delgado et al. 2005), particularly with bacteriocins 
produced during the stationary growth phase (Jiminez-diaz et al. 
1993). Accordingly, Delgado et al. (2007) reported that bacteriocin 
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production by Lactobacillus plantarum 17.2b, although associated with 
growth, was not correlated to biomass, and hence followed mixed, 
rather than primary, metabolite kinetics.  
 
In some cases bacteriocin production starts at the early stages of 
growth, while in others production is delayed to late logarithmic 
phase or early stationary phase. Todorov and Dicks (2005,b) recorded 
detectable levels of bacteriocin from Lactobacillus plantarum in MRS 
broth as early as 5 hours of incubation. Similar results were reported 
for plantaricin Y (Chin et al. 2001), bacteriocins produced by 
Pediococcus acidilactici (Nieto-Lozano et al. 2002) and a bacteriocin 
produced by Lactobacillus lactis subsp. lactis (Cheigh et al. 2002). In the 
present study bacteriocin production (inhibitory activity) was 
reported as early as four (isolate R1), five (isolates M2 and M3) or 
seven (isolate K5) hours from inoculation, which is similar to the 
above findings. Moreover, production of the inhibitory activity by the 
present isolates seemed, in most of the cases, to follow primary 
metabolite kinetics as it was generally correlated with growth.  
 
On the other hand, production of plantaricin 35d (Messi et al. 2001), 
plantaricin UG1 (Enan et al. 1996) and plantaricin KW30 (Kelly et al. 
1996) in MRS was dependent on the bacterial growth phase. In case of 
plantaricin 35d, the bacterium (Lactobacillus plantarum) started to 
produce the bacteriocin (about 60 AU/ml) during the late logarithmic 
phase, and reached a maximum (320AU/ml) after 19 hours of 
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incubation. Todorov and Dicks (2005,b) reported low levels of 
bacteriocin activity (less than 200 AU/ml) after six hours of growth of 
Lactobacillus pentosus in MRS broth, but optimal production was not 
started before 24 hours of growth and only when incubated at 30 °C. 
Production of the inhibitory activity by isolate K8 (Lactobacillus 
fermentum) in the present study was detected as late as 10 hours from 
inoculation. 
 
A decrease in inhibitory activity levels after logarithmic growth has 
been observed for lactacin B (Barefoot and Klaenhammer, 1984; 
Joerger and Klaenhammer, 1986), mesenterocin 5 (Daba et al. 1991) 
and enterocin 1146 (Parente and Ricciardi 1999). In many of these 
cases, loss of activity has been ascribed to proteolytic degradation, 
protein aggregation, adsorption to cell surfaces and feedback 
regulation (Parente et al. 1994; Parente and Ricciardi 1994; De Vuyst et 
al. 1996; Leyeune et al. 1998; Aasen et al. 2000). 
 
In lactic acid bacteria the environmental control seems to play an 
important role in bacteriocin production as has been observed by 
Aasen et al. (2000), Nel et al. (2001) and Guerra and Pastrana (2002). 
Food preservation using in situ bacteriocin production requires a 
thorough understanding of the relationship between growth and 
bacteriocin production. Bacteriocin production is very sensitive to 
environmental conditions and can be triggered or inactivated by very 
slight changes in environmental conditions.  
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In the present study the effects of pH, temperature and incubation 
period were found to show a high degree of interaction. The primary 
effects of any one of these three factors were not enough to determine 
the best level of that factor for growth or production of the inhibitory 
activity as was shown in the tables depicting these effects (Tables 12-
29). Although each isolate had its unique combinations of 
temperature, pH and incubation period for maximum growth and 
optimal production of inhibitory activity, the pH range of 5.0-5.5 and 
the temperature of 30-37 °C were generally the most suitable, while 
great variation was shown in case of the length of the incubation 
period. Moreover, in many cases the pH or temperature for maximal 
growth did not coincide with those for production of highest 
inhibitory activity. Bacteriocin production was reported to be higher 
at uncontrolled pH, as happens during natural fermentation (Moretro 
et al. 2000), and maximal production of inhibitory activity has been 
reported mostly in the pH range of 4.5-5.5 (Krier et al. 1998; 
Klostermaier et al. 1999;  Calderon-Santoyo et al. 2001). In Lactobacillus 
curvatus L442, optimum pH for bacteriocin production was 5.5 while 
the optimum for growth was 6.0 -6.5, and bacteriocin production was 
favoured by relatively low growth rates (Mataragas et al. 2003). 
Drosinos et al. (2006) also found that the optimum pH value for 
bacteriocin production did not coincide with the best pH value for 
growth, and that bacteriocin production was favoured by relatively 
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slow growth rates, probably due to the better utilization of energy at 
these low growth rates. 
As for the effect of temperature, Messi et al. (2001) found that 
production of the inhibitory activity by Lactobacillus plantarum 
remained at the same level when the producer strain was incubated 
at 18, 22 or 30 °C, but production was reduced at 37 or 40 °C. Enan et 
al. (1996) also reported maximum bacteriocin production when a 
broth culture of L. plantarum was incubated at 25-30 °C. A shift-down 
of temperature appeared to stimulate bacteriocin production. Higher 
bacteriocin concentrations at temperatures sub-optimal for growth 
has been reported by several authors (Krier et al. 1998; Moretro et al. 
2000; Calderon-Santoyo et al. 2001; Delgado et al. 2005; 2007). The 
apparent stimulation of bacteriocin production at sub-optimal 
growth temperatures has been explained as a result of slow growth 
that frees up more energy for bacteriocin production (De Vuyst et al. 
1998). 
 
Finally, it has to be stated that bacteriocins produced by lactic acid 
bacteria have attracted special interests due to their potential use as 
safe and natural antimicrobials which can be applied as food 
preservatives. Screening programs, of which the present one is a 
modest contribution, have yielded a large arsenal of bacteriocins with 
different properties, target species and producer organisms. 
Furthermore, the estimates of the percentage of bacteria that produce 
bacteriocins indicate that many other bacteriocins remain to be 
 190 
 
identified and exploited, and this will be passed over as a 
recommendation for other potential research workers in this vital 
field of research. 
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CONCLUSIONS AND RECOMMENDATIONS 
This work has demonstrated that production of bacteriocins is of 
widespread occurrence among the lactic acid bacteria isolated during 
the present study.  
One major application of this property is the utilization of 
bacteriocinogenic strains of lactic acid bacteria as starter cultures in 
food fermentations. This will improve the microbiological quality of 
the end-product through controlling the growth of other, unwanted, 
microorganisms; in addition to imparting enhanced organoleptic 
attributes to the fermented product. 
Another important application is seen through the use of such 
isolates as probiotic strains that can have a positive influence on 
health through modulating colon microflora. 
In the end, the acceptance and use of purified bacteriocins in food 
preservation as safe and natural additives is expected to expand 
rapidly. It is, therefore, recommended that further probing and 
exploration of bacteriocionogenic strains of bacteria, particularly 
lactic acid bacteria, should be undertaken. 
It is hoped that the presently flourishing local food industry should 
back such efforts, as well as seek ways of making practical use of 
research findings in this field. This will certainly be more than 
welcome in view of the increasing demand by consumers for more 
"natural" food preservation methods. 
 192 
 
CHAPTER SIX 
REFERENCES 
 
Aasen, I. M.; Moretro, T.; Katla, T.; Axelsson, L. and Storro, I. (2000). 
Influence of complex nutrients, temperature and pH on 
bacteriocin production by Lactobacillus sakei CCUG 42687. 
Applied Microbiology and Biotechnology, 53, 159–166. 
Abee, T.; Krockel, L. and Hill, C. (1995). Bacteriocins: modes of action 
and potential in food preservation and control of food 
poisoning. Int. J. Food Microbiol. 28, 169–185. 
Abrionel, H.; Valdivia, E.; Galvez, A. and Maqueda, M. (2001). 
Influence of physicochemical factors on the oligomerization and 
biological activity of bacteriocin AS-48. Curr. Microbiol. 42, 89–
59. 
Anastasiadou, S.; Papagianni, M.; Filiousis, G.; Ambrosiadis, I. and  
Koidis, P. (2008). Pediocin SA-1, an antimicrobial peptide from 
Pediococcus acidilactici NRRL B5627: Production conditions, 
purification and characterization. Bioresource Technology 99, 
5384–5390. 
Arici, M.; Bilgin, B.; Sagdic, O; and Ozdemir, C. (2004). Some 
characteristics of Lactobacillus isolates from infant faeces. Food 
Microbiology 21, 19-24. 
 193 
 
Axelsson L. (2004). Lactic acid bacteria: Classification and physiology. 
Pp 1-67 in: Lactic Acid Bacteria: Microbiological and Functional 
Aspects (Salminen, S.; Wright, A.V. and Ouwehand, A.; eds). 3rd 
edition. Marcel Dekker, New York. 
Aymerich, T.; Holo, H.; Havarstein, L.S.; Hugas, M.; Garriga, M. and 
Nes, I.F. (1996). Biochemical and genetic characterization of 
enterocin A from Enterococcus faecium, a new antilisterial 
bacteriocin in the pediocin family of bacteriocins. Appl. Environ. 
Microbiol. 62, 1676-1682. 
Aymerich, M.; Hugas, M. and Monfort, J. (1998). Review: 
Bacteriocinogenic lactic acid bacteria associated with meat 
products. Food Science and Technology International, 4, 141–158. 
Baba, T. and Schneewind, 0. (1996). Target cell specificity of  a 
bacteriocin molecule: a C-terminal signal directs lysostaphin to 
the cell wall of Staphylococcus aureus.  EMBO J. 15, 4789-4797. 
Bailey, F.J. and Hurst, A. (1971). Preparation of a highly active form 
of nicin from Streptococcus lactis. Can. J. Microbiol. 17, 61-67. 
Balla, E.; Dicks, L.M.T.; Du Toit, M.; Van der Merwe, M.J. and 
Holzapfel, W.H. (2000). Characterization and cloning of the 
genes encoding Enterocin 1071A and Enterocin 1071B, two 
antimicrobial peptides produced by Enterococcus faecalis BFE 
1071. Appl. Environ. Microbiol. 66, 1298– 1304. 
 
 194 
 
Barefoot, S.F. and Klaenhammer,T.R. (1983). Detection and activity of 
lactacin B, a bacteriocin produced by Lactobacillus acidophilus. 
Appl. Environ. Microbiol. 45, I8-15. 
Barefoot. S.F. and Klaenhammer, T.R. (1984). Purification and 
characterization of Lactobacillus acidophilis bacteriocin lactacin B. 
Antimicrob. Agents Chemother. 26, 328 -334. 
Baquero, F.; Bouanchaud, D.; Martinez-Perez, M.C. and Fernandez, C. 
(1978). Microcin plasmids: a group of extrachromosomal 
elements coding for low-molecular-weight antibiotics in 
Escherichia coli. J. Bacteriol.  135, 342–347. 
Benkerroum, R.and Sandine, W.E. (1988). Inhibitory action of nisin 
against Listeria monocytogenes. J. Dairy Sci. 71, 3237–3245. 
Bennik, M.H.J.; Vanloo, B.; Brasseur, R.; Gorris, L.G.M. and Smid, E.J. 
(1998). A novel bacteriocin with a YGNGV motif from 
vegetable-associated Enterococcus mundtii: full characterization 
and interaction with target organisms. Biochim. Biophys. Acta 
1373, 47-58. 
Benz, R.; Jung, G. and Sahl, H.-G. (1991). Mechanism of channel-
forming lantibiotics in black lipid membranes. Pp. 359– 372 in: 
Nisin and Novel Lantibiotics (Jung, G. and Sahl, H.G., eds.). 
ESCOM, Leiden, The Netherlands. 
 
 195 
 
Berry, E.D., Liewen, M.B., Mandigo, R.M., Hutkins, R.W. (1990). 
Inhibition of Listeria monocytogenes by bacteriocin-producing 
Pediococcus during manufacture of fermented semi-dry sausage. 
J. Food Protect. 53, 194–197. 
Blackburn, P. and Goldstein, B. P. (1995). Nisin compositions to 
prevent the promotion of tooth decay by suppressing formation 
of acid from foods by oral bacteria.  Applied Microbiology, Inc. 
International Patent Application WHO 97/10801. 
Bolotin, A. ; Mauger, S.; Malarme, K.; Ehrlich, S.D. and Sorokin, A. 
(1999). Low redundancy sequencing of the entire Lactococcus 
lactis IL1403 genome. Antonie van Leeuwenhoek  1-4, 27-76. 
Bowman, J.P. (2004). Order VII: Methylococcales. Pp. 248-269 in: 
Bergys Manual of Systematic Bacteriology, 2nd edition, Part C 
(Brenner, D.J.; Krieg, N.R. and Garrity, G.M., eds). Elsevier 
Publishing.  
Braun, V.; Pilsl, H.and Groß, P. (1994). Colicins: structures, modes of 
actions, transfer through membranes, and evolution. Arch. 
Microbiol. 161, 199–206. 
Breidt, F.; Crowley, K.A. and Flemming, H.P. (1993). Isolation and 
characterization of nisin-resistant Leuconostoc mesenteroides for use 
in cabbage fermentations. Appl. Environ. Microbiol. 59, 3778-3783. 
Breukink, E.; Weidemann, I.; van Kraaij, C.; Kuipers, O. P.; Sahl, H.-G. 
and de Kruijff, B. (1999). Use of cell wall precursor lipid II by a 
poreforming peptide antibiotic. Science 286, 2361–2364. 
 196 
 
Brotz, H.; Bierbaum, G.; Leopold, K.; Reynolds, P. E. and Sahl, H.-G. 
(1998). The lantibiotic mersacidin inhibits peptidoglycan 
synthesis by targeting lipid II. Antimicrobial Agents and 
Chemotherapy  42, 154–160. 
Bruno, M.E.C. and Montville, T.J. (1993) Common mechanistic action 
of bacteriocin from lactic acid bacteria. Appl. Environ. Microbiol. 
59, 3003- 3010. 
Buzby, J.C. and Roberts, T. (1997). Economic costs and trade impacts 
of microbial foodborne illness. World Heath Stat. Q. 50, 57–66. 
Çadirci B.H. and Çitak, S. (2005). A comparison of two methods used 
for measuring antagonistic activity of lactic acid bacteria. 
Pakistan Journal of Nutrition 4, 237-241. 
Calderon-Santoyo, M.; Mendoza-Garcia, P.G.; Garcija-Alvarado, M.A. 
and Escudero-Abarca, B.I. (2001). Effect of physical factors on 
the production of bacteriocins from Pediococcus acidilactici ITV 
26. J. Ind. Microbiol. Biotechnol. 26, 191-195. 
Callaway, T.R.; Anderson, R.C.; Edrington, T.S.; Genovese, K.J.; 
Harvey, R.B.; Poole, T.L. and Nisbet, D.J. (2004). Recent pre-
harvest supplementation strategies to reduce carriage and 
shedding of zoonotic enteric bacterial pathogens in food 
animals. Anim. Health Res. Rev. 5, 35–47. 
 
 197 
 
Callewaert, R.; Holo, H.; Devreese, B.; Van Beeumen, J.; Nes, I. and 
De Vuyst, L. (1999). Characterization and production of 
amylovorin L471, a bacteriocin purified from Lactobacillus 
amylovorus DCE471 by a novel three-step method. Microbiology 
145, 2559-2568. 
 
Callewaert, R.; Hugas, M. and De Vuyst, L. (2000). Competitiveness 
and bacteriocin production of enterococci in the production of 
Spanish style fermented sausages. International Journal of Food 
Microbiology 57, 33–42. 
 
Caplice, E. and Fitzgerald, G.F. (1999). Food fermentations: role of 
microorganisms in food production and preservation. Int. J. 
Food Microbiol. 50, 131– 149. 
 
Caridi, A. (2002). Selection of Escherichia coli-inhibiting strains of 
Lactobacillus paracasei subsp. paracasei. J. Ind. Microbiol. 
Biotechnol. 29, 303– 308. 
 
Carolissen-Mackay, V.; Arendse, G. and Hastings, J.W. (1997). 
Purification of bacteriocins of lactic acid bacteria: problems and 
pointers. International Journal of Food Microbiology 34, l-16. 
 
Casla , D.; Requena, T. and Gomez, R. (1996). Antimicrobial activity 
of lactic acid bacteria isolated from goat’s milk and artisanal 
 198 
 
cheeses: characteristics of a bacteriocin produced by 
Lactobacillus curvatus IFPL 105. J. Appl. Bacteriol. 81, 35–41. 
 
Chaskes, S. (2009). Stains for light microscopy. Pp. 37-51 in: Practical 
Handbook of Microbiology (Goldman, E. and Green, L.H., eds). 2nd 
edition. CRC Press, Boca Raton, London, New York. 
 
Chavan, M.A. and Riley, M.A. (2007). Molecular evolution of 
bacteriocins in Gram-negative bacteria. Pp. 19-44 in: 
Bacteriocins: Ecology and Evolution (Riley, M.A. and Chavan, 
M.A., eds). Springer-Verlag, Berlin Heidelberg. 154 pp. 
 
Cheigh, C.-I.; Choi, H.-J.; Park, H.; Kim, S.-B.; Kook, M.-C.; Kim, 
T.-S.; Hwang, J.-K. and Pyun, Y.-R. (2002). Influence of growth 
conditions on the production of a nisin-like bacteriocin by 
Lactococcus lactis subsp. lactis A164 isolated from kimchi. J. 
Biotechnol. 95, 225– 235. 
 
Chen, H. and Hoover, D.G. (2003). Bacteriocins and their food 
applications. Comprehensive Reviews in Food Science and Food 
Safety, 2, 82-100. 
 
Chikindas, M.L.; Novak, J.; Driessen, A.J.; Konings, W.N.; Schilling, 
K.M. and Caufield, P.W. (1995). Mutacin II, a bactericidal 
antibiotic from Streptococcus mutans. Antimicrob. Agents 
Chemother. 9,2656–2660. 
 199 
 
 
Chin, H.S.; Chin, J.S.; Kim, J.M.; Yang, R. and Yoon, S.-S. (2001). 
Detection and antibacterial activity of a bacteriocin produced 
by Lactobacillus plantarum. Food Sci. Biotechnol. 10, 335–341. 
 
Choi, H.J.; Lee, H.S.; Her, S.; Oh, D.H. and Yoon, S.S.(1999). Partial 
          characterization and cloning of leuconocin J, a bacteriocin 
          produced by Leuconostoc sp. J2 isolated from the Korean 
           fermented vegetable Kimchi. J. Appl. Microbiol. 86, 175–181. 
 
Cintas, L.M.; Casaus, P.; Havarstein, L.S.; Hernandez, P.E. and Nes, 
I.F. (1997). Biochemical and genetic characterization of 
enterocin P, a novel sec-dependent bacteriocin from 
Enterococcus faecium P13 with a broad antimicrobial spectrum. 
Appl. Environ. Microbiol. 63, 4321-4330. 
 
Cleveland, J., Montville, T.J., Nes, I.F., Chikindas, M.L. (2001). 
Bacteriocins: safe, natural antimicrobials for food preservation. 
International Journal of Food Microbiology 71, 1– 20. 
 
Cogan, T.M. and Hill, C. (1993). Cheese starter cultures. In: Cheese: 
Chemistry, Physics and Microbiology, Vol. 1, Second Edition, (Fox, 
P.F., ed.), Chapman and Hall, London, pp. 193–255. 
 
 200 
 
Collee, J.G.; Duguid, J.P.; Fraser, A.G. and Marmion, B.P. (1992). 
Mackie and McCartney Practical Medical Microbiology. 13th edition. 
Churchill Livingstone. Edinburgh, London. 
 
Cotter, P.D.; Hill, C. and Ross, R.P. (2005). Bacteriocins: developing 
innate immunity for food. Nature Rev. Microbiol. 3, 777–788. 
 
Daba, H., Pdndian, S., Gosselin, J.F. Simard. R.E., Huang. J. and 
Lacroix, C. (1991) Detection and activity of a bacteriocin 
producted by  Leuconostoc mesenteroides. Appl. Environ. Microbiol. 
57, 3450-3455. 
 
Daeschel, M.A. (1989). Antimicrobial substances from lactic acid 
bacteria for use as food preservatives. Food Technol. 43, 164–166. 
 
Daeschel, M. A.; Jung, D. S. and Watson, B. T. (1991). Controlling 
wine malolactic fermentations with nisin and nisin-resistant 
strains of Leuconostoc oenos. Appl. Environ. Microbiol. 57, 601–603. 
 
Deegan, L.H.; Cotter, P.D.; Hill, C. and Ross, P. (2006). Bacteriocins: 
Biological tools for bio-preservation and shelf-life extension. 
International Dairy Journal 16, 1058–1071. 
 
 201 
 
Delgado, A.; Brito, D.; Fevereiro, P.; Tenreiro, R. and Peres, C. (2005). 
Bioactivity quantification of crude bacteriocin solutions. Journal 
of Microbiological Methods 62, 121-124. 
 
Delgado, A.; Lopez, F.N.A.; Brito, D.; Peres, C.; Fevereiro, P. and 
Garrido-Fernandez, A. (2007). Optimum bacteriocin production 
by Lactobacillus plantarum 17.2b requires absence of NaCl and 
apparently follows a mixed metabolite kinetics. Journal of 
Biotechnology 130, 193-201. 
 
De Lima, E.T. and Filho, R.L.A. (2005). Bacteriocins: nomenclature, 
detection, mechanism of action and potential use in poultry 
production. Journal of Food, Agriculture and Environment  3, 62-
66. 
 
Delves-Broughton, J. (1990). Nisin and its uses as a food preservative. 
Food Technol. 44, 100–117. 
 
de Man, J.C.; Rogosa, M. and Sharpe, M.E. (1960). A medium for the 
cultivation of lactobacilli. J. Appl. Bacteriol. 23, 130–135. 
 
De Martinis , E.C.P. and Freitas, F.Z. (2003). Screening of lactic acid 
bacteria from Brazilian meats for bacteriocin formation. Food 
Control 14, 197-200. 
 
 202 
 
Devlieghere, F.; Vermeiren, L. and Debevere, J. (2004). New 
preservation technologies: Possibilities and limitations. 
International Dairy Journal 14, 273–285. 
 
De Vos, W.M.; Mulders, J.W.M.; Siezen, R.J.; Hugenholtz, R. and 
Kuipers, O.P. (1993). Properties of nisn Z, and distributton of its 
gene, nisZ, in Lactococcus lactis. Appl. Environ. Microbiol. 59, 213-
218. 
 
De Vuyst, L. and Leroy, F. (2007). Bacteriocins from lactic acid 
bacteria: production, purification, and food applications. J. Mol. 
Microbiol. Biotechnol. 13, 194–199. 
 
De Vuyst, L. and Vandamme, E.J. (1994). Antimicrobial potential of 
lactic acid bacteria. Pp. 91-142 in: Bacteriocins of Lactic Acid 
bacteria: Microbiology, Genetics and Applications (De Vuyst, L.and 
Vandamme, E.J., eds.). Blackie Academic and Professional, 
London. 
 
De Vuyst, L.; Callewaert, R. and Crabbe, K. (1996). Primary 
metabolite kinetics of bacteriocin biosynthesis by Lactobacillus 
amylovorus and evidence for stimulation of bacteriocin 
production under unfavorable growth conditions. Microbiology 
142, 817–827. 
 
 203 
 
De Vuyst, L.; Callewaert, R. and Crabbe, K. (1998). Primary 
metabolite kinetics of bacteriocin biosynthesis by Lactobacillus 
amylovorus and evidence for situation of bacteriocin production 
under unfavourable growth conditions. Microbiology 142, 817-
827. 
 
Driessen, A.J.M.; van den Hooven, H.W.; Kuiper, W.; van de Kamp., 
M.; Sahl, H.-G.; Konings, R.N.H. and Konings, W.N. (1995). 
Mechanistic studies of Iantibiotic-induced permeabilization of 
phospholipids vesicles. Biochemistry 34, 1606-1614. 
 
Drosinos, E.H.; Mataragas, M. and Metaxopoulos, J. (2006). Modeling 
of growth and bacteriocin production by Leuconostoc 
mesenteroides E131. Meat Science 74, 690-696. 
 
Duffes, F.; Leroi, F.; Dousset, X. and Boyaval, P. (2000). Use of a 
         bacteriocin producing Carnobacterium piscicola strain, isolated 
from fish, to control Listeria monocytogenes development in 
vacuum-packed cold-smoked salmon stored at 4 ˚C. Sci. 
Aliment. 20, 153–158. 
 
Dunne, C.; Murphy, L.; Flynn, S.; O'Mahony, L.; O'Halloran, S.; 
Feeney, M.; Morrissey, D.; Thornton, G; Fitzgerald, G.: Daly, C.; 
Kiely, B.; Quigly, E.M.M.; O'Sullivan, G.C.; Shanahan, F. and 
Collins, J.K. (1999). Probiotics: from myth to reality. 
 204 
 
Demonstration of functionality in animal models of disease and 
in human clinical trials. Antonie Van Leeuwenhoek 76, 279–292. 
 
 Dykes, G.A. (1995). Bacteriocins: ecological and evolutionary 
significance. TREE 10 (5), 186-189. 
 
 Eckner, K.F. (1992). Bacteriocins and food applications. Dairy, Food 
Environ. Sanit. 12 (4), 204– 209. 
 
EEC (1983). EEC commission directive 83/463/EEC. 
 
Eijsink, V. G.; Skeie, M.; Middelhoven, P. H.; Brurberg, M. B. and Nes,  
I. F. (1998). Comparative studies of class IIa bacteriocins of 
lactic acid bacteria. Appl. Environ. Microbiol. 64, 3275–3281.  
 
Einarsson, H.and Lauzon, H.L. (1995). Biopreservation of brined 
shrimp (Pandalus borealis) by bacteriocins from lactic acid 
bacteria.  Appl. Environ. Microbiol. 61 (2), 669–676. 
 
Enan, G.; el Essawy, A.A.; Uyttendaele, M. and Debevere, J. (1996). 
Antibacterial activity of Lactobacillus plantarum UG1 isolated 
from dry sausage: characterization, production and bactericidal 
action of plantaricin UG1. Int. J. Food Microbiol. 30, 189–215. 
 
 205 
 
Ennahar, S.; Sonomoto, K. and Ishizaki, A. (1999). Class IIa 
bacteriocins from lactic acid bacteria: antibacterial activity and 
food preservation. J. Biosci. Bioeng. 87, 705-716. 
 
Ennahar, S.; Sashihara, T.; Sonomoto, K. and Ishizaki, A. (2000). Class 
IIa bacteriocins: biosynthesis, structure and activity. FEMS 
Microbiology Reviews 24, 85-106. 
 
Faye, T.; Langsrud, T.; Nes, I.F. and Holo, H. (2000). Biochemical and 
genetic characterization of Propionicin T1, a new bacteriocin 
from Propionibacterium thoenii. Appl. Environ. Microbiol. 66, 4230-
4236.  
 
Federal Register (1988) Nisin preparation: affirmation of GRAS status 
as a direct human food ingredient. Fed. Regist. 54, 11247-11251. 
 
Fimland, G.; Blingsmo, O.R.; Sletten, K.; Jung, G.; Nes, I.F and Nissen-
Meyer, J. (1996). New biologically active hybrid bacteriocins 
constructed by combining regions from various pediocin-like 
bacteriocins: the C-terminal region is important for determining 
specificity. Appl. Environ. Microbiol. 62, 3313-3318. 
 
Fontaine, E.A.;  Claydon, E. and Tayler-Robinson, D. (1996). Lac- 
         tobacilli from women with or without bacterial vaginosis and 
 206 
 
        observations on the significance of hydrogen peroxide.   
Microbiol. Ecol. Health Dis. 9, 135–141. 
 
 Fredericq, P. (1957). Colicins. Annu. Rev. Microbiol. 11, 7–22. 
 
 Fredericq, P. (1963). On the nature of colicinogenic factors: a review. 
J. Theor. Biol 4, 159–165. 
 
Fricourt, B.V.; Barefoot, S.F.; Testin, R.F. and Hayasaka, S.S. (1994). 
         Detection and activity of plantaricin F an antibacterial substance 
from Lactobacillus plantarum BF001 isolated from 
         processed channel catfish. J. Food Prot. 57, 698–702. 
 
Galvez , A.; Lopez , R.L.; Abriouel , H.; Valdivia , E., and Omar , N.B. 
( 2008 ). Application of bacteriocins in the control of foodborne 
pathogenic and spoilage bacteria. Crit. Rev. Biotechnol. 28 , 125 – 
152 . 
 
Garver, K.1. and Muriana, P.M. (1994). Purification and partial amino 
acid sequence of curvaticin FS47, a heat-stable bacteriocin 
produced by Lactobacillus curvatus  FS47. Appl. Environ. 
Microbiol. 60, 2191 2195. 
 
 207 
 
Ghrairi, T.; Frere, J.; Berjeaud, J.M. and Manai, M. (2008). Purification 
and characterisation of bacteriocins produced by Enterococcus 
faecium from Tunisian rigouta cheese. Food Control 19, 162–169. 
 
Gillor O, Kirkup BC, Riley MA (2004) Colicins and microcins: the next 
generation antimicrobials. Adv. Appl. Microbiol. 54, 129–146. 
 
Gomez, K.A. and Gomez, A.A. (1984). Statistical Procedures for 
Agricultural Research. John Wiley and Sons, New York. 
 
Gongora-Nieto, M. M., Sepulveda, D. R., Pedrow, P., Barbarosa-
Canovas, G. V., & Swanson, B. G. (2002). Food processing by 
pulsed electric fields treatment delivery, inactivation level, and 
regulatory aspects. Lebensmittel-Wissenschaft und Technologie  35, 
375–388. 
 
Gonzalez, C. F. and  Kunka, B. S. (1987). Plasmid-associated 
bacteriocin production and sucrose fermentation in Pediococcus  
acidilactici. Appl. Environ. Microbiol. 53, 2534–2538. 
 
Gonzalez, B.; Arca, P.; Mayo, B. and Suarez, J.E. (1994). Detection, 
purification and partial characterization of plantaricin C, a 
bacteriocin produced by a Lactobacillus plantarum strain of dairy 
origin. Appl. Environ. Microbiol. 60, 2158-2163. 
 
 208 
 
Gordon, D. and Riley, M.A. (1999). A theoretical and empirical 
investigation of the invasion dynamics of coliconogeny. 
Microbiology 145, 655–661. 
  
Gordon, D.; Oliver, E. and Littlefield-Wyer, J. (2007). The diversity of 
bacteriocins in Gram-negative bacteria. Pp. 5-18 in: Bacteriocins: 
Ecology and Evolution (Riley, M.A. and Chavan, M.A., eds). 
Springer-Verlag, Berlin Heidelberg. 154 pp. 
  
 
Gratia, A. (1925). Sur un remarquable exemple d’antagonisme entre 
deux souches de Colibacille. C. R. Soc. Biol. 93, 1040–1041.  
 
Guerra, N. P. and Pastrana, L. (2002). Modelling the influence of pH 
on the kinetics of both nisin and pediocin production and 
characterization of their functional properties. Process 
Biochemistry  37, 1005–1015. 
 
Harley-Prescott (2002). Laboratory Exercises in Microbiology, 5th edition. 
McGraw-Hill Company. 449 pp. 
 
Harris, L.J.; Flemming, H.P. and Klaenhammer, T.R. (1992). Novel 
paired starter culture system for sauerkraut, consisting of a 
nisin-resistant Leuconostoc mesenteroides strain and a nisin-
producing Lactococcus lactti strain. Appl. Environ. Microbiol. 58, 
1484-1489. 
 
 209 
 
Hastings, J.W.; Sailer, M.; Johnson, K.; Roy, K.L.; Vederas, J.C. and 
Stiles, M.E. (1991). Characterization of leucocin A-UAL 187 and 
cloning of the bacteriocin gene from Leuconostoc gelidum. J. Appl. 
Bacteriol. 173, 7491-7500. 
 
Hauge, H.H. ; Mantzilas, D.; Moll, G.N.; Konings, W.N.; Driessen, 
A.J.; Eijssink, V.G.and Nissen-Meijer, J (1998). Plantaricin is an 
amphiphilic alphahelical bacteriocin-like pheromone which 
exerts antimicrobial and pheromone activities through different 
mechanisms. Biochem. 37, 16026-16032. 
 
 Hechard, Y. and Sahl, H.G. (2002). Mode of action of modified and 
unmodified bacteriocins from Gram-positive bacteria. Biochimie  
84, 545-557. 
 
Héchard, Y.;  Dheibomez, M.; Cenatiempo, Y. and  Letellier, F. (1990). 
Antagonism of lactic acid bacteria from goats’ milk against  
pathogenic strains assessed by the ‘sandwich method’. Lett. 
Appl. Microbiol. 11, 185-188. 
 
Helander , I.M.; von Wright , A. and Mattila - Sandholm , T.M. 
         (1997). Potential of lactic acid bacteria and novel              
antimicrobials against Gram - negative bacteria. Trends Food Sci 
Technol. 8 , 146–150 . 
 
 210 
 
Heng, N.C.K.; Wescombe, P.A.; Burton, J.P.; Jack, R.W. and Tagg, J.R. 
(2007). The diversity of bacteriocins in Gram-positive bacteria. 
Pp. 45-92 in: Bacteriocins: Ecology and Evolution (Riley, M.A. and 
Chavan, M.A., eds). Springer-Verlag, Berlin Heidelberg. 154 pp. 
 
 
Hickey, R. M.; Ross, R. P. and Hill, C. (2004).Controlled autolysis and 
enzyme release in a recombinant lactococcal strain expressing 
the metalloendopeptidase enterolysin A. Appl. Environ. 
Microbiol. 70, 1744–1748.  
 
 Holck, A.L.; Azelsson, L.; Hiihne, K.and Kröckel, L. (1994). 
Purification and cloning of sakacin 674, a bacteriocin from 
Lactobacillus sake Lb674. FEMS Microbiol. Lett. 115, 143-150. 
 
 Holzapfel, W. H., Geisen, R., & Schillinger, U. (1995). Biological 
preservation of foods with reference to protective cultures, 
bacteriocins and food-grade enzymes. International Journal of 
Food Microbiology  24, 343–362. 
 
Hugenholtz, J.and De Veer, G.J.C.M. (1991). Application of nisin A 
and nisin Z in dairy  technology. Pp.  440–448 in: Nisin and 
Novel Lantibiotics  (Jung, G.and Sahl, H.-G., eds.).  ESCOM, 
Leiden. 
 
 211 
 
Hugas, M., (1998). Bacteriocinogenic lactic acid bacteria for the 
biopreservation of meat and meat products. Meat Sci. 49, S139–
S150. 
 
Hugas, M.; Pages, F.;  Garriga, M. and Monfort, J. (1998). Application 
of the bacteriocinogenic Lactobacillus sakei CTC494 to prevent 
growth of Listeria in fresh and cooked meat products packed 
with different atmospheres. Food Microbiology, 15, 639–650. 
 
Hurst, A. (1981) Nisin. Adv. Appl. Microbiol. 27, 85-123. 
 
Ivanova, I.; Miteva, V.; Stefanova, Ts.; Pantev, A.; Budakov, I.; 
Danova, S.; Moncheva, P.; Nikolova, I.; Dousset, X. and 
Boyaval, P. (1998). Characterization of a bacteriocin produced 
by Streptococcus thermophilus 81. Int. J. Food Microbiol. 42, 147– 
158. 
 
Jack, R.W., Tagg, J.R. and Ray, B (1995). Bacteriocins of gram-positive 
bacteria. Microbiol. Rev. 59, 171–200. 
 
 Jacob, F.; Lwoff, A.; Siminovitch, L. and Wallman, E. 
(1953).Definition de quelques termes relatifs a la Pysogenie. 
Ann. Inst. Pasteur 84, 222-224. 
 
Janes, M.E.; Nannapaneni, R.and Johnson, M.G. (1999). Identification 
and characterization of two bacteriocin-producing bacteria 
isolated from garlic and ginger root. J. Food Prot. 62, 899– 904. 
 212 
 
 
Jiminez-Diaz, R.; Rios-Sanchez, R.M.; Desmazeaud, M.; Ruiz-Barba, 
J.L. and Piard, J-C. (1993). Plantaricin S and T, two new 
bacteriocins produced by Lactobacillus plantarum LPCO 10 
isolated from a green olive fermentation. Appl. Environ. 
Microbiol. 59, 1416-1424. 
 
 Joerger, M. C. and Klaenhammer, T. R. (1986). Characterization and 
purification of helveticin J and evidence for chromosomally 
determined bacteriocin produced by Lactobacillus helveticus 481. 
Journal of Bacteriology 167, 439–446. 
 
 Joerger, R. D.; Hoover, D. G.; Barefoot, S. F.; Harmon, K. M.; 
Grinstead, D. A. and Nettles-Cutter, C.G. (2000). Bacteriocins. 
Pp. 383-397 in: Encyclopedia of Microbiology, vol. 1 (Lederberg, 
ed.). 2nd ed. Academic Press, San Diego, U,S.A. 
Jofré, A.; Aymerich, T and Garriga, M. (2009). Improvement of the 
food safety of low acid fermented sausages by enterocins A and 
B and high pressure. Food Control 20, 179-184. 
Kanatani, K.; Oshimura, M. and Sano, K. (1995). Isolation and 
characterization of acidocin A and cloning of the bacteriocin 
gene from Lactobacillus acidophilus. Appl. Environ. Microbiol. 61, 
1061-1067. 
 
 213 
 
Kelly,W.J.; Amundson, R.V. and Huang, C.M. (1996). 
Characterization of plantaricin KW30, a bacteriocin produced 
by Lactobacillus  plantarum. J. Appl. Bacteriol. 81, 657–662. 
 
 Kemperman, R.; Jonker M.; Nauta, A.; Kuipers, O.P. and Kok, J. 
(2003). Functional analysis of the gene cluster involved in 
production of the bacteriocin circularin A by Clostridium 
beijerinckii ATCC 25752. Appl. Environ. Microbiol. 69, 5839–5848. 
 
 Kimura, H.; Nagano, R.; Matsusaki, H.; Sonomoto, K. and Ishizaki, 
A. (1997). A bacteriocin of strain Pediococcus sp. ISK-1 isolated 
from Nukadoko, bed of fermented rice bran. Biosci. Biotechnol. 
Biochem. 61, 1049–1051. 
 
 Kirkup B.C. and Riley, M.A. (2004). Antibiotic-mediated antagonism 
leads to a bacterial game of rock-paper-scissors in vivo. Nature 
428, 412–414. 
 
 Klaenhammer, T.R. (1988). Bacteriocins of lactic acid bacteria. 
Biochimie 70, 337–349. 
 
 Klaenhammer, T.R. (1993) Genetics of bacteriocins produced by lactic 
acid bacteria. FEMS Microbiol. Rev. 12, 39 86. 
 
 214 
 
Klaenhammer, T.; Altermann, E.; Arigoni, F.; Bolotin, A.; Breidt, F.; 
Broadbent, J.; Cano, R.; Chaillou, S.; Deutscher, J.; Gasson, M.; 
van de Guchte, M.; Guzzo, J.; Hartke, A.; Hawkins, T.; Hols, P.; 
Hutkins, R.; Kleerebezem, M.; Kok, J.; Kuipers, O.; Lubbers, M.; 
Maguin, E.; McKay, L.; Mills, D.; Nauta, A.; Overbeek, R.; Pel, 
H.; Pridmore, D.; Saier, M.; van Sinderen, D.; Sorokin, A.; 
Steele, J.; O’Sullivan, D.; de Vos, W. M.; Weimer, B.; Zagorec, M. 
and Siezen, R. (2002). Discovering lactic acid bacteria by 
genomics. Antonie Van Leeuwenhoek 82, 29–58. 
 
Klein, C., Entian, K.D., 1994. Genes involved in self-protection against 
the lantibiotic subtilin produced by Bacillus subtilis ATCC 6633. 
Appl. Environ. Microbiol. 60, 2793–2801. 
 
Klostermaier, P.; Scheyhing, C.H.; Ehrmann, M. and Vogel, R.F. 
(1999). Mathematical evaluation of plantaricin formation 
supports an auto-induced production mechanism. Appl. 
Microbiol. Biotechnol. 51, 462-469. 
 
Ko, S.H. and Ahn, C.(2000). Bacteriocin production by Lactococcus 
lactis KCA2386 isolated from white kimachi. Food Sci. Biotechnol. 
9, 263– 269. 
 
 215 
 
Konings, W.N. ; Kok, J.; Kuipers, O.P. and Poolman, B. (2000). Lactic 
acid bacteria: the bugs of the new millennium. Current Opinion 
in Microbiology 3, 276–282. 
    
Kordel, M.; Benz, R. and Sahl, H.-G. (1988). Mode of action of the 
staphylococcin like peptide Pep 5: Voltage-dependent 
depolarization of bacterial and artificial membranes. Journal of 
Bacteriology 170, 84–88. 
 
Krier, F.; Revol-Junelles, A.M. and Germain, P. (1998). Influence of 
temperature and pH on production of two bacteriocins by 
Leuconostoc mesenteroides subsp. mesenteroides FR52 during batch 
fermentation. Appl. Microbiol. Biotechnol. 50, 359–363. 
 
Kröckel, L. (1992). Bacteriocine von Milchsiiurebakterien fiir 
Fleischerzeugnisse. Mittbl. Bundesanst. Fleischforsch. Kulmbach 
31, 207-215. 
 
Kuipers, O. P.; Beerthuyzen, M.; Siezen, R. J. and de Vos, W. M. 
(1993). Characterization of the nisin gene cluster nisABTCIPR of 
Lactococcus lactis: Requirement of expression of the nisA and 
nisI genes for development of immunity. European Journal of 
Biochemistry  216, 281–291. 
 
 216 
 
Kuroda, K. and Kagiyama, R. (1983). Biochemical relationship among 
three F-type pyocins, pyocin F1, F2, and F3, and phage KF1. J. 
Biochem. (Tokyo) 94, 1429–1441. 
 
Larsen, A.G.; Vogensen, F.K. and Josephsen, J. (1993). Antimicrobial 
activity of lactic acid bacteria isolated from sour doughs: 
purification and characterization of bavaricin A, a bacteriocin 
produced by Lactobacillus bavaricus MI401. J. Appl. Bacteriol. 75, 
113-122. 
 
Leal-Sánchez,  M.V.; Jiménez-Díaz, R.; Maldonado-Barragán, A.; 
Garrido-Fernández, A. and Ruiz-Barba, J. L. (2002). 
Optimization of bacteriocin production by batch fermentation 
of Lactobacillus plantarum LPCO10. Appl. Environ. Microbiol. 68, 
4465-4471. 
 
Leroy, F. and De Vuyst, L. (1999). Temperature and pH conditions 
that prevail during the fermentation of sausages are optimal for 
the production of the antilisterial bacteriocin sakacin K. Appl. 
Environ. Microbiol.  65, 974– 981. 
 
Leroy, F.; Foulquie´ Moreno, M.R.;  De Vuyst, L. (2003). Enterococcus 
faecium RZS C5, an interesting bacteriocin producer to be used 
as a co-culture in food fermentation. Int. J. Food Microbiol. 88, 
235–240. 
 217 
 
 
Leyeune, R.; Callewaert, R.; Crabbe, K. and De Vuyst, L.(1998). 
Modelling the growth and bacteriocin production by 
Lactobacillus amylovorus DCE 471 in batch cultivation. J. Appl. 
Microbiol., 84, 159–168. 
 
Lewus, C. B. and Montville, T. J. (1991). Detection of bacteriocins 
produced by lactic acid bacteria. Journal of Microbiology Methods 
13, 145–150. 
 
Lewus, C. B.; Kaiser, A. and Montville, T. J. (1991). Inhibition of 
foodborne bacteria pathogens by bacteriocins from lactic acid 
bacteria isolated from meat. Appl. Environ. Microbiol. 57, 1683–
1688. 
 
Lewus, C.B.; Sun, S. and Montville, T.J. (1992). Production of an 
amylase-sensitive bacteriocin by an atypical Leuconostoc 
paramesenteroides strain. Appl. Environ. Microbiol. 58, 143-149. 
 
 Linnett, P. E. and Strominger, J. L. (1973). Additional antibiotic 
inhibitors of peptidoglycan synthesis. Antimicrobial Agents and 
Chemotherapy  4, 231–236. 
 
Losteinkit, C.; Uchaiyama, K.; Ochi, S.; Takaoka, T.; Nagahisa, K. and 
Shioya, S. (2001). Characterization of bacteriocin N15 produced 
 218 
 
by Enterococcus faecium N15 and cloning of the related genes. J. 
Biosci. Bioeng. 91, 390– 395. 
 
 Luchansky, J.B.; Glass, K.A.; Harsono, K.D.; Degnan, A.J.; Faith, 
N.G.; Cauvin, B.; Baccus-Taylor, G.; Arinara, K.; Bater, B.; 
Maurer, A.J. and Cassens, R.G. (1992). Genomic analysis of 
Pediococcus starter cultures used to control Listeria monocytogenes 
in Turkey summer sausage. Appl. Environ. Microbiol. 85, 3053-
3059. 
 
Maisnier-Patin, S.; Deschamps, N.; Tatini, S.R. and Richard, J. (1992). 
Inhibition of Listeria monocytogenes in Camembert cheese made 
with a nisin-producing starter. Lait  72, 249–263. 
 
Mataragas, M.; Metaxopoulosa, J.; Galiotoub, M. and Drosinos, E.H. 
(2003). Influence of pH and temperature on growth and 
bacteriocin production by Leuconostoc mesenteroides L124 and 
Lactobacillus curvatus L442. Meat Science 64,  265–271. 
 
Mataragas, M.; Drosinos, E.H.; Tsakalidou, E. and Metaxopoulos, E. 
(2004). Influence of nutrients on growth and bacteriocin 
production by Leuconostoc mesenteroides L124 and Lactobacillus 
curvatus L442. Antonie van Leeuwenhoek  85, 191–198. 
 
 219 
 
Mattic,  A.T.R. and Hirsch, A. (1947). Further observations on an 
inhibitory substance (nisin) from lactic streptococci. Lancet 2, 5–
7. 
 
McAuliffe, O.; Ryan, M.P.; Ross, P.R.; Hill, C.; Breeuwer, P.; Østlie, 
H.; Floberghagen,V.; Reinbold, G.; Hammond, G.;Vegarud and 
Abee, T. (1998). Lacticin 3147, a broad-spectrum bacteriocin 
which selectively dissipates the membrane potential. Appl. 
Environ. Microbiol. 64, 439–445. 
 
McAuliffe, O., Hill, C., Ross, P.R. (1999). Inhibition of Listeria 
monocytogenes in cottage cheese manufactured with a lacticin 
3147-producing starter culture. J. Appl. Microbiol. 86, 251–256. 
 
McDermott, P.F.; Zhao, S.; Wagner, D.D.; Simjee, S.; Walker, R. D. 
and White, D.G. (2002). The food safety perspective of antibiotic 
resistance. Anim. Biotechnol. 13, 71–84. 
 
Mead, P.S.; Slutsker, L.; Dietz, V.; McCaig, L.F.; Bresee, J.F.; Shapiro, 
C.; Griffin, P.M. and Tauxe, R.V. (1999). Food-related illness 
and death in the United States. Emerging Infect. Dis. 5, 607–625. 
 
Meseguer, I.; Rodriguez-Valera, F. and Ventosa, A. (1986). 
Antagonistic interactions among halobacteria due to halocin 
production. FEMS Microbiol. Lett. 36, 177–182. 
 220 
 
 
Messi, P.;  Bondi, M.; Sabia, C.; Battini, R. and Manicardi, G. (2001). 
Detection and preliminary characterization of a bacteriocin 
(plantaricin 35d) produced by a Lactobacillus plantarum strain. 
International Journal of Food Microbiology 64, 193–198. 
 
Michel-Briand, Y. and Baysse, C. (2002). The pyocins of Pseudomonas 
aeruginosa. Biochimie 84, 499–510. 
 
Mishra, C. and Lambert, J. (1996).Production of anti-microbial 
substances by probiotics. Asia Pacific J. Clin. Nutr. 5: 20-24. 
 
Moll, G.N.; van Den, A.E.; Hauge, H..H.; Nissen-Meyer, J.; Nes, I.F.; 
Konings, W.N.; Driessen, A.J. (1999). Complementary and 
overlapping selectivity of the two-peptide bacteriocins 
plantaricin EF and JK. J. Bacteriol. 181, 4848–4852. 
 
Moreno, F.; Gonzalez-Pastor, J.E.; Baquero, M.R. and Bravo, D. (2002). 
The regulation of microcin B, C and J operons. Biochimie 84, 
521–529. 
 
Moretro, T.; Aassen, I.M.; Storro, I. and Axelsson, L. (2000). 
Production of sakacin P by Lactobacillus sakei in a completely 
defined medium. J. Appl. Microbiol. 88, 536-545. 
 
 221 
 
Mǿrtvedt, C.I.; Nissen-Meyer, J.; Sletten, K. and Nes, I.F. (1991). 
Purification and amino acid sequence of lactacin F, a bacteriocin 
produced by Lactobacillus sake L45. Appl. Environ. Microbiol. 57, 
1829-1834. 
 
Motlagh, A.M.; Bhunia, A.K.; Szostek, F.; Hansen, T.R. and Ray, 
B.(1992). Nucleotide, and amino acid sequence of pap-gene 
(pediocin AcH production) in Pediococcus acidilactici H. Lett. 
Appl. Microbiol. 15, 45–48.  
 
Muriana, P.M. and Klaenhammer, T.R. (1991). Purification and partial 
characterization of lactacin F, a bacteriocin produced by 
Lactobacillus acidophilus 11088. Appl. Environ. Microbiol. 57, 114-
121. 
 
Myers, R.H. and Montgomery, D.C. (2002). Response Surface 
Methodology. Process and Products Optimization Using Designed 
Experiments. John Wiley and Sons, New York. 
 
Nakayama, K.; Takashima, K.; Ishihara, H.; Shinomiya, T.; Kageyama, 
M.; Kanaya, S.; Ohnishi, M.; Murata, T.; Mori, H. and Hayashi, 
T. (2000). The R-type pyocin of Pseudomonas aeruginosa is related 
to P2 phage, and the F-type is related to lambda phage. Mol. 
Microbiol. 38, 213–231. 
 
 222 
 
Nel, H. A.; Bauer, R.; Vandamme, E. J. and Dicks, L. M. T. (2001). 
Growth optimization of Pediococcus damnosus NCFB 1832 and 
the influence of pH and nutrients on the production of pediocin 
PD-1. Journal of Applied Microbiology, 91, 1131–1138. 
 
Nes, I.F.; Diep, D.B.; Havarstein, L.S.; Brurberg, M.B.; Eijsink, V. and 
Holo, H. (1996). Biosynthesis of bacteriocins in lactic acid 
bacteria. Antonie van Leeuwenhoek 70, 113–128. 
 
Nieto-Lozano, J.C.; Reguera-Useros, J.I.; Pelaez-Martinez, M.C. and 
De la Torre, A.H. (2002). Bacteriocinogenic activity from starter 
culture used in Spanish meat industry. Meat Sci. 62, 237–243. 
 
Nilsen, T.; Nes, I.F. and Holo, H. (2003). Enterolysin A, a cell wall-
degrading bacteriocin from Enterococcus faecalis LMG 333. Appl. 
Environ. Microbiol. 69, 2975-2984. 
 
Nissen-Meyer, J., Havarstein, L.S., Holo, H., Sletten, K., Nes, I.F., 
1993. Association of the lactococcin A immunity factor with the 
cell membrane: purification and characterization of the 
immunity factor. J. Gen. Microbiol. 139, 1503–1509. 
 
Nout, M. J. R.  and Rombouts, F. M. (1992). Fermentative 
preservatron of plant foods.  Appl. Bacteriol. Symp. Suppl. 73, 
1365-1478. 
 223 
 
 
O’Connor, E.M. and Shand, R.F. (2002). Halocins and sulfolobicins: 
The emerging story of archaeal protein and peptide antibiotics. 
J. Indust. Microbiol. Biotechnol. 28, 23–31. 
 
Ogden, K. and Tubb, R. S. (1985). Inhibition of beer-spoilage lactic 
acid bacteria by nisin. J. Inst. Brew. 91, 390–392. 
 
Ogunbanwo, S.T.; Sanni, A.I. and Onilude, A.A. (2003). 
Characterization of bacteriocin produced by Lactobacillus 
plantarum F1 and Lactobacillus brevis OG1. African Journal of 
Biotechnology 2, 219-227. 
 
Ogunshe, A.A.O.; Omotoso, M.A. and Adeyeye, J.A. (2007). In vitro 
antimicrobial characteristics of bacteriocin-producing 
Lactobacillus strains from Nigerian indigenous fermented foods. 
Afr. J. Biotechnol. 6, 445-453. 
 
Olukoya, D.K.; Ebigwei, S.I.; Olasupo, N.A. and Ogunjimi, A.A.         
(1994). Production of DogiK: an improved ogi (Nigerian fer- 
        mented weaning food) with potentials for use in diarrhea        
control. J. Tropical Pediatrics 40, 108–113. 
 
 224 
 
O’Sullivan, L.; Ross, R. P. and Hill, C. (2002). Potential of bacteriocin-
producing lactic acid bacteria for improvements in food safety 
and quality. Biochimie  84, 593–604. 
 
Oumer, A.; Garde, S.; Gaya, P.; Medina, M. and Nunez, M. (2001). 
The effects of cultivating lactic starter cultures with bacteriocin-
producing lactic acid bacteria. J. Food Prot. 64, 81–86. 
 
Ouwehand, A.C. and Vesterlund, S. (2004). Antimicrobial 
components from lactic acid bacteria. Chapter 11 in: Lactic Acid 
Bacteria: Microbiological and Functional Aspects, (Salminen, S.; 
Wright, A.V. and Ouwehand, A., eds). 3rd edition. Marcel 
Dekker, New York.  
  
 
Parente, E. and Hill, C. (1992a). Characterization of enterocin 1146, a 
bacteriocin from Enterococcus faecium inhibitory to Listeria 
monocytogenes. J. Food Protect. 55, 497-502. 
 
 Parente, E. and Hill, C. (1992b). Inhibition of Listeria in buffer, broth, 
and milk by enterocin 1146, a bacteriocin produced by 
Enterococcus faecium. J. Food Protect. 55, 503-508. 
 
 225 
 
Parente, E. and Ricciardi, A. (1999). Production, recovery and 
purification of bacteriocins from lactic acid bacteria. Appl. 
Microbiol. Biotechnol.  52:628-38. 
 
Parente, E. and Ricciardi, A. (1994). Influence of pH on the 
production of enterocin 1146 during batch fermentation. Lett. 
Appl. Microbiol. 19, 12–15. 
 
Parente, E.; Ricciardi, A. and Addario, G. (1994). Influence of pH on 
growth and bacteriocin production by Lactococcus lactis subsp. 
lactis 140 NWC during batch fermentation. Applied Microbiology 
Biotechnology, 41, 388–394. 
 
 Parret, A.H.A. and De Mot, R. (2000). Novel bacteriocins with 
predicted tRNAse and poreforming activities in Pseudomonas 
aeruginosa PAO1. Mol. Microbiol. 35, 472–473. 
 
Patterson, M. (2000). High pressure treatments of foods. Pp. 1059–
1065 in Encyclopedia of Food Microbiology (Robinson, R.K.; Batt, 
C.A. and Patel, P.D., eds.). Academic Press, San Diego. 
 
Peschel, A. and Gotz, F. (1996).Analysis of the Staphylococcus 
epidermidis genes epiF, -E, and-G involved in epidermin 
immunity. J. Bacteriol. 178, 531–536. 
 
 226 
 
Pinto, A.L.; Fernandes, M.; Pinto, C.; Albano, H.; Teixeira, P.; 
Castilho, F. and Gibbs, P.A. (2007). Partial characterization of 
bacteriocins produced by Pediococcus pentosaceus and 
Enterococcus faecium isolated from ready-to-eat seafood. 
Abstracts / Journal of Biotechnology 131S,  S211–S241. 
 
Piva, A. and Headon, D.R. (1994). Pediocin A, a bacteriocin produced 
by Pediococcus pentosaceus FBB61. Microbiol. 140, 697-702. 
 
Pugsley, A.P. (1984). The ins and outs of colicins. Part I. Production, 
and translocation across membranes. Microbiol. Sci. 1:168–175. 
 
Prangishvili, D.; Holz, I.; Stieger, E.; Nickell, S.; Kristjansson, J.K. and 
Zillig, W. (2000). Sulfolobicins, specific proteinaceous toxins 
produced by strains of the extremely thermophilic archaeal 
genus Sulfolobus. J. Bacteriol. 182, 2985–2988. 
 
 Price, L.B. and Shand, R.F. (2000). Halocin S8: a 36-amino-acid 
microhalocin from the haloarchaeal strain S8a. J. Bacteriol. 182, 
4951–4958. 
 
Quadri, L. E.; Sailer, M.; Terebiznik, M.R.; Roy, K. L.; Vederas, J. C. 
and Stiles, M. E. (1995). Characterization of the protein 
conferring immunity to the antimicrobial peptide 
 227 
 
carnobacteriocin B2 and the expression of carnobacteriocin B2 
and BM1. Journal of Bacteriology 177, 1144–1151. 
 
Rammelsberg, M.; Muller, E. and Radler, F. (1990). Caseicin 80: 
purification and characterization of a new bacteriocin from 
Lactobacillus casei. Arch. Microbiol. 154, 249-252. 
 
Rantsiou , K.; Drosinos , E.H.; Gialitaki , M.; Metaxopoulos , I.; Comi , 
G.  and Cocolin , L. ( 2006 ). Use of molecular tools to 
characterize Lactobacillus spp. isolated from Greek traditional 
fermented sausages.  Int. J. Food Microbiol. 112 , 215 – 222 
 
Reeves, P. (1965). The bacteriocins. Bacteriol. Rev. 29, 25–45. 
 
Reis, M., and Sahl, H.-G. (1991). Genetic analysis of the producer self-
protection mechanism immunity against Pep5. Pp. 320–332 in: 
Nisin and Novel Lantibiotics (Jung, G. and Sahl, H.-G., eds.). 
ESCOM Scientific Publishers BV, Leiden, The Netherlands. 
 
Reisinger, P.; Seidel, H.; Tschesche, H. and Hammes, W.P. (1980). The 
effect of nisin on murein synthesis. Archives of Microbiology 127, 
187–193. 
 
 228 
 
Rekhif, N.; Atrih, A. and Lefebvre, G. (1995). Activity of plantaricin  
SA6, a bacteriocin produced by Lactobacillus plantarum SA6 
isolated from fermented sausage. J. Appl. Bacteriol. 78, 349–358. 
 
 Renter, D.G. and Sargeant, J.M. (2002). Enterohemorrhagic Escherichia 
coli O157: epidemiology and ecology in bovine production 
environments. Anim. Health. Res. Rev. 3, 83–94. 
 
 Riley, M.A. (1993).  Positive selection for colicin diversity in bacteria. 
Mol. Biol. Evol. 10, 1048–1059. 
 
Riley, M.A. (1998). Molecular mechanisms of bacteriocin evolution. 
Annu. Rev. Genet. 32, 255–278. 
 
Riley, M.A. and Chavan, M.A. (eds) (2007). Bacteriocins: Ecology and 
Evolution. Springer-Verlag, Berlin Heidelberg. 154 pp. 
 
Riley, M.A. and Gordon, D. (1992). A survey of Col plasmids in 
natural isolates of Escherichia coli and an investigation into the 
stability of Col-plasmid lineages.  J. Gen. Microbiol. 138, 1345–
1352. 
   
Riley, M.A. and Gordon, D.M. (1999). The ecological role of 
bacteriocins in bacterial competition. Trends Microbiol. 7, 129–
133. 
 
 229 
 
Riley, M.A. and Wertz, J.E. (2002). Bacteriocin diversity: ecological 
and evolutionary perspectives. Biochimie 84, 357–364. 
 
Riley, M.A.; Pinou, T.; Wertz, J.E.; Tan, Y. and Valletta, C.M. (2001). 
Molecular characterization of the klebicin B plasmid of Klebsiella 
pneumoniae. Plasmid, 45, 209–221. 
 
Riley, M.A.; Goldstone, C.M.; Wertz, J.E. and Gordon, D. (2003). A 
phylogenetic approach to assessing the targets of microbial 
warfare. J. Evol. Biol. 16, 690–697. 
 
Rodriguez-Valera, F.; Juez, G. and Kushner, D.J. (1982). Halocins: salt-
dependent bacteriocins produced by extremely halophilic rods. 
Can. J. Microbiol. 28, 151–154. 
 
Rodriguez, E.; Martinez, M.I.; Medina, M.; Hernandez, P.E. and 
Rodriguez, J.M. (1998). Detection of enterocin AS-48-producing 
dairy enterococci by dot-blot and colony hybridization. J. Dairy 
Res. 65, 143-148. 
 
Rodriguez, E.; Gonzalez, B.; Gaya, P.; Nunez, M. and Medina, M. 
(2000). Diversity of bacteriocins produced by lactic acid bacteria 
isolated from raw milk. International Dairy Journal  10, 7-15. 
 
 230 
 
Rodriguez, J. M.; Martinez, M. I. and Kok, J. (2002). Pediocin PA-1, a 
wide-spectrum bacteriocin from lactic acid bacteria. Crit. Rev. 
Food Sci. Nutr. 42, 91–121.  
 
Rodriguez, E.; Arques, J.L.; Rodriguez, R.; Nunez, M. and Medina, M. 
(2003). Reuterin production by lactobacilli isolated from pig 
faeces and evaluation of probiotic traits. Lett. Appl. Microbiol. 37, 
259–263. 
  
Russell, J.B. and Mantovani, H.C. (2002). The bacteriocins of ruminal 
bacteria and their potential as an alternative to antibiotics. J. 
Mol. Microbiol. Biotechnol. 4, 347–355. 
 
Ryan, M.P., Rea, M.C., Hill, C., Ross, R.P. (1996). An application in 
cheddar cheese manufacture for a strain of Lactococcus lactis 
producing a novel broad spectrum bacteriocin, lacticin 3147. 
Appl. Environ. Microbiol. 62, 612–619. 
 
Ryan, M.P.; Meaney,W.J.; Ross, P.R.and Hill, C. (1998). Evaluation of 
lacticin 3147 and a teat seal containing this bacteriocin for 
inhibition of mastitis pathogens. Appl. Environ. Microbiol. 64, 
2287–2290. 
 
Ryan, M. P.; Flynn, J.; Hill, C.; Ross, R. P. and Meaney, W. J. (1999). 
The natural food grade inhibitor, lacticin 3147, reduced the 
incidence of mastitis after experimental challenge with 
 231 
 
Streptococcus dysgalactiae in nonlactating dairy cows. J. Dairy Sci. 
82, 2625–2631.  
 
Ryan, M.P.; Hill, C. and Ross, R.P. (2002). Peptide Antibiotics: 
Discovery, Modes of Action and Applications. Pp. 193– 242 in: 
Exploitation of Lantibiotic Peptides for Food and Medical Uses 
(Dutton, C.J.; Haxell, M.A.; McAuthor, H.A.I. and Wax, R.G.,  
eds.), Marcel Dekker, New York. 
 
Sahl, H..G.; Kordel, M.and Benz, R. (1987). Voltage-dependent 
depolarization of bacterial membranes and artificial lipid 
bilayers by the peptide antibiotic nisin. Archives of Microbiology 
149, 120– 124. 
 
Samelis, J.; Roller, S. and Metaxopuolos, J. (1994). Sakacin B, a 
bacteriocin produced by Lactobacillus sake isolated from Greek 
dry fermented sausages. J. Appl. Bacteriol. 76, 475–486. 
 
SAS (1989). Release 6.11 of the SAS system for Windows. SAS Institute 
Inc., Cary, NC, U.S.A. 
 
Schamberger, G.P. and Diez-Gonzalez, F. (2004). Characterization of 
colicinogenic Escherichia coli strains inhibitory to 
enterohemorrhagic E. coli. J. Food Prot. 67, 486–492. 
 
 232 
 
Schamberger, G.P.; Phillips, R.L.; Jacobs, J.L. and Diez-Gonzalez, F. 
(2004). Reduction of Escherichia coli O157:H7 populations in 
cattle by feeding colicin E7-producing E. coli. Appl. Environ. 
Microbiol. 70, 6053–6060. 
 
Schillinger, U. and Lüke, F.K. (1987). Identification of lactobacilli 
from meat and meat products. Food Microbiol. 4, 199–208. 
 
Schillinger, U. and Lüke, F.K. (1989). Antibacterial activity of L. sake 
isolated from meat. Appl. Environ. Microbiol. 55, 1901-1906. 
 
Seigers, K. and Entian, K.D. (1995). Genes involved in immunity to 
the lantibiotic nisin produced by Lactococcus lactis 6F3. Appl. 
Environ. Microbiol. 61, 1082–1089. 
 
Settanni , L. , and Corsetti , A. ( 2008 ) Application of bacteriocins in 
vegetable food biopreservation . Int. J. Food Microbiol. 121 , 123 – 
138 . 
 
Shahidi, F. (1991). Developing alternative meat-curing systems. 
Trends Food Sci. Technol. 2, 219–222. 
 
Skytta, E.;  Hereijgers, W.; Mattila-Sandholm, T. (1991). Broad 
spectrum antibacterial activity of Pediococcus damnosus and 
 233 
 
Pediococcus pentosaseus in minced meat. Food Microbiol. 8, 231-
237. 
 
Smarda, J. and Obdrzalek, V. (2001) Incidence of colicinogenic strains 
among human Escherichia coli. J. Basic Microbiol. 41, 367–374. 
 
Sobrino, O.J.; Rodriguez, J. M.; Moreira, W. L.; Fernandez, M. F.; 
Bernabesanz, M. F. and Hernandez, P. E. (1991). Antibacterial 
activity of Lactobacillus sake isolated from dry fermented 
sausages. Int. J. Food Microbiol. 13, 1-10. 
 
Soomoro, A.H.; Masud, T. and Anwaar, K. (2002). Role of lactic acid 
bacteria (LAB) in food preservation and human health – a 
review. Pakistan Journal of Nutrition 1, 20-24. 
 
Sprules, T.; Kawulka, K. E. and Vederas, J. C. (2004). NMR solution 
structure of ImB2, a protein conferring immunity to 
antimicrobial activity of the type IIa bacteriocin, 
carnobacteriocin B2. Biochemistry 43(37), 11740–11749. 
 
Stachura, I.; McKinley, F.W.; Leidy, G. and Alexander, H.E. (1969). 
Incomplete bacteriophage-like particles in ultraviolet-irradiated 
haemophilus. J. Bacteriol. 98, 818–820. 
 
 234 
 
Stein, T.; Heinzmann, S.; Dusterhaus, S.; Borchert, S. and Entian, K.-
D. (2005). Expression and functional analysis of the subtilin 
immunity genes spaIFEG in the subtilin-sensitive host Bacillus 
subtilis MO1009. Journal of Bacteriology 187(3), 822–828. 
 
Stevens, K.A.; Sheldon, B.W.; Klapes, N.A. and Klaenhammer, T.R. 
(1991). Nisin treatment for the inactivation of Salmonella species 
and other Gram-negative bacteria. Appl. Environ. Microbiol. 57, 
3613-3615. 
 
Stevens, K.A.; Sheldon, B.W.; Klapes, N.A. and Klaenhammer, 
T.(1992). Effect of treatment conditions on nisin inactivation of 
Gram-negative bacteria. J. Food Prot. 55, 763–766. 
 
Stiles, M.E. and Hastings, J.W. (1991) Bacteriocin production by lactic 
acid bacteria: potential for use in meat preservation. Food Sci. 
Technol. 2, 235-263. 
 
Stiles, M.E.and Holzapfel, W.H. (1997). Lactic acid bacteria of foods 
and their current taxonomy. Int. J. Food Microbiol. 36, 1 – 29. 
 
Stoffels, G.; Nissen-Meyer, J.; Sletten, K. and Nes, I.F. (1992). 
Purification and characterization of a new bacteriocin isolated 
from a Camobacterium sp. Appl. Environ. Microbiol. 58, 1417-1422. 
 
 235 
 
Strauch, E.; Kaspar, H.; Schaudinn, C.; Damasko, C.; Konietzny, A.; 
Dersch, P.; Skurnik, M. and Appel, B. (2003). Analysis of 
enterocoliticin, a phage tail-like bacteriocin. Adv. Exp. Med. Biol. 
529, 249–251. 
 
Strompfova, V. and Laukova, A. (2007). In vitro study on  bacteriocin 
production of Enterococci associated with chickens. Anaerobe 
13,  228–237. 
 
 
Tagg, J.R. (1992). Bacteriocins of Gram-positive bacteria: an opinion 
regarding their nature, nomenclature and numbers. Pp 33–35 
in: Bacteriocins, Microcins and Lantibiotics. (James, R.; Lazdunski, 
C. and Pattus, F., eds). Springer, Berlin, Heidelberg, New York, 
NATO ASI Series vol H65. 
 
Tagg, J.R.. Dajani. A.S. and Wannamaker, L.W. (1976) Bacteriocins of 
Gram-positive bacteria. Bacteriologic. Rev. 40, 722- 756. 
 
Talarico , T.L. ; Axelsson , L.T.; Novotny , J. ; Fiuzat , M.  and 
Dobrogosz , W.J. ( 1990 ). Utilization of glycerol as a hydrogen 
acceptor by Lactobacillus reuteri : Purifi cation of 1,3 -
propanediol:NAD oxidoreductase. Appl. Environ. Microbiol.          
56 , 943 – 948 . 
 
 236 
 
Taylor, L.; Cann, D.D. and Welch, B.J. (1990). Antibotulin properties 
of nisin in fresh fish packaged in an atmosphere of carbon 
dioxide. J. Food Protect. 53, 953-959. 
 
ten Brink,B.; Minekus, M.; van der Vossen, J.M.B.M.; Leer, R.J. and 
Huis in’t Veld,J.H.J. (1994). Antimicrobial activity of lactobacilli: 
preliminary characterization and optimization of production of 
acidocin B, a novel bacteriocin produced by Lactobacillus 
acidophilus M46. J. Appl. Bacteriol. 77, 140–148. 
 
Thomas, T. D. and Crow, V. L. (1983).Mechanism of D-lactic acid 
formation in cheddar cheese. N. Z. J. Dairy Sci. Technol. 18, 131–
141. 
 
Thompson, J.K., Collins, M.A., Mercer,W.D. (1996). Characterization 
of a proteinaceous antimicrobial produced by Lactobacillus 
helveticus CNRZ 450. J. Appl. Bacteriol. 80, 338–348. 
 
Tichaczek, P.S.; Nissen-Meyer, J.; Nes, I.F.; Vogel, R.F. and Hammes, 
W.P. (1992). Characterization of the bacteriocins curvacin A 
from Lactobacillus curvatus  LTIH I I74 and sakacin P from L. sake 
LTH673. Sys. Appl. Microbiol. I5, 460 468. 
 
Tichaczek, P.S.; Vogel, R.F. and Hammes, W.P. (1994). Cloning and 
sequencing of sakP encoding sakacin P, the bacteriocin 
produced by Lactobacillus sake LTH 673. Microbiology 140, 361-
367. 
 
 237 
 
Timmerman, H.M.; Koning, C.J.; Mulder, L.; Rombouts, F.M. and 
Beynen, A.C. (2004). Monostrain, multistrain and multispecies 
probiotics: A comparison of functionality and efficacy. Int. J. 
Food. Microbiol. 96, 219–233. 
 
Todorov, S.D. and Dicks, L.M.T. (2004). Influence of growth medium 
on bacteriocin production by Lactobacillus pentosus ST112BR, a 
strain isolated from traditional South African beer. Pp 132-136 
in: Proceedings of National Conference.  Volume IV, Human 
Medicine. Part 1. Clinical and Molecular Biology, Microbiology. 
Physiology and Pharmacology. 3-4 June, 2004, Stara Zagora, 
Bulgaria. Publishing group: Stara Zagora Union of Scientists. 
 
Todorov, S.D. and Dicks, L.M.T. ( 2005,a). Pediocin ST18, an 
antilisterial bacteriocin produced by Pediococcus pentosaceus 
ST18 isolated from boza, a traditional cereal beverage from 
Bulgaria. Process Biochem. 40, 365–370. 
 
Todorov, S.D. and Dicks, L.M.T. (2005, b). Lactobacillus plantarum 
isolated from molasses produces bacteriocins active against 
Gram-negative bacteria. Enzyme and Microbial Technology 36, 
318–326. 
 
Todorov, S.D. and Dicks, L.M.T. (2007). Bacteriocin production by 
Lactobacillus pentosus st712bz isolated from boza. Brazilian 
Journal of Microbiology 38,166-172. 
 
 238 
 
Torreblanca, M.; Meseguer, I. and Ventosa, A. (1994). Production of 
halocin is a practically universal feature of archaeal halophilic 
rods. Lett. Appl. Microbiol. 19, 201–205. 
 
Upreti, G. C. and Hindsdill, R.D. (1975). Production and mode of 
action of lactocin 27; bacteriocin from a homofermentative 
Lactobacillus. Antimicrob. Agents Chemother. 7: 139-145. 
 
Valdes-Stauber, N. and Scherer, S. (1994). Isolation and 
characterization of Linocin M18, a bacteriocin produced by 
Brevibacterium linens. Appl. Environ. Microbiol. 60, 3809–3814.  
 
van Belkum, M.J.; Kok, J.; Venema, G.; Holo, H.; Nes, I.F.; Konings, 
W.N. and Abee, T. (1991). The bacteriocin Lactococcin A 
specifically increases the permeability of lactococcal 
cytoplasmic membranes in a voltage-independent, protein-
mediated manner. J. Bacteriol. 173, 7934-7941. 
 
Vandamme, P.; Pot, B.; Glllis, M.; de Vos, P.; Kersters, K. and Swings, 
J. (1996). Polyphasic taxonomy, a consensus approach to 
bacterial systematics. Microbiol. Rev. 60, 407-438. 
van Reenen, C.A.; Dicks, L.M.T. and Chikindas, M.L. (1998). Isolation, 
purification and partial characterization of plantaricin 423, a 
bacteriocin produced by Lactobacillus plantarum. J. Appl.  
Microbiol. 84, 1131–1137. 
 239 
 
Venema, K.; Abee, T.; Haandrikman, A.J.; Leenhouts, K.J.; Kok,  J.; 
Konings, W.N. and Venema, G. (1993). Mode of action of 
lactococcin B, a thiolo-activated bacteriocin from Lactococcus  
lactis. Appl. Environ. Microbiol. 59, 1041–1048. 
Venema, K.; Haverkort, R.E.; Abee, T.; Haandrikman, A.J.; Leenhouts, 
K.J.; de Leij, L.; Venema, G. and Kok, J. (1994). Mode of action of 
LciA, the lactococcin A immunity protein. Mol. Microbiol. 14, 
521–532. 
Venema, K.; Venema, G. and Kok, J. (1995). Lactococcal bacteriocins: 
mode of action and immunity. Trends Microbiol. 3, 299–304. 
Venema, K.; Chikindas, M.L.;  Seegers, J.F.M.L.;  Haandrikman, A.J.; 
Leenhouts, K.J.; Venema, G. and Kok,J. (1997). Rapid and 
efficient purification method for small, hydrophobic, cationic 
bacteriocins: Purification of lactococcin B and pediocin PA-1. 
Appl. Environ. Microbiol.  63, 305–309. 
Venema, G.; Kok, J. and van Sinderen, D.(1999). From DNA sequence 
to  application: possibilities and complications. Antonie van 
Leeuwenhoek 1-4, 3-26. 
Verellen, T.L.J.; Brugemann, G.; Van Reenen, C.A.; Dicks, I.M.T. and 
Vandamme, E.J. (1998). Fermentation optimization of 
plantaricin 423, a bacteriocin produced by Lactobacillus 
plantarum 423. J. Ferment. Bioeng. 86, 174-179. 
Verluyten, J.; Leroy, F. and De Vuyst, L. (2004). Influence of complex 
nutrient source on growth of and curvacin A production by 
 240 
 
sausage isolate Lactobacillus curvatus LTH 1174. Appl. Environ. 
Microbiol.  70: 5081–5088. 
Wachsman, M.B.; Castilla, V.; de Ruiz Holdago, A.P.; De Torres, R.A.; 
Sesma, F. and Coto, C.E. (2003). Enterocin CRL35 inhibits late 
stages of HSV-1 and HSV-2 replication in vitro. Antivir. Res. 58, 
17–24. 
WHO (World Health Organization). (1969). Specifications for Identity 
and Purity of some Antibiotics. World Health Organization/Food 
Add 69.34:53-67. 
Wolf, C.E. and Gibbons, W.R. (1996). Improved method for 
quantification of the bacteriocin nisin. J. Appl. Bacteriol. 80, 453–
457. 
Wood, B.J.B. and Holzapfel W.H. (1995). The Genera of Lactic Acid 
Bacteria. London, Blackie Academic and Professional. 
Young, L. L.; Reverie, R. D. and Cole, A. B. (1988). Freshred meats: A 
place to apply modified atmospheres. Food Technology, 42(9), 
64–66, 68–69. 
Yousef, A.E.; Luchansky, J.B.; Degnan, A.J. and Doyle, M.P. (1991). 
Behavior of Listeria monocytogenes in Wiener exudates in the 
presence of Pediococcus acidilactici or Pediocin AcH during 
storage at 4 or 25°C. Appl. Environ. Microbiol. 57, 1461-1467. 
Yuan, J.; Zhang, Z. Z.; Chen, X. Z.; Yang, W. and Huan, L. D. (2004). 
Site-directed mutagenesis of the hinge region of nisin Z and 
properties of nisin Z mutants. Applied Microbiology and 
Biotechnology, 64, 806–815.  
